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ABSTRACT	
Nephromyces,	a	genus	in	the	phylum	Apicomplexa,	has	recently	been	described	as	having	a	mutualistic	relationship	with	its	host:	tunicates	in	the	Molgulidae	family	(Saffo	et	al.	2010).	If	true,	Nephromyces	would	be	the	only	known	example	of	a	mutualistic	apicomplexan	genus.	In	addition	to	the	possible	switch	to	mutualism,	Nephromyces	is	one	of	a	few	apicomplexan	groups	containing	bacterial	endosymbionts.	To	test	the	hypothesis	that	endosymbiotic	bacteria	facilitated	the	transition	of	Nephromyces	from	parasitism,	the	metabolic	capabilities	of	Nephromyces	and	its	bacterial	endosymbionts	need	to	be	determined.	The	transition	from	obligate	parasite	to	endosymbiont	is	predicted	to	involve	different	selective	pressures	leading	to	wide	spread	genomic	changes.	Identifying	these	changes	will	lead	to	a	better	understanding	of	the	dynamics	between	the	different	biological	players	in	this	system.		Using	data	from	Illumina	HiSeq,	we	have	assembled	and	annotated	the	transcriptomes	of	Nephromyces	and	Cardiosporidium	cionae.	Using	data	from	a	combination	of	platforms;	Illumina	MiSeq,	HiSeq,	and	Pacific	Biosciences,	we	have	partially	assembled	a	pan-genome	for	Nephromyces	and	have	assembled	the	genomes	of	its	bacterial	endosymbionts.	Using	amplicon	sequencing,	we	have	estimated	the	genetic	diversity	and	prevalence	of	multispecies	infections	of	
Nephromyces	and	its	bacterial	endosymbionts	in	its	host	Molgula	manhattensis.	In	addition	to	the	implementation	of	next-generation	sequencing	technologies,	this	work	is	also	based	on	laboratory	cultures	and	species	isolation	experiments.	With	the	aforementioned	data	we	are	able	to	describe	the	transcriptome
of	Nephromyces	and	Cardiosporidium	as	well	as	the	genomes	of	all	three	bacterial	endosymbionts,	providing	a	basic	overview	of	the	metabolism	of	this	system.	
Nephromyces	and	Cardiosporidium	both	encode	a	complete	purine	degradation	pathway,	which	enables	them	to	break	uric	acid	into	pyruvate	and	glycine,	additionally	Nephromyces	is	also	able	to	create	malate	from	uric	acid.	This	could	represent	the	primary	route	of	carbon,	nitrogen	and	energy	acquisition	in	
Nephromyces.	The	genomes	of	the	bacterial	endosymbionts	are	severely	reduced,	but	relatively	enriched	for	vitamin	and	amino	acid	biosynthesis	(at	least	in	the	Betaproteobacteria	and	Bacteroidetes	symbionts).	It	is	likely	that	the	bacterial	endosymbionts	are	supplementing	vitamins	and	amino	acids	to	the	limited	diet	of	uric	acid	found	in	Nephromyces.	Our	amplicon	data	reveals	that	nearly	all	M.	
manhattensis	are	infected	with	multiple	species	of	Nephromyces.	The	community	of	Nephromyces	forms	a	tightly	integrated	system	of	metabolic	inter-dependencies	based	of	the	different	bacterial	endosymbionts.
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CHAPTER	1	
	
INTRODUCTION	
	Apicomplexa	is	a	large,	diverse	phyla	thought	to	be	composed	entirely	of	parasites	of	metazoans	(Morrison	2009).	It	is	believed	that	every	species	of	metazoan	is	host	to	at	least	one	species	of	apicomplexan	parasite.	Some	apicomplexans	are	of	particular	significance	to	humans	including	Plasmodium,	the	etiological	agent	of	malaria.	Plasmodium	is	estimated	to	have	driven	the	evolution	of	4.3	percent	of	the	human	genome	(Whitfield	2002;	McManus	et	al.	2017).	Another	apicomplexan	of	note	is	Toxoplasma,	which	is	able	to	infect	all	warm-blooded	animals	and	is	estimated	to	infect	a	third	of	the	global	human	population	(Wilking	et	al.	2016).	Cryptosporidium	is	a	waterborne	apicomplexan	responsible	for	90%	of	occurrences	of	severe	diarrhea	in	children	under	five,	and	a	continuing	challenge	for	municipal	water	treatment	(Sow	et	al.	2016).	In	addition	to	the	medical	significance	of		apicomplexans,	there	has	been	research	into	apicomplexans	on	the	effects	of	parasitism	on	an	organisms	genome,	due	to	their	long	700-900	million	year	history	as	a	lineage	of	obligate	parasites	(Kuo	et	al.	2008).			Obligate	parasites	face	different	challenges	than	free-living	organisms,	resulting	in	different	evolutionary	pressures	and	unusual	life	histories	as	well	as	dramatic	genomic	changes	in	parasitic	lineages	(Janouskovec	&	Keeling	2016).	One	of	the	problems	faced	by	parasites	is	the	host’s	immune	system.	The	need	to	evade	the	host’s	immune	system	results	in	a	complex	evolutionary	arms	race	
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between	host	and	parasite,	and	is	a	core	component	of	the	red	queen	hypothesis	(van	Valen	1973).	Apicomplexans	have	developed	numerous	and	diverse	strategies	for	evading	their	host’s	immune	system,	including	the	var	family	of	genes	in	Plasmodium.	Var	proteins	are	cell	surface	antigens	which	are	capable	of	reorganizing	into	a	wide	number	of	protein	conformations	to	keep	the	host	from	recognizing	the	infection	(Kyes	et	al.	2007).	Another	strategy,	used	by	
Toxoplasma	is	to	suppress	immune	response	by	silencing	signal	pathways	and	by	forming	the	latent	bradyzoite	cyst	stage,	which	causes	chronic	infection	(Blader	&	Saeij	2014).		In	addition	to	evasion	of	the	host’s	immune	system,	intracellular	parasites	have	ready	access	to	an	abundance	of	pre-formed	metabolites.	Access	to	these	pre-formed	metabolites	leads	to	one	of	the	most	common	and	pronounced	consequences	of	parasite	genome	evolution,	the	loss	of	many	basic	biosynthesis	pathways,	which	are	critical	in	free-living	organisms	(Janouskovec	&	Keeling	2016).	This	loss	of	biosynthesis	capabilities	is	particularly	pronounced	in	Apicomplexa.	Amino	acid	biosynthesis,	vitamin	and	cofactor	biosynthesis,	purine	synthesis,	purine	degradation,	and	fatty	acid	biosynthesis	have	all	been	lost	in	Apicomplexa	(Woo	et	al.	2015).	Because	these	losses	are	observed	throughout	the	phylum,	it	was	believed	that	these	losses	occurred	early	in	apicomplexan	evolution.	However,	there	has	been	a	recent	proposal	that	these	losses	are	a	continuous	gradual	process	(Zarowiecki	&	Berriman	2015).	In	either	case,	loss	of	biosynthetic	pathways	creates	a	dependence	on	the	host	for	not	only	primary	
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carbon	and	nitrogen,	but	also	a	dependence	on	salvaging	the	hosts	premade	metabolites.	This	has	led	to	a	number	of	intricate	and	elegant	strategies	for	host	manipulation.	As	a	consequence	of	the	extraction	of	nutrients	and	metabolites,	a	parasite’s	growth	and	reproduction	imposes	a	cost	to	their	host.	The	total	impact	on	the	host	by	the	parasite	is	known	as	virulence	(Read	1994).	If	a	parasite’s	virulence	is	too	great	the	host	will	die,	either	directly	due	to	the	parasite,	or	as	a	consequence	of	being	weakened;	i.e.,	the	host	is	too	weak	to	find	food,	the	host	becomes	easy	prey	for	predators,	or	the	weakened	immune	system	makes	the	host	vulnerable	to	other	pathogens.	If	the	host	dies	before	the	parasite	can	complete	its	life	cycle,	or	before	it	can	infect	a	new	host,	then	the	parasites	fitness	falls	to	zero.	This	leads	to	a	complex	balance	between	parasite	growth	and	transmission	to	a	new	host.	Factors	involved	in	transmission	and	virulence	include	host	genotype,	parasite	genotype,	host	health,	parasite	load,	as	well	as	external	factors	such	as	other	parasites	infecting	the	same	host	simultaneously	(Frank	1996a).	The	interplay	of	these	factors	creates	a	dynamic	relationship	between	host	and	parasite	and	has	led	to	a	wide	variety	of	strategies	(Alizon	et	al.	2009).	One	common	strategy,	adopted	by	many	parasite	species,	is	to	lower	their	virulence	to	the	host	(Cressler	et	al.	2016).	Parasites	often	achieve	this	by	lowering	their	reproduction	levels.	Lower	parasite	density	means	lower	virulence	to	the	host,	and	as	long	as	there	is	still	good	transmission	to	other	hosts,	this	low-density	strategy	is	often	successful.	A	different	strategy	is	
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exemplified	by	Plasmodium.	Plasmodium	merozoites	proliferate	within	the	host’s	liver	cells	through	schizogony	by	simultaneously	inhibiting	cell	death	(thereby	avoiding	immunity)	until	parasite	levels	are	high	enough	to	cause	cell	death,	releasing	release	sporozoites	into	the	bloodstream.	The	high	density	of	sporozoites	overwhelms	the	immune	system	and	creates	a	high	likelihood	that	a	mosquito	feeding	on	the	host	will	ingest	blood	with	sporozoites,	maximizing	transmission	success.	After	simultaneous	release	sporozoites	re-infect	the	liver	to	repeat	the	cycle	again.	This	cycle	causes	the	episodic	fevers	seen	in	malaria	patients.	The	episodic	overwhelming	of	the	host	immune	system	causes	the	high	virulence	found	with	Plasmodium	infections.	Plasmodium	falciparum	is	particularly	virulent,	even	among	Plasmodium	species.	Some	of	the	virulence	of	P.	
falciparum	has	been	attributed	to	the	large	number	of	other	human	parasites	found	in	the	same	locations.	With	the	presence	of	other	parasites	the	likelihood	of	multiple	parasitic	infections	increases,	which	then	leads	to	the	virulence	of	all	pathogens	present	being	cumulative.	Rather	than	a	long	sustained	infection	with	low	probability	of	transmission	over	a	longer	time,	with	the	possibility	of	host	death	from	other	pathogens,	P.	falciparum,	has	adopted	a	high	density,	high	virulence	infection	combined	with	periods	hidden	from	the	immune	system,	which	maximizes	transmission	over	a	short	period	of	time.							Although	transmission	strategies	are	diverse	there	are	predictable	patterns	of	a	disease’s	epidemiology	and	the	type	of	strategy	a	parasite	is	using.	Parasites	with	high	virulence	are	characterized	by	low	prevalence	in	a	population	
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or	by	low	prevalence	with	sporadic	outbreaks	(Frank	1996b).	Parasites	using	this	strategy	may	reach	high	cellular	densities	in	an	effort	to	maximize	transmission	before	the	host	dies.	Alternatively,	high-sustained	prevalence	in	a	host	population	indicates	low	virulence.	Parasites	using	this	strategy	often	maintain	low	cell	densities	with	lower	transmission	rates	over	a	longer	period	of	time.	Parasite	virulence	and	transmission	strategies	are	not	dichotomous,	but	rather	a	continuum.	Parasites	with	the	highest,	sustained	prevalence	being	the	least	virulent	and	parasites	with	the	lowest	prevalence	being	the	most	virulent.	Of	course	such	predictions	about	virulence	only	apply	to	parasites	that	have	co-evolved	with	their	host,	and	does	not	apply	to	parasites	infecting	a	new	or	incidental	host.	In	these	instances,	virulence	is	often	extremely	high	and	often	results	in	the	host	death	before	transmission,	leading	to	a	self-limiting	infection	pattern,	i.e.	Ebola	in	humans.	The	relationship	between	prevalence	and	virulence	is	important	for	this	work	because	Nephromyces	mutualistic	relationship	with	their	hosts,	Molgula	tunicates	was	solely	based	on	the	nearly	100%	year	round	infection	prevalence	(Saffo	et	al.	2010).		As	infection	prevalence	only	predicts	virulence,	and	not	host/endosymbiont	relationship,	this	characterization	may	have	been	unfounded	and	premature.	Characterization	of	mutualism	based	solely	on	infection	prevalence	for	Nephromyces	is	particularly	surprising,	because	it	becomes	the	only	mutualistic	genus	in	a	phylum	composed	entirely	of	parasites.	However,	there	are	other	indicators,	besides	prevalence,	suggesting	that	the	relationship	
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between	Nephromyces	and	its	host	is	unusual.	Unlike	other	pathogens	with	low	virulence,	Nephromyces	reaches	extremely	high	cell	densities	inside	its	host.	This	high	cell	density	becomes	apparent	when	you	compare	Nephromyces	to	its	closest	known	relative	Cardiosporidium	cionae,	a	blood	parasite	that	infects	a	number	of	solitary	tunicates	outside	of	the	Molgulidae	family	(Ciancio	et	al.	2008;	Kumagai	et	al.	2010).	As	with	Nephromyces,	C.	ciona	has	a	high	sustained	infection	prevalence	reaching	~95%	in	Ciona	intestinalis.	Such	high,	sustained	prevalence	indicates	that,	like	Nephromyces,	C.	ciona	is	largely	avirulent.	However,	
Nephromyces	reaches	over	an	order	of	magnitude	higher	cell	densities	than	Ciona.	In	two	such	closely	related	organisms	with	closely	related	hosts	with	similar	epidemiology	in	other	respects,	the	difference	in	relative	cell	densities	is	striking.		Typically,	the	higher	the	parasite	load	the	greater	the	virulence,	but	paradoxically	Nephromyces	can	remain	avirulent	and	reach	extremely	high	cell	densities.	Rather	than	focus	on	the	proposed	mutualistic	relationship	between	
Nephromyces	and	its	host,	which	remains	unclear,	this	work	will	focus	on	the	apparent	paradox	in	Nephromyces’	epidemiology.			In	order	to	consider	the	unusual	epidemiology	of	Nephromyces,	it	is	necessary	to	examine	its	other	life	history	traits.	The	phylum	Apicomplexa	has	a	tremendous	amount	of	variation	in	hosts,	cell	types	infected,	transmission	methods,	host	manipulation	strategies,	life	cycles,	reproduction,	and	morphology	(Roos	2005).	Even	with	so	much	diversity,	Nephromyces	stands	out	as	unusual	for	an	apicomplexan.	One	of	the	most	unusual	aspects	of	Nephromyces’	biology	is	
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where	it	lives.	Nephromyces	is	only	found	and	completes	its	entire	life	cycle	inside	the	renal	sac	(Saffo	1982).	Specifically,	Nephromyces	is	found	in	the	lumen	of	the	renal	sac	and,	unlike	other	apicomplexans,	is	extra-cellular,	with	no	part	of	its	life	cycle	inside	or	joined	to	its	host’s	cells.	The	renal	sac	is	a	large,	ductless,	structure	present	only	in	tunicates	in	the	Molgulidae	family	(Goodbody	1965).	The	function	of	the	renal	sac	has	not	been	determined,	and	despite	its	name,	the	renal	sac	does	not	function	as	a	typical	kidney	(Saffo	1978).	The	renal	sac	was	named	for	the	large	deposits	of	uric	acid	and	calcium	oxalate,	nitrogenous	compounds	that	are	the	major	constituents	of	kidney	stones	(Saffo	&	Lowenstam	1978).	Localized	deposits	of	uric	acid	are	not	exclusive	to	Molgula	tunicates	and	many	ascidians	have	crystallized	uric	acid	deposits	located	in	various	tissues,	but	the	deposits	in	
Molgula	are	by	far	the	largest	(Lambert	et	al.	1998).		Another	unusual	aspect	about	Nephromyces	is	the	presence	of	bacterial	endosymbionts.	Even	though	it	is	not	unusual	for	Eukaryotes	to	have	bacterial	endosymbionts,	it	is	unusual	in	the	phylum	Apicomplexa.	The	only	other	apicomplexan	known	to	harbor	a	bacterial	endosymbiont	is	C.	ciona.	Bacterial	endosymbionts	are	a	common	way	for	an	organism	to	add	novel	functionality	to	its	metabolism,	and	the	acquisition	and	maintenance	of	bacterial	endosymbionts	is	a	major	driver	of	eukaryotic	evolution	Prominent	examples	include	the	alphaproteobacterium	that	became	the	mitochondria	and	the	cyanobacterium	that	gave	rise	to	the	chloroplast	(John	&	Whatley	1975;	Mereschkowsky	1905).	More	recent	bacterial	endosymbionts	provide	their	hosts	with	a	wide	variety	of	
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metabolic	capabilities	including	vitamin	and	co-factor	biosynthesis,	amino	acid	biosynthesis,	methanogenesis,	photosynthesis,	and	protection	from	parasitoids.	(Moran	et	al.	2005;	Gijzen	et	al.	1991;	Marin	et	al.	2005;	Hansen	et	al.	2012).	These	functions	allow	their	hosts	to	colonize	new	habitats	and	take	advantage	of	novel	food	sources.		One	of	the	consequences	of	a	parasitic	lifestyle	is	the	loss	of	biosynthetic	capabilities,	and	bacterial	endosymbionts	can	supplement	a	host’s	metabolism.	It	was	hypothesized	that	Nephromyces	bacterial	endosymbionts	were	an	important	factor	in	Nephromyces’	colonization	of	the	renal	sac	and	its	paradoxical	epidemiology	(Saffo	et	al.	2010).	Therefore,	it	was	necessary	to	determine	how	
Nephromyces	bacterial	endosymbionts	were	contributing	to	the	host’s	metabolome.	One	hypothesis	suggested	that	bacterial	endosymbionts	of	
Nephromyces	are	capable	of	degrading	the	abundant	amounts	of	uric	acid	in	the	renal	sac(Saffo	et	al.	2010).	The	degradation	of	uric	acid	was	also	proposed	as	the	host	benefit	that	made	Nephromyces	mutualistic	instead	of	parasitic.					A	previous	study	had	found	three	different	bacterial	endosymbionts	in	
Nephromyces:	an	alphaproteobacteria,	a	betaproteobacteria,	and	a	bacteroidetes	(Seah	et	al.	2011).	This	study	also	detailed	how	these	different	bacterial	endosymbionts	were	never	found	together	in	the	same	Nephromyces	cell.	No	explanation	of	how	a	species	of	a	single-celled	organism	could	maintain	three	different	endosymbionts	without	the	endosymbionts	ever	being	together	was	given.	What	this	study	failed	to	recognize	is	there	were	multiple	species	of	
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Nephromyces	inside	the	same	renal	sac,	and	that	different	Nephromyces	species	contained	a	single	type	of	bacterial	endosymbiont	(Chapter	4).		Organisms	harboring	multiple	endosymbionts	are	not	uncommon	(Bennett	&	Moran	2013;	Moran	et	al.	2008;	Gruwell	et	al.	2010).	Many	organisms	that	are	dependent	on	bacterial	endosymbionts	contain	two	or	three	different	endosymbionts.	Multiple	endosymbionts	are	often	required	due	to	the	evolutionary	consequences	of	a	free-living	bacteria	becoming	an	endosymbiont	(Wernegreen	2017,	2015;	Mccutcheon	&	Moran	2011;	Moran	1996).	One	driver	of	bacterial	endosymbionts’	evolution	is	a	tiny	population	size	relative	to	free-living	bacterial.	Another	is	when	only	a	few,	or	just	a	single	bacterium,	is	vertically	transmitted	to	subsequent	host	generations.	Small	population	size,	coupled	with	extreme	bottlenecks	repeated	every	host	generation,	produces	profound	effects	from	genetic	drift	and	results	in	an	accelerated	Muller’s	ratchet	(Moran	1996).	One	of	the	consequences	of	the	accelerated	Muller’s	ratchet	on	bacterial	endosymbionts	is	a	severe	reduction	of	all	non-essential	genes.	Some	of	the	genes	commonly	lost	are	DNA	repair	genes	(Kuwahara	et	al.	2007).	The	loss	of	DNA	repair	genes	combined	with	the	effects	of	genetic	drift	leads	to	high	mutation	rates,	a	low	ratio	of	synonymous/non-synonymous	mutations,	and	an	AT	bias.	Over	time	this	results	in	endosymbiont	genomes,	which	are	small,	gene	poor,	and	AT	rich	(Moran	2002).		The	genomic	instabilities	of	bacterial	endosymbionts	can	quickly	make	them	a	burden	and	a	liability	to	the	host.	As	bacterial	endosymbionts	decrease	in	
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function,	the	host	must	support	their	symbionts	to	a	greater	and	greater	degree.	If	a	host	is	dependent	on	their	symbionts,	this	can	result	in	reduced	fitness	if	the	endosymbiont	requirements	outpace	the	host’s	ability	to	meet	them.	A	common	solution	to	the	problem	of	symbiont	degradation	is	acquiring	additional	bacterial	endosymbionts.	In	such	cases	either	the	original	bacterial	endosymbiont	is	replaced	in	favor	of	the	new	endosymbiont,	or	both	bacterial	endosymbionts	can	be	maintained	together	(McCutcheon	&	Moran	2007).	When	both	bacterial	endosymbionts	are	retained,	the	metabolisms	of	the	bacterial	endosymbionts	can	become	tightly	intertwined.	One	such	example	from	McCutcheon	and	Moran	(2007)	involves	the	endosymbionts	of	the	glassy	winged	sharpshooter	
Homalodisca	vitripennis,	which	maintains	two	bacterial	endosymbionts	Sulcia	
muelleria	and	Baumannia	cicadellinicola.	These	two	endosymbionts	show	tight	metabolic	integration,	with	S.	muelleria	capable	of	biosynthesizing	8	of	10	essential	amino	acids,	menaquinone,	and	fabF	for	fatty	acid	biosynthesis.	
Baumannia	cicadellinicola	is	capable	of	biosynthesizing	the	remaining	two	essential	amino	acids,	a	number	of	vitamins	and	cofactors,	but	not	menaquinone,	and	has	the	rest	of	the	genes	needed	for	fatty	acid	biosynthesis	except	fabF	(McCutcheon	&	Moran	2007).			The	genus	Nephromyces	contains	three	different	bacterial	endosymbionts,	and	although	all	three	types	of	bacterial	endosymbiont	are	regularly	found	in	the	same	renal	sac,	no	species	of	Nephromyces	is	known	to	contain	more	than	one	type	of	bacterial	endosymbiont.	It	is	currently	unknown	if	the	different	
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endosymbionts	are	providing	the	same	metabolic	functions	or	not.	If	the	bacterial	endosymbionts	are	providing	different	functions,	it	is	unclear	if	there	is	any	interaction	between	the	endosymbionts,	as	is	seen	in	H.	vitripennis.	A	significant	difference	between	the	two	systems	is	that	H.	vitripennis	contains	multiple	symbionts,	and	Nephromyces	only	contain	one	endosymbiont	per	organism.	Given	the	very	different	habitats	of	Cardiosporidium	and	Nephromyces	and	the	rarity	of	endosymbionts	in	apicomplexans,	it	seemed	likely	that	the	bacterial	endosymbionts	might	have	contributed	to	Nephromyces	ability	to	colonize	the	renal	sac	and	even	to	the	unusual	epidemiology	of	Nephromyces.				 In	order	to	explore;	one,	how	Nephromyces	is	able	to	remain	avirulent	and	reach	such	high	cell	densities,	two,	how	Nephromyces	was	able	to	thrive	in	the	unusual	renal	sac	environment,	three,	what	the	relationship	between	
Nephromyces	and	its	host	is,	four,	determine	what	effects	this	possibly	mutualistic	relationship	had	on	Nephromyces	genome,	five,	the	role	of	the	bacterial	endosymbionts,	and	six,	the	differences	between	Nephromyces	and	other	apicomplexans,	we	used	a	combination	of	next	generation	sequencing,	culturing,	and	amplicon	sequencing.	Using	Illumina	HiSeq	we	sequenced	and	assembled	the	transcriptomes	of	Nephromyces,	Cardiosporidium,	their	respective	bacterial	endosymbionts,	Molgula	manhattensis,	and	Ciona	intestinalis	(Chapter	2).	Using	a	combination	of	Illumina	MiSeq,	HiSeq,	and	Pacific	Biosciences	we	sequenced	and	partially	assembled	Nephromyces	genome,	and	assembled	two	of	Nephromyces	bacterial	endosymbionts	genomes	(alphaproteobacteria	and	bacteroidetes)	
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(Chapter	3).	Using	amplicon	sequencing	targeting	18s	rRNA,	16s	rRNA,	and	COI,	we	identified	the	diversity	of	Nephromyces	and	its	bacterial	endosymbionts	(Chapter	4).	With	these	data,	in	combination	with	culturing	and	isolation	experiments,	we	were	able	to	make	substantial	progress	on	characterizing	the	biology	of	both	Nephromyces	and	Cardiosporidium,	as	well	as	their	bacterial	endosymbionts.	This	includes	the	unusual	epidemiology,	how	Nephromyces	survives	in	the	renal	sac,	the	role	of	the	bacterial	endosymbionts,	and	how	
Nephromyces	compares	to	Cardiosporidium	and	other	apicomplexans.	In	addition,	we	have	uncovered	some	unexpected	results,	including	a	highly	unusual	basis	for	an	apicomplexan	metabolism	and	genus	specific	co-dependent	species	complex.			
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Chapter	2	
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CHAPTER	2	
Abstract	The	Phylum	Apicomplexa	is	a	quintessentially	parasitic	lineage,	whose	members	infect	a	broad	range	of	animals.	One	exception	to	this	may	be	the	apicomplexan	genus	Nephromyces,	which	has	been	described	as	having	a	mutualistic	relationship	with	its	host.	Here	we	analyze	transcriptome	data	from	Nephromyces	and	its	parasitic	sister	taxon,	Cardiosporidium,	revealing	an	ancestral	purine	degradation	pathway	thought	to	have	been	lost	early	in	apicomplexan	evolution.	The	predicted	localization	of	many	of	the	purine	degradation	enzymes	to	peroxisomes,	and	the	in	silico	identification	of	a	full	set	of	peroxisome	proteins,	indicates	that	loss	of	both	features	in	other	apicomplexans	occurred	multiple	times.	The	degradation	of	purines	is	thought	to	play	a	key	role	in	the	unusual	relationship	between	Nephromyces	and	its	host.	Transcriptome	data	confirm	previous	biochemical	results	of	a	functional	pathway	for	the	utilization	of	uric	acid	as	a	primary	nitrogen	source	for	this	unusual	apicomplexan.			Key	words:	Apicomplexan,	tunicates,	Peroxisomes,	Purine	degradation,	
Nephromyces,	Cardiosporidium		
Introduction	Apicomplexans	are	most	well	known	for	being	parasites	of	humans	and	livestock.	Species	in	the	genus	Plasmodium,	for	instance,	are	the	etiological	agents	of	malaria.	Apicomplexan	species	show	tremendous	variation	in	transmission	
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methods,	life	cycles,	host	range,	host	manipulation	strategies,	cell-types	infected,	metabolic	capabilities,	immune	evasion	strategies,	and	virulence	(Roos	2005;	Reid	et	al.	2012;	Kemp	et	al.	2013;	Cardoso	et	al.	2016).	Because	of	this	variability,	there	are	few	apicomplexan	characteristics	shared	throughout	the	phylum.	Among	the	few	universal	apicomplexan	features	are	a	parasitic	life-history	and	an	inability	to	degrade	purines	(Janouskovec	&	Keeling	2016).	
Nephromyces,	a	derived	apicomplexan	genus	of	uncertain	phylogenetic	placement,	appears	to	be	an	exception	to	both	of	these	traits.			
Nephromyces	was	misclassified	as	a	fungus	for	more	than	a	100	years,	based	on	long	hyphal-like	cell	structures,	flagellated	spores	interpreted	by	some	as	chytrid	zoospores	and	cell	walls	made	of	a	chitin	(Giard	1888).	It	was	not	until	the	application	of	molecular	methods	that	Nephromyces	was	confirmed	as	a	member	of	the	derived	apicomplexans	(Saffo	et	al.	2010).	Although	some	analyses	have	tentatively	placed	it	sister	to	adeleids,	coccidia,	or	piroplasmida,	the	precise	phylogenetic	position	of	Nephromyces	remains	unresolved	(Saffo	et	al.	2010;	Janouškovec	et	al.	2015).	Nephromyces	species	are	monoxenous	(infecting	a	single	host)	and	are	found	exclusively	in	the	Molgulidae	family	of	tunicates	(Saffo	&	Davis	1982).	In	a	phylum	composed	of	obligate	parasites,	the	feature	that	distinguishes	Nephromyces	is	its	apparent	mutualistic	relationship	with	its	tunicate	hosts.	The	mutualistic	relationship	has	been	inferred	based	primarily	on	the	nearly	100%	infection	rate	and	lack	of	clearance	from	the	host	(	Saffo	1978,	1988,	1990,	Saffo	et	al.	2010).		We	use	this	label	with	caution,	given	how	complex	
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host-symbiont	dynamics	can	be,	how	the	costs	and	benefits	of	both	“harmful”	and	“beneficial”	symbioses	can	be	difficult	to	determine,	and	how	they	can	vary	with	genomic	changes	in	hosts	and	symbionts	(Leung	&	Poulin	2008;	Saffo	2104;	Mushegian	&	Ebert	2016).		A	shift	in	lifestyle	from	obligate	parasite	to	mutualistic	symbiont	is	quite	rare,	and	completely	unknown	from	deep	within	a	eukaryotic	lineage	with	such	a	long	evolutionary	history	of	parasitism.	One	common	consequence	of	a	parasitic	lifestyle	is	a	loss	of	genes	essential	to	free	living	organisms	(Greganova	et	al.	2013;	Janouškovec	et	al.	2015;	Zarowiecki	&	Berriman	2015;	Petersen	et	al.	2015).	In	an	intracellular	environment,	if	precursor	molecules	can	be	scavenged,	there	is	less	selective	pressure	to	maintain	biosynthesis	pathways,	and	many	are	consequently	lost	(Keeling	2004;	Sakharkar	et	al.	2004;	Morrison	et	al.	2007).	In	phyla	such	as	Apicomplexa,	these	losses	can	be	extreme	and	over	half	of	the	genes	found	in	their	photosynthetic	sister	group,	chromerids,	have	been	lost	in	apicomplexans	(Woo	et	al.	2015).		With	so	many	basic	metabolic	functions	lost,	and	with	such	dependence	on	the	host,	it	is	difficult	to	see	how	the	relationship	between	host	and	parasite	could	change	to	a	mutualistic	interaction.	However,	one	way	for	an	organism	to	rapidly	change	its	metabolic	capabilities	is	to	take	on	a	bacterial	symbiont.	
Nephromyces	has	done	just	that,	leading	to	the	hypothesis	that	bacterial	endosymbionts	inside	Nephromyces	perform	some	of	the	metabolic	functions	lost	in	Apicomplexa,	and	potentially	contribute	something	beneficial	to	the	tunicate	
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host	(Saffo	1990;	Saffo	et	al.	2010).	Bacterial	endosymbionts	are	common	across	the	tree	of	life	(although	rare	in	apicomplexans)	and	perform	a	wide	variety	of	functions	for	their	hosts	(Nowack	&	Melkonian	2010).	These	include	amino	acid	metabolism	and	vitamin	metabolism	(Moran	et	al.	2005),	nitrogen	metabolism	(Lopez-Sanchez	et	al.	2009),	defense	(De	Souza	et	al.	2009),	chemotrophic	energy	production	(Urakawa	et	al.	2005),	and	photosynthesis	(Marin	et	al.	2005),	to	name	a	few.	A	tempting	hypothesis	for	the	functional	role	of	Nephromyces	bacterial	endosymbionts	is	the	break	down	of	purines	to	urea	in	the	purine	degradation	pathway	(Saffo	1990).	In	support	of	this	hypothesis	Nephromyces	infected	tunicates	have	quite	high	levels	of	the	enzyme	urate	oxidase,	which	catalyzes	conversion	of	uric	acid	to	5-hydroxyisourate,	but	the	enzyme	is	undetectable	in	uninfected	tunicates	(Mahler	et	al.	1955;	Saffo	1988).	Coupled	with	the	fact	that	all	known	apicomplexans	and	tunicates	have	lost	the	purine	degradation	pathway,	these	data	were	suggestive	of	a	bacterial	contribution	to	purine	degradation.			In	a	yet	unexplained	quirk	of	tunicate	biology,	many	tunicate	species	have	localized	deposits	of	uric	acid	(Lambert	et	al.	1998;	Saffo	&	Lowenstam	1978;	Goodbody	1965).	Storage	as	a	form	of	excretion,	nitrogen	storage	for	future	release,	and	structural	support,	are	among	the	proposed	functions	of	tunicate	urate	deposits	(Goodbody	1965;	Saffo	1988;	Lambert	et	al.	1998).	Tunicates	in	the	Molgulidae	family	have	the	largest	uric	acid	deposits,	which	are	localized	to	a	
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specialized,	ductless	structure,	called	a	renal	sac	(Saffo	&	Lowenstam	1978).	These	uric	acid	deposits	occur	regardless	of	infection	status,	indicating	a	tunicate	origin	of	these	purine	deposits.	Despite	the	name,	the	renal	sac	has	many	features	(most	notably,	the	absence	of	any	ducts	or	macroscopic	openings)	atypical	for	an	excretory	organ,	and	its	biological	function	has	yet	to	be	determined.	
Nephromyces	infects	feeding	molgulid	tunicates	after	the	post-metamorphic	onset	of	host	feeding	and	completes	its	entire	lifecycle	within	the	renal	sac.	Four	factors	led	to	the	conclusion	that	the	bacterial	endosymbionts	within	Nephromyces	are	the	source	of	urate	oxidase	activity	in	this	system:	1)	the	colonization	of	
Nephromyces	within	a	structure	with	high	concentrations	of	urate,	2)	the	absence	of	urate	oxidase	activity	in	the	molgulid	hosts	(Saffo,	1988,	1991),	3)	the	high	urate	oxidase	activity	found	in	Nephromyces		(including	its	bacterial	symbionts:	Saffo,	1988,	1991),	coupled	with	4)	the	lack	of	obvious	ultrastructural	evidence	of	peroxisomes	in	Nephromyces		(Saffo,	1990).		It	is	logical	to	think	that	the	addition	of	bacterial	endosymbionts	to	
Nephromyces	might	have	been	key	to	colonizing	this	novel	purine–rich	niche,	and	is	how	Nephromyces	escaped	the	“evolutionary	dead	end”	of	a	parasitic	lifestyle.		In	order	to	test	this	directly,	and	examine	the	metabolic	relationships	between	the	tunicate	host,	Nephromyces,	and	its	bacterial	endosymbionts,	we	sequenced	the	community	transcriptome.	To	identify	possible	evolutionary	or	physiological	changes	involved	in	coevolution	of	Nephromyces	with	its	molgulid	hosts,	we	also	sequenced	the	transcriptome	of	a	sister	taxon	of	Nephromyces,	Cardiosporidium	
 19 
cionae	(Ciancio	et	al.,	2008;	Saffo	et	al.,	2010),	an	apicomplexan	parasite	found	in	the	blood	in	a	broad	range	of	non-molgulid	ascidian	hosts,	including	Ciona	
intestinalis,	Styela	clava,	Halocynthia	roretzi,	and	Ascidiella	aspersa	(Ciancio	et	al.	2008;	Dong	et	al.	2006).	Interestingly,	Cardiosporidium	cionae	also	harbors	bacterial	endosymbionts,	which	allows	for	a	more	direct	comparison	between	
Nephromyces	and	Cardiosporidium.	Here	we	confirm	the	exceptionally	high	levels	of	urate	oxidase	activity	in	tunicates	with	Nephromyces,	and	extend	this	result	to	include	high	expression	levels	of	all	the	genes	in	the	purine	degradation	pathway	(xanthine	dehydrogenase,	urate	oxidase,	5-hydroxyisourate	hydrolase,	2-oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline	decarboxylase,	and	allantoinase).	The	breakdown	of	purines	starts	by	conversion	to	xanthine.	Xanthine	then	enters	the	ureide	pathway	and	the	enzyme	xanthine	dehydrogenase	catalyzes	the	reaction	of	xanthine	to	urate	(Xi	et	al.	2000;	Nishino	et	al.	2008).	Urate	oxidase	catalyzes	the	oxidation	of	uric	acid	to	5-hydroxyisourate.	Following	conversion	the	enzyme	5-hydroxyisourate	hydrolase	catalyzes	5-hydroxyisourate	to	5-hydroxy-2-oxo-4-ureido-2,5-dihydro-1H-imidazole-5-carboxylate	(Kahn	&	Tipton	1998).	This	is	further	processed	into	(s)-allantoin	by	the	enzyme	2-oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline	decarboxylase	(Jung	et	al.	2006).	Allantoinase	catalyzes	(s)-allantoin	into	allantoate.	From	this	point	there	are	a	few	different	pathways	with	different	endpoints	that	organisms	are	able	to	shuttle	allantoate	to	(Cusa	et	al.	1999).	A	common	end	point	is	to	process	allantoate	into	urea	and	
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ureidoglycolate,	to	be	further	converted	into	carbon	dioxide	and	ammonia.	Alternatively,	ureidoglycolate	can	be	converted	to	glyoxylate,	or	the	urea	may	be	excreted	as	waste	(Schultz	et	al.	2001;	Werner	et	al.	2009).	We	confirm	that	all	the	genes	necessary	for	purine	degradation	are	encoded	by	Nephromyces	and	Cardiosporidium,	and	not	their	endosymbiotic	bacteria.	Whereas	the	expression	of	urate	oxidase	by	Nephromyces	and	
Cardiosporidium	is	unexpected,	a	parallel	issue	is	where	the	urate	oxidase	is	physically	located	in	the	cell,	given	that	apicomplexans	reportedly	lack	peroxisomes	(Schlüter	et	al.	2006).	Urate	oxidase	activity	is	restricted	to	peroxisomes	in	eukaryotes,	due	to	the	numerous	toxic	byproducts	that	are	produced	in	the	break	down	of	uric	acid.	Research	into	peroxisomes	in	Apicomplexa	has	a	complex	and	contradictory	history,	with	studies	reporting	both	the	presence	(Kaasch	&	Joiner	2000;	Gabaldon	et	al.	2016)	and	absence	(Ding	et	al.	2000;	Schlüter	et	al.	2006;	Gabaldon	2010)		of	peroxisomes	in	Apicomplexa.	Recent	work	by	Moog	et.	al	(2017)	and	Ludewig-Klingner	et	al.	(2018)	demonstrates	compelling	support	for	peroxisomes	in	coccidians.	Both	studies	present	comprehensive	bioinformatic	(and	also	proteomic,	in	part)	evidence	for	the	presence	of	peroxisomal	biogenesis	factors	(peroxins)	and	typical	peroxisomal	metabolic	enzymes	(including	predicted	relevant	targeting	signals)	in	coccidians	(Moog	et	al.	2017;	Ludewig-Klingner	et	al.	2018).	However,	neither	paper	provides	explicit	experimental	evidence	(for	example,	microscopic)	for	the	formation	of	peroxisomes	in	these	organisms.	Although	direct	evidence	is	
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still	absent,	both	studies	point	to	(Lige	et	al.	2009)and	their	identification	of	peroxisome-like	vesicles	in	T.	gondii,	for	possible	microscopic	support.	Our	data	demonstrate	that	Nephromyces	encodes	a	complete	purine	degradation	pathway	and	a	number	of	proteins	predicted	to	be	targeted	to,	or	involved	in,	peroxisome	biogenesis,	maintenance	and	protein	import,	providing	novel	support	of	peroxisomes	in	Apicomplexa.	Additionally,	we	propose	the	functional	significance	of	purine	degradation	in	Nephromyces,	and	reject	the	hypothesis	that	bacterial	endosymbionts	facilitated	an	escape	from	parasitism	by	providing	genes	in	the	purine	degradation	pathway.		
Methods	
Molgula	manhattensis	collection	and	laboratory	culture	
Molgula	manhattensis	tunicates	were	collected	from	a	dock	in	Greenwich	Bay,	Rhode	Island	(41°39'22.7"N	71°26'53.9"W)	on	July	2014.	For	transcriptomic	analysis,	a	single	renal	sac	was	separated	from	one	tunicate,	and	all	extraneous	tissue	removed.	The	intact	renal	sac	was	placed	in	liquid	nitrogen	for	5	min	and	then	stored	at	-80°C	for	later	RNA	extraction.	Gonads	were	dissected	from	five,	sexually	mature,	M.	manhattensis,	collected	from	the	same	population	in	Greenwich	Bay,	Rhode	Island	August	2014.	Eggs	and	sperm	were	mixed	with	sterile	seawater	and	divided	evenly	between	two	petri	dishes.	Plates	were	incubated	at	room	temperature	for	two	days	with	daily	100%	water	changes.	Tunicate	larvae	attached	to	the	bottom	and	sides	of	the	petri	dishes	by	day	three.	
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By	day	four,	larvae	had	metamorphosed	into	adults	and	were	actively	feeding.	Plates	were	moved	to	an	incubator	at	18°	C	with	a	24	hr.	dark	cycle	to	limit	growth	of	contaminants.	Tunicates	were	fed	by	100%	water	exchange	with	cultures	of	Isochrysis	galbana	and	Chaetoceros	gracilis	three	days	a	week.	After	several	weeks	tunicates	were	moved	to	aerated	beakers	to	meet	their	increased	nutrient	and	gas	exchange	requirements.	Feeding	regimen	remained	the	same	except	that	food	volume	was	increased	with	tunicate	growth.	Tunicates	were	grown	for	six	months	until	they	were	~10mm	across.	Each	renal	sac	was	placed	into	a	1.5ml	Eppendorf	tube	and	flash	frozen	in	liquid	nitrogen.	PCR	screens	confirmed	Nephromyces	was	absent	from	lab-raised	individuals.	Lab	grown	tunicates	were	split	into	two	groups.	Renal	sacs	were	harvested	from	three	tunicates	to	use	as	transcriptome	controls.	A	second	group	was	infected	with	
Nephromyces	oocysts.	Oocysts	were	collected	from	a	wild	M.	manhattenensis	and	serially	diluted	by	50x	to	limit	co-infections	from	multiple	species,	and	raised	for	genomic	analysis.		
Cardiosporidium	cionae	collection,	isolation	and	concentration	
Ciona	intestinalis	were	collected	from	docks	in	Snug	Harbor	RI	(41.3890°	N,	71.5201°	W),	in	August	2017.	Tunics	were	removed	and	the	body	wall	was	opened	to	allow	access	to	the	heart.	A	sterile	syringe	was	used	to	remove	cardiac	blood	as	cleanly	as	possible.	Blood	was	kept	at	4°	C	until	Cardiosporidium	infection	was	verified	using	Giemsa	stain	to	visualize	Cardiosporidium.	Heavily	
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infected	samples	were	pooled	together	and	centrifuged	at	500	g	for	5	minutes.	The	resulting	supernatant	was	removed	and	the	samples	were	frozen	in	liquid	nitrogen	and	stored	at	-80°	C.	Samples	with	low	rates	of	infection	were	enriched	for	Cardiosporidium	using	sucrose	gradients	(Ogedengbe	et	al.	2015;	Arrowood	and	Sterling	2016).	Gradients	of	20,	25,	30,	35,	40%	sucrose	solutions	in	phosphate	buffer	were	layered	together.	Approximately	5	ml	of	tunicate	blood	was	added	to	the	column	and	centrifuged	at	500	g	for	30	mins	at	4°	C.	The	25%	and	30%	layers	were	collected	(based	on	visual	screens	showing	high	
Cardiosporidium	cell	density	and	low	tunicate	cell	density),	washed	in	PBS,	pelleted	and	then	frozen	in	liquid	nitrogen	and	stored	at	-80°	C.			RNA	Extraction	RNA	extraction	buffer	(Zymo	Research	LLC.	Irvine,	CA)	was	added	to	samples	and	ground	with	a	pestle.	Following	grinding,	the	Zymo	Quick-RNA	kit	(Zymo	Research	LLC.	Irvine,	CA)	was	used	and	the	manufacturer’s	protocol	was	followed.	RNA	was	converted	to	cDNA	and	sequenced	at	the	School	of	Medicine	Genome	Resource	Center,	University	of	Maryland.	Five	separate	paired-end	RNA	libraries	(two	from	infected	renal	sac,	and	three	uninfected	renal	sac)	were	multiplexed	on	one	lane	of	the	Illumina	HiSeq	platform,	resulting	in	326,299,923;	327,957,761	and	316,754,780	reads	for	the	three	renal	sacs	without	
Nephromyces,	and	40,606,230	from	the	wild	M.	manhattensis	renal	sac.	For	
Cardiosporidium,	three	samples	of	C.	intestinalis	blood	were	used:	one	with	
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unseparated	blood,	one	enriched	with	cells	collected	at	the	25%	sucrose	gradient,	and	one	enriched	with	cells	from	the	30%	sucrose	gradient	were	multiplexed	on	one	lane	of	the	Illumina	HiSeq	platform,	resulting	in	92,250,706;	109,023,104	and	110,243,954	respectively.	Transcriptome	data	was	assembled	and	proteins	were	predicted	with	the	Trinity/Trinotate	pipeline	version	2.4.0	run	on	the	server	at	Brown	University	Center	for	Computation	and	Visualization	(Haas	et	al.	2014).	Reads	assembled	into	115,457;	388,535	109,446	contigs	from	infected,	uninfected	samples,	and	C.	intestinalis	respectively.		Protein	sequences	were	predicted	using	Transdecoder	(Haas	et	al.	2014).	Transcriptome	completeness	was	assessed	with	Busco	v3	against	the	Eukaryotic	reference	data	sets	(Simão	et	al.	2015).	Genomic	DNA	Extraction		The	renal	sacs	from	8	lab	grown	M.	manhattensis	individuals	were	dissected	and	their	renal	fluid	was	pooled	in	a	1.5ml	Eppendorf	tube.	Contents	were	centrifuged	at	8000	g	for	5	min	to	pellet	Nephromyces	cells,	and	following	centrifugation	the	renal	fluid	was	discarded.	Five	hundred	microliters	of	CTAB	buffer	with	5ul	of	proteinase	K	and	ceramic	beads	were	added	to	the	pelleted	
Nephromyces	cells.	The	sample	was	placed	in	a	bead	beater	for	3	min.	and	then	on	a	rotator	for	1.5hrs	at	room	temp.	Five	hundred	microliters	of	chloroform	was	added,	mixed	gently	and	centrifuged	for	5	min.	The	top	layer	was	removed	and	2x	the	sample	volume	of	ice	cold	100%	EtOH	and	10%	sample	volume	of	3M	sodium	acetate	were	added	to	the	sample	and	incubated	a	-20oC	overnight.	The	sample	
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was	centrifuged	at	16000Xg	for	30min.	and	the	liquid	was	removed.	Ice	cold	70%	EtOH	was	added	and	centrifuged	at	16000xg	for	15min.	Liquid	was	removed	and	sample	air	dried	for	2	min.	DNA	was	re-eluted	in	50ul	of	deionized	water.		Illumina	Sequencing	A	nanodrop	(2000c,	ThermoScientific)	was	used	to	assess	DNA	purity	and	DNA	concentration,	and	an	agarose	gel	was	run	to	assess	genomic	DNA	fragmentation.	Following	quality	control,	an	Illumina	library	was	constructed.	Library	prep	and	sequencing	were	done	at	the	URI	Genomics	and	Sequencing	Center	(URIGSC).	The	completed	library	was	sequenced	on	the	Illumina	MiSeq	platform	at	the	URIGSC	and	the	HiSeq	platform	at	the	University	of	Baltimore	sequencing	center	on	three	lanes.		Pacific	Biosciences	Sequencing	Using	the	contents	of	150	(done	in	batches	of	10	then	pooled)	M.	
manhattensis	renal	sacs,	the	same	DNA	extraction	protocol	was	performed	as	for	Illumina	sequencing.	DNA	was	sequenced	using	three	SMRT	cells	on	the	Pacific	Biosciences	platform	at	the	University	of	Baltimore	sequencing	center.	Illumina	sequence	data	assembly	One	MiSeq	lane	and	three	lanes	of	HiSeq,	all	from	the	same	library,	were	trimmed	using	Trimmomatic	(Bolger	et	al.	2014)	and	then	assembled	using	Spades		assembler	(Bankevich	et	al.	2012)	on	the	URI	server	BlueWaves.			Pacific	Biosciences	sequence	data	assembly	Pacific	Biosciences	reads	were	error	corrected	using	pbsuite/15.8.24	
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(English	et	al.	2012)	on	the	Brown	University	server,	Oscar.	Reads	were	then	assembled	using	Canu	(Koren	et	al.	2014).	Contigs	generated	by	Canu	were	combined	with	Illumina	MiSeq/HiSeq	short	reads	with	Abyss	v2.02	(Jackman	et	al.	2017).			
	Sequence	annotation	Genes	in	the	urate	pathway	were	identified	initially	using	KEGG	GhostKOALA	and	KASS	and	subsequently	by	BLASTP	searches	against	NCBI’s	nr	protein	database	(Kanehisa	et	al.	2016).	All	candidate	genes	were	screened	using	InterProScan	to	predict	function	(Finn	et	al.	2017).	A	curated	database	of	phylogenetically	representative	species	with	good	quality	annotations	for	the	three	purine	degradation	genes	and	malate	synthase	were	downloaded	from	NCBI.	These	genes	were	then	used	to	construct	gene	trees.			Sequences	were	aligned	with	MAFFT	(Katoh	&	Standley	2013)	using	FFT-NS-i.	Maximum	likelihood	phylogenetic	trees	were	constructed	performed	with	RAxML	(Stamatakis	2014)	using	the	GAMMA	model	with	1000	seed	trees	and	1000	bootstrap	replicates.	Trees	were	viewed	and	modified	using	Figtree	(v1.4.0,	http://tree.bio.ed.ac.uk/software/figtree/).	Protein	sequences	were	used	to	search	against	PeroxisomeDB	(Schlüter	et	al.	2009)	and	BLAST	hits	lower	than	e-20	were	retained	and	used	in	a	BLASTP	query	against	NCBI’s	Refseq	protein	database	(Schlüter	et	al.	2009).	Additional	peroxisomal	genes	were	identified	with	KAAS	(Moriya	et	al.	2007).	As	many	of	
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these	peroxisome	genes	are	encoded	by	M.	manhattensis,	all	copies	that	had	a	closest	hit	to	opisthokonta	or	bacteria	were	removed.	Transcripts	from	uninfected	M.	manhattensis	were	used	to	screen	additional	tunicate	genes	using	cd-hit	at	a	90%	identity	level	(Li	&	Godzik	2006).	Remaining	genes	were	tested	for	signal	motifs	and	subcellular	location	predictions	with	Wolf	PSORTII,	Ppero,	TargetP,	topcons,	and	Predotar	(Supplementary	Table	1)(Nakaia	&	Horton	1999;	Wang	et	al.	2017;	Emanuelsson	et	al.	2007;	Bernsel	et	al.	2009;	Small	et	al.	2004).	
Nephromyces	specific	RNAseq	reads	were	mapped	to	our	genomic	assembly	using	bowtie2	(Langmead	&	Salzberg	2012)	with	the	–very	sensitive	flag	set.	Following	mapping,	Bedtools	(Quinlan	&	Hall	2010)	was	used	to	quantify	coverage	across	contigs,	which	were	separated	based	on	coverage	levels.	Contigs	identified	as	Nephromyces	were	annotated	using	Maker2	with	ab	initio	gene	predictions	from	Augustus	(Holt	&	Yandell	2011;	Stanke	et	al.	2004).			
Results	The	contents	of	a	single	renal	sac	from	an	individual	Molgula	manhattensis	resulted	in	195,694	transcripts	from	M.	manhattensis,	Nephromyces,	and	the	bacterial	endosymbionts.	After	binning	by	species,	60,223	transcripts	were	attributed	to	Nephromyces.		The	cardiac	fluid	from	40	infected	Ciona	intestinalis	individuals	resulted	in	109,446	transcripts,	including	15,541	Cardiosporidium	transcripts.	The	BUSCO	algorithm	was	used	to	assess	the	completeness	of	the	transcriptomes	and	reported	81.8%	complete	transcripts	and	6.3%	partial	for	the	
Nephromyces	data	and	69.7%	complete	and	11.9%	partial	for	Cardiosporidium.		
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The	Nephromyces	genome	assembly	consisted	of	1176	contigs	greater	than	5kb	with	a	maximum	length	of	287,191	bp	and	an	average	length	of	36	kb	(Paight	
et	al,	in	prep).	This	dataset	was	used	to	search	for	purine	degradation	genes	to	determine	their	genomic	context.	All	of	the	purine	degradation	genes,	as	well	as	malate	synthase,	were	predicted	and	annotated	in	the	genome	by	Maker2.	All	genes	but	URAD	contained	introns,	and	neighboring	genes	on	the	identified	contigs	had	top	BLAST	hits	to	apicomplexans	in	all	cases	(Table	1),	indicating	that	they	are	encoded	in	the	Nephromyces	genome,	not	the	endosymbiotic	bacteria	or	host	Molgula	manhattensis.	Phylogenetic	trees	for	xanthine	dehydrogenase,	uric	oxidase,	malate	synthase	and	allantoicase	consistently	resolved	the	monophyly	of	
Nephromyces,	Cardiosporidium,	and	Chromerids	(Figure	1).		Chromerids	are	the	photosynthetic	and	the	closest	free-living	relatives	of	Apicomplexa	(Moore	et	al.	2008),	indicating	a	vertical	inheritance	of	this	pathway	from	the	common	ancestor	of	apicomplexans.		The	presence	of	urate	oxidase	also	provides	further	support	for	peroxisomes	in	some	lineages	of	Apicomplexa	(Moog	et	al.	2017;	Ludewig-Klingner	et	al.	2018),	because	urate	oxidase	activity	is	confined	to	peroxisomes	in	eukaryotes	(Usuda	et	al.	1994).	In	addition	to	urate	oxidase,	Nephromyces	and	
Cardiosporidium	encode	more	peroxisome-associated	proteins	than	Plasmodium,	and	nearly	the	same	complement	of	genes	encoded	by	Toxoplasma	(Table	2).	There	are	a	few	notable	differences	between	Toxoplasma	and	
Nephromyces/Cardiosporidium,	including	the	absence	of	PEX3,	PEX16,	VLACS,		
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Gene
Introns	in	
gene Contig
Contig	length	
(kb)
Predicted	
Genes	on	
Contig
Genes	with	top	
apicomplexan	
BLAST	hits
XDH 4 Neph_3686418 24.5 4 2
UO 7 Neph_3687015 82.5 12 7
uraH 2 Neph_3685393 94.3 6 4
URAD 0 Neph_3687674 30.9 6 5
ALLC 10 Neph_3687655 116.3 16 11
MS 6 Neph_3671841 7 2 1
Table	1.	Genomic	context	of	the	annotated	purine	degradation	genes	and	malate	synthase,	
in	the	Nephromyces	genomic	assembly.	The	phylogenetic	affiliation	of	neighboring	genes	
on	each	contig	was	identified	by	top	hit	against	the	NCBI	nr	database	using	BLASTp.	Every	
contig	encoding	a	target	gene	included	other	apicomplexan	genes,	and	genes	that	did	not	
hit	apicomplexans	had	no	strong	affinity	for	other	organisms.
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Figure 1. Maximum likelihood protein trees of A) Xanthine 
Dehydrogenase, B) Urate oxidase, C) Allantoicase D) Malate synthase. 
Genes A-C are involved in purine degradation and their position supports 
an ancestral apicomplexan purine degradation pathway in 
Nephromyces/Cardiosporidium. Malate synthase, D), acts on glyoxylate 
and acetyl-CoA to produce malate to complete the pathway. Stramenopiles 
are paraphyletic in the malate synthase phylogeny, possibly indicating a 
deep gene duplication. Whereas the support for deeper nodes is variable 
among all four genes, there is consistent support for a monophyletic origin 
of Nephromyces/Cardiosporidium genes with Chromerids (red box). Major 
lineages have been collapsed for presentation. Support values are 
percentage bootstrap support above 50%. 
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Protein Abbr. Vb Cv C N Tg Pf Cp
Glyoxylate	pathway
Isocitrate	lyase ICL x x - - - - -
Malate	synthase MLS x x x - - -
Citrate	synthase CS x x x x x x -
Aconitase ACO x x x x x x -
Malate	dehydrogenase MDH x x x x x x x
Peroxisome
Biogenesis	factor	1 Pex1 x x - x x - -
Biogenesis	factor	2 Pex2 x x x x x - -
Biogenesis	factor	3 Pex3 x x - - x - -
Ubiquitin	carrier	protein Pex4 x x x x x x x
Biogenesis	protein	5 Pex5 x x x x x - -
Biogenesis	protein	6 Pex6 x x x x x - -
Biogenesis	protein	7 Pex7 x x x x x - -
Biogenesis	protein	10 Pex10 x x x x x - -
Biogenesis	factor	11 Pex11 x x x x x - -
Biogenesis	protein	12 Pex12 x x - x x - -
Biogenesis	factor	13 Pex13 - - - - - - -
Membrane	protein	14 Pex14 x x x x x - -
Membrane	protein	15 Pex15 - - - - - - -
Biogenesis	factor	16 Pex16 x x - - x - -
Membrane	protein	receptor Pex19 x - - - - - -
Biogenesis	protein	22 Pex22 x x x x x x x
Biogenesis	factor	26 Pex26 - - - - - - -
Membrane	channel PMP22 x x x x - - -
Membrane	protein	4 PMP27 - - - - - - -
ATP/ADP-transporter PMP34 x x x x x - -
Fatty	acid	ABC-transporter PMP70 x x x x x - -
ROS	metabolism MPV17 x x x x x x -
Protein Abbr. Vb Cv C N Tg Pf Cp
 Fatty	acid	oxidation
 a-oxidation  2-Hydroxyacyl-CoA	lyase  HPCL2 - x - - - x -
 Phytanoyl-CoA	hydrolase  PHYH x x - - - - -
 B-oxidation  a-Methylacyl-CoA-racemase  AMACR - - - - - - -
 Acyl-CoA-oxidase  ACOX x x x x x - -
 Multifunctional	protein  DBP x x x x x - -
 Sterole	carrier	protein	2  SCPX - x - - x - -
Table	2.	Peroxiomal	genes	identified	in	Nephromyces	and	Cardiosporidium	and	their	functional	catagory.	(X)	
denotes	presence	of	gene	and	(-)	absence.	Vitrella	brassicaformis	(Vb)	Chromera	velia	(Cv)	Cardiosporidium	(C)	
Nephromyces	(N)	Toxoplasma	gondii	(Tg)	Plasmodium	falciparum	(Pf)	Cryptosporidium	parvum	(Cp).	Table	
modified	based	on	Ludwig-Klinger	et	al.	(2017).
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 Multifunctional	protein  PBE - - - - - - -
 Acetyl-CoA	acyltransferase	1  ACAA1 x x x x x - -
 2,	4-dienoyl-CoA	reductase  PDCR x x x x x - -
 d(3,	5)-d(2,	4)-dienoyl-CoA	isomerase  ECH x x x x x - -
ATP-binding	cassette,	subfamily	D  ABCD x x x x x - -
 Long-chain	acyl-CoA	synthetase  ACSL x x x x x x -
 Solute	carrier	family	27,	member	2  VLACS x x - - x - -
 Other	oxidation  Acyl-CoA	thioesterase	8  PTE - - - - - - -
 Nucleoside	disphosphate-linked	m.  NUDT19 - x - - - - -
 Amino	acid	metabolism - -
 Multifunctional	protein  AGT x x x x x - -
 D-Amino-acid	oxidase  DAO - - - - - - -
 Isocitrate	dehydrogenase  IDH x x x x x x -
 N1-acetylpolyamine	oxidase  PAOX x x - - - - -
L-Pipecolate	oxidase  PIPOX x x - - - - -
 hydroxymethylgluatryl-CoA	lyase  HMGCL x x x x x - -
(S)-2-hydroxy-acid	oxidase  HAO x x x x - - -
 Antioxidant	system - -
 Hydrogen	peroxide	metabolism  Catalase  CAT x - x x x - -
 Superoxide	dismutase  SOD - - x x x x x
Nitric-oxide	synthase,	inducible  INOS - - - - - - -
 Peroxiredoxin	1  PRDX1 x x - x x x x
 Peroxiredoxin	5  PRDX5 - - - - - - -
 Glutathione	metabolism
 Glutathione	S-transferase	kappa	1  GSTK1 x x x x - - -
Protein Abbr. Vb Cv C N Tg Pf Cp
 Etherphospholipid	biosynthesis
 Dihydroxyacetone	phosphate	acyltr.  DHAPAT x x x x x - -
 Alkyldihydroxyacetonephosphate	syn  AGPS x x x - - - -
 Fatty	acyl-CoA	reductase  FAR x x - x x - -
 Purine	metabolism
 Xanthine	dehydrogenase  XDH x x x x - - -
Urate	oxidase UO x x x x - - -
 Retinol	metabolism
 Dehydrogenase/reductase	SDR	family  DHRS4 x x x x - - -
 Sterol	precursor	biosynthesis
 Mevalonate	kinase  MVK - - - - - - -
 Phosphomevalonate	kinase  PMVK - - - - - - -
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	and	SCPX	in	Nephromyces/Cardiosporidium	and	the	absence	of	PMP22,	GSTK1,	DHRS4,	XDH,	and	UO	in	Toxoplasma.	Additionally,	Nephromyces	encodes	a	copy	of		Malate	synthase	(MLS)	absent	in	both	Cardiosporidium	and	Toxoplasma.	Malate	synthase	is	a	key	gene	in	the	glyoxylate	cycle,	a	pathway	maintained	in	the	photosynthetic	Chromera	velia	and	Vitrella	brassicaformis,	but	lost	in	all	other	apicomplexans	(Ludewig-Klingner	et	al.	2018).	Nephromyces/Cardiosporidium	also	encode	the	enzyme	serine-pyruvate	transaminase	(AGXT),	which	also	uses	glyoxylate	as	a	substrate.	AGXT	converts	glyoxylate	into	glycine	and	pyruvate	and	is	often	localized	to	peroxisomes,	however	the	localization	of	AGXT	in	
Nephromyces/Cardiosporidium	is	unclear	(Supplementary	Table	1).		
Discussion	The	recent	scrutiny	by	Moog	et	al	(2017),	and	Ludewig-Klingner	et	al.	(2018)	has	built	a	case	for	the	presence	of	peroxisomes	in	some	apicomplexan	lineages.	While	some	apicomplexans	may	have	lost	peroxisomes,	it	seems	likely	that	this	loss	is	not	a	universally	shared	trait	in	the	phylum.	Despite	the	extensive	search	for	peroxisome-associated	functions	in	apicomplexans,	no	genes	involved	in	purine	degradation	were	found	in	other	sequenced	apicomplexan	genomes,	with	the	lone	exception	of	allantoicase	in	Plasmodium	(Gardner	et	al.	2002).	Our	
in	silico	predictions	indicate	a	complete	purine	degradation	pathway	in	
Nephromyces	and	Cardiosporidium.	In	addition	to	highly	expressed	transcripts	for	
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the	genes	involved,	all	of	the	identified	purine	degradation	genes	and	MLS	have	been	located	on	genomic	contigs	from	Nephromyces.		Based	on	neighboring	genes	and	the	presence	of	introns	in	the	Nephromyces	genes	matching	the	expressed	transcripts,	these	contigs	almost	certainly	originate	from	the	Nephromyces	genome	(Table	1).	Additionally,	none	of	the	purine	degradation	transcripts	attributed	to	Nephromyces	were	detected	in	uninfected	tunicates	(Table	3).	Phylogenetic	trees	of	purine	degradation	genes	are	poorly	supported	at	an	inter-phylum	level,	indicating	a	rapid	evolutionary	rate.	Whereas	most	genes	are	phylogenetically	uninformative	across	the	spectrum	of	eukaryotes,	these	gene	trees	have	strong	support	for	monophyly	of	purine	degradation	genes	from	
Nephromyces	and	Cardiosporidium	with	Chromerids	(Figure	1).	The	combination	of	gene	trees,	expression	only	when	Nephromyces	is	present,	and	preliminary	genomic	assemblies	strongly	suggest	that	these	genes	were	present	since	the	divergence	of	Apicomplexa	and	Chromerida	and	have	been	vertically	transmitted.	Thus,	these	genes	have	been	subsequently	lost	across	apicomplexans,	possibly	multiple	times.	Although	the	exact	placement	of	Nephromyces	and	
Cardiosporidium	is	not	certain	(Saffo	et	al.	2010),	multi-gene	phylogenies	place	them	in	the	subclass	Hematozoa	(Muñoz	et	al.	in	prep),	suggesting	that	purine	degradation	was	independently	lost	multiple	times	in	Apicomplexa	as	well	as	maintained	long	after	apicomplexans	had	become	obligate	parasites.		The	presence	of	predicted	purine	degradation	genes	in	Nephromyces	and	
Cardiosporidium,	adds	a	function	not	previously	demonstrated	in	apicomplexan	
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peroxisomes	(Table	2;	Moog	et	al	2017;	Ludewig-Klingner	et	al.	2018).	While	
Toxoplasma	and	Cardiosporidium/Nephromyces	share	many	of	the	same	peroxisomal	marker	genes,	no	copy	of	PEX3	has	been	found	in	
Cardiosporidium/Nephromyces.	PEX3	(along	with	PEX10,	PEX12,	and	PEX19)	is	one	of	the	4	genes	reportedly	required	for	peroxisome	function	(Schluter	et	al.	2006).	However,	the	fundamentals	of	peroxisome	biology	have	been	described	from	a	limited	set	of	eukaryotes,	and	organisms	such	as	ciliates	have	peroxisomes	but	also	lack	PEX3	(Ludewig-Klingner	et	al.	2017).	Therefore,	PEX3	may	not	be	critical	to	peroxisome	function	for	alveolates,	and	possibly	other	under-studied	eukaryotic	lineages.	Extreme	sequence	conservation	of	PEX3	and	PEX19	is	only	found	in	opisthokonta	and	sequence	divergence	in	other	lineages	may	indicate	alternative	functions	(Hua	et	al.	2015).	Two	other	genes	(Sterol	carrier	protein	2,	SCPX	and	Solute	carrier	family	27,	member	2,	VLACS)	missing	from	Cardiosporidium/Nephromyces,	but	found	in	
Toxoplasma,	are	involved	in	β-fatty	acid	oxidation.	Both	
Cardiosporidium/Nephromyces	encode	the	seven	other	β-fatty	acid	oxidation	genes	encoded	in	Toxoplasma,	suggesting	β-fatty	acid	oxidation	forms	part	of	the	functional	capabilities	of	the	Cardiosporidium/Nephromyces	peroxisome.	Fatty	acid	oxidation	is	often	a	central	component	of	peroxisome	function	and	has	been	hypothesized	to	be	the	impetus	for	the	evolution	of	peroxisomes	(Speijer	2011).	Based	on	transcript	abundance,	purine	degradation	in	Nephromyces	peroxisomes	appears	to	be	heavily	utilized.	Only	0.13%	of	genes	had	a	higher	
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transcription	rate	than	urate	oxidase	in	our	data	from	wild	collected	
Nephromyces,	and	the	other	genes	in	the	purine	degradation	pathway	are	among	the	most	highly	expressed	transcripts	in	both	wild	and	lab	grown	Nephromyces	samples	(Table	3).	This	result	aligns	with	the	previously	reported	high	levels	of	urate	oxidase	protein	in	the	renal	sac	of	infected	Molgula	(Saffo	1988),	indicating	that	the	expression	levels	reported	here	do	translate	to	protein.	Much	of	this	pathway	is	expressed	over	the	99th	percentile	of	all	transcripts	in	Nephromyces,	which	corresponds	to	the	top	100	genes.	Expression	of	purine	degradation	genes	in	Cardiosporidium	is	far	lower,	and	in	the	70-90	percentile	range	(Table	3).	Such	high	expression	in	Nephromyces	represents	an	enormous	metabolic	investment	and	it	is	unlikely	that	these	transcripts	go	largely	untranslated.		Both	Nephromyces	and	Molgula	manhattensis	encode	xanthine	dehydrogenase,	and	are	able	to	convert	xanthine	into	uric	acid.	Since	we	have	identified	the	tunicate	host	as	the	source	of	purines,	this	raises	the	question	of	why	Nephromyces	is	expressing	xanthine	dehydrogenase	in	the	97.87th	percentile,	compared	with	similarly	high	tunicate	expression	(93.64th	percentile).	Although	the	percentile	ranking	between	these	two	organisms	cannot	be	directly	compared,	such	high	xanthine	dehydrogenase	expression	in	Nephromyces	is	surprising.	It	seems	unlikely	that	so	much	xanthine	dehydrogenase	production	is	needed	to	convert	only	endogenous	purines	of	Nephromyces.	However,	xanthine	is	only	detected	in	the	renal	sac	in	small	quantities,	not	nearly	as	abundant	as	uric	acid,	and	xanthine	dehydrogenase	activity	is	restricted	to	the	renal	wall,	not	the		
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Table	3.	Expression	percentile	ranking	of	purine	degradation	genes,	from	total	
expressed	transcripts	in	Nephromyces	(Neph),	Cardiosporidium	(Cardio)	and	
Molgula	(Mm).	The	wild	Nephromyces	and	Molgula	manhattensis	data	
originate	from	the	same	RNA	extraction	and	were	bioinformatically	
separated.	Data	was	also	generated	from	laboratory	grown	tunicates,	
artificially	infected	with	Nephromyces	(Lab	grown	Neph	1	&	2).	
Cardiosporidium	fractions	represent	1)	unfiltered	pericardial	fluid,	2)	the	25%	
and	3)	30%	fractions	extracted	from	a	sucrose	gradient,	and	may	contain	
different	proportions	of	Cardiosporidium	life	stages.	The	three	uninfected	
Molgula	manhattensis	were	raised	from	gametes	in	the	lab	and	never	
exposed	to	Nephromyces	infection.		The	(-)	denotes	the	transcript	was	not	
recovered	in	that	dataset	whereas	(N/A)	indicates	the	transcript	was	
assembled,	but	the	transcripts	per	million	(TPM)	was	<1. 
 
Gene Wild	Neph
Lab	grown	
Neph	1
Lab	grown	
Neph	2
Cardio	
Fraction	1
Cardio	
Fraction	2
Cardio	
Fraction	3
Mm
Uninfected	
Mm	1
Uninfected	
Mm	2
Uninfected	
Mm	3
xanthine	dehydrogenase 97.87 93.17 94.83 none 76.88 69.5 93.64 N/A N/A N/A
urate	oxidase	 99.87 99.44 99.54 86.75 87.24 70.98 - - - -
5-hydroxyisourate	hydrolase 99.16 91.31 88.41 87.67 83.27 79.1 - - - -
OHCU	decarboxylase 93.38 - - - - - - - - -
allantoinase 99.09 98.38 98.23 73.61 90.32 71.89 - - - -
amindohydrolase 99.75 79.25 89.18 87.43 92.27 92.08 - - - -
malate	synthase 59.17 93.81 93.11 - - - - - - -
serine-pyruvate	transaminase 99.85 99.57 99.79 84.64 80.81 77.79 85.65 91.17 71.85 75.05
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	renal	lumen	(Nolfi	1970).	One	possible	explanation	is	that	Nephromyces	exports	its	xanthine	dehydrogenase	into	the	renal	wall	in	order	to	drive	the	production	of		xanthine	from	hypoxanthine	before	the	purine	salvage	enzymes	adenine	phosphoribosyltransferase	and	hypoxanthine-guanine	phosphoribosyltransferase	can	salvage	hypoxanthine	into	adenine	and	guanine.		High	expression	of	purine	degradation	genes	in	Nephromyces	is	clear,	but	the	purpose	is	uncertain.	It	does	indicate	purine	degradation	is	an	important	pathway	for	Nephromyces,	however,	the	functional	significance	is	not	immediately	obvious.	Pathway	analysis	predicts	that	Nephromyces	is	able	to	convert	xanthine	into	urea	and	ureidoglycolate,	however	neither	compound	is	biologically	useful	without	further	conversion.	We	propose	that	the	products	of	purine	degradation	in	Nephromyces	are	converted	to	glyoxylate.	One	possible	route	is	the	conversion	of	ureidoglycolate	into	glyoxylate.	There	are	two	known	enzymes	able	to	catalyze	this	conversion:	ureidoglycolate	lyase,	found	in	fungi	and	bacteria,	which	catalyzes	(s)-ureidoglycolate	to	glyoxylate	and	urea,	and	ureidoglycolate	amidohydrolase,	found	in	plants	and	bacteria,	which	catalyzes	(s)-ureidoglycolate	to	glyoxylate,	carbon	dioxide,	and	ammonia	(Muñoz	et	al.	2006;	Percudani	et	al.	2013;	Wells	&	Lees	1991;	Werner	et	al.	2010;	Shin	et	al.	2012;	Serventi	et	al.	2010).	Both	ureidoglycolate	lyase	and	ureidoglycolate	amidohydrolase	are	amidohydrolases	-	hydrolases	that	use	amide	bonds	as	substrates.	No	orthologs	to	either	ureidoglycolate	lyase	and	
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ureidoglycolate	amidohydrolase	have	been	found	in	the	Nephromyces	transcriptome.	However,	an	amidohydrolase	is	present,	which	is	predicted	to	be	structurally	similar	to	the	ureidoglycolate	amidohydrolase	found	in	Arabidopsis,	including	similar	location	and	number	of	zinc	binding	domains.	This	amidohydrolase	also	has	a	similarly	high	expression	level	as	the	other	purine	degradation	enzymes	(Table	3).	In	order	to	determine	if	the	amidohydrolase	found	in	Nephromyces	is	capable	of	catalyzing	(s)-ureidoglycolate,	functional	assays	will	need	to	be	performed.			While	the	functionality	of	this	particular	amidohydrolase	has	yet	to	be	determined,	its	ability	to	act	on	an	(s)-ureidoglycolate	is	an	attractive	hypothesis	for	a	few	reasons.	One,	there	are	two	known	enzymes	capable	of	breaking	the	amide	bond	in	(s)-ureidoglycolate	that	have	independently	evolved:	ureidoglycolate	lyase	and	ureidoglycolate	amidohydrolase.	This	pathway	has	not	been	widely	explored	across	eukaryotes	and	the	modification	to	a	class	of	molecules	able	to	break	amide	bonds	to	accommodate	the	structure	of	(s)-ureidoglycolate	may	not	be	a	complex	evolutionary	step.	Two,	(s)-ureidoglycolate	is	unstable	and	will	spontaneously	convert	to	glyoxylate,	albeit	without	the	stereospecific	conversion	present	when	catalyzed	by	ureidoglycolate	amidohydrolase	(Werner	et	al.	2010).	Spontaneous	conversion	of	glyoxylate	results	in	a	50%	loss	of	efficiency	versus	enzymatic	conversion,	presumably	creating	strong	evolutionary	pressure	to	enzymatically	degrade	(s)-ureidoglycolate	to	maintain	stereochemistry.	
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Glyoxylate	is	a	common	substrate	for	a	number	of	enzymes	including	glyoxylate	oxidase,	which	catalyzes	glyoxylate	with	water	and	oxygen	to	form	oxalate	and	hydrogen	peroxide	(Kasai	et	al.	1963).	Notably,	no	copy	of	glyoxylate	oxidase	has	been	identified	in	Nephromyces,	which	is	surprising	given	that	another	common	component	of	the	renal	sac	is	calcium	oxalate	(Saffo	&	Lowenstam	1978).	We	have	not	identified	any	genes	suggesting	that	
Nephromyces	or	its	bacterial	endosymbionts	can	produce	or	process	oxalate.	Calcium	oxalate	is	also	found	in	uninfected	hosts	indicating	that	the	tunicate	is	the	source.	Another	enzyme	that	uses	glyoxylate	as	a	substrate,	which	is	present	in	Nephromyces/Cardiosporidium,	is	serine-pyruvate	transaminase	(AGXT),	which	can	be	localized	to	peroxisomes	or	mitochondria,	and	catalyzes	glyoxylate	to	glycine	and	pyruvate	(Takada	&	Noguchi	1985).		An	alternative	enzyme	for	processing	glyoxylate	is	malate	synthase	(MLS),	which	is	also	targeted	to	the	peroxisome	and	missing	from	apicomplexans,	including	Cardiosporidium,	but	is	found	in	Nephromyces	(Figure	1).		Malate	synthase	is	one	of	two	genes	integral	to	the	glyoxylate	cycle,	an	alternative	pathway	for	part	of	the	citrate	cycle.	In	the	glyoxylate	cycle,	isocitrate	is	converted	into	glyoxylate	and	succinate	by	isocitrate	lyase	(McFadden	&	Howes	1965).	Glyoxylate	is	combined	with	acetyl-CoA	to	create	malate	(Molina	et	al.	1994).	This	cycle	allows	for	the	creation	of	glucose	from	fatty	acids	directly	(Kornberg	&	Krebs	1957).	The	presence	of	malate	synthase	indicates	at	least	a	piece	of	the	glyoxylate	cycle	is	present	in	Nephromyces.	No	copy	of	isocitrate	lyase	
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is	predicted	from	the	Nephromyces	transcriptome,	and	only	a	small	fragment	of	a	possible	isocitrate	synthase	has	been	identified	in	Cardiosporidium.	However,	under	the	model	proposed	here,	the	generation	of	glyoxylate	is	from	uric	acid,	and	isocitrate	synthase	would	not	be	required.	Both	AGXT	and	MLS	(in	Nephromyces)	show	similarly	high	expression	as	the	purine	degradation	genes	(Table	3),	which	is	consistent	with	our	proposed	uric	acid	to	glyoxylate	pathway.	In	particular,	AGXT	is	among	the	most	highly	expressed	Nephromyces	transcripts,	with	consistently	higher	expression	than	MLS,	possibly	indicating	it	is	the	primary	route	of	glyoxylate	conversion.	The	products	of	AGXT,	glycine	and	pyruvate,	are	versatile	substrates	and	used	by	a	number	of	pathways.	Glycine	is	the	simplest	amino	acid	and	an	essential	component	of	many	important	biological	compounds,	as	a	nitrogen	source	in	a	readily	useable	form.	Pyruvate	is	extremely	versatile	and	involved	in	several	critical	biological	pathways.		A	non-inclusive	list	includes	amino	acid	biosynthesis,	acetyl-CoA	biosynthesis,	fatty	acid	biosynthesis,	and	the	citric	acid	cycle.	These	pathways	represent	both	carbon	and	energy	acquisition	(Figure	2).	Additionally,	Nephromyces	has	the	ability	to	use	MLS	to	convert	glyoxylate	and	acetyl-CoA	into	malate,	a	compound	central	to	the	citric	acid	cycle,	allowing	for	another	mechanism	of	carbon	and	energy	acquisition	(Figure	2).	The	hypothesized	conversion	of	uric	acid	to	glyoxylate	in	Nephromyces	creates	several	possibilities.	First,	it	allows	for	the	metabolic	waste	product,	uric	acid,	to	be	converted	into	glycine,	pyruvate,	and	malate	(Figure	2).	Second,	it		
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	provides	an	explanation	for	the	exceptionally	high	expression	of	the	purine	degradation	pathway.	Third,	it	gives	Nephromyces	access	to	a	primary	carbon,		nitrogen,	and	an	energy	source	at	no	cost	to	its	host.	And	finally,	this	change	in	primary	carbon,	nitrogen,	and	energy	could	conceivably	reduce	the	impact	of	
Nephromyces	on	its	host,	allowing	Nephromyces	densities	to	increase	while	decreasing	virulence.	Reduction	in	virulence	would	have	been	a	necessary	first	step	toward	mutualism.				Uric	acid	as	a	primary	carbon	and	energy	source	is	not	completely	unknown.	Bacterial	species	have	been	found	in	chicken	hutches	that	were	able	to	grow	solely	on	uric	acid	(Rouf	&	Lomprey	1968;	Thong-On	et	al.	2012),	and	some	species	of	fungi	are	able	to	grow	on	media	solely	containing	uric	acid	(Middelhoven	et	al.	1989).		However,	this	is	a	novel	substrate	for	an	apicomplexan	to	grow	on,	and	while	it	is	unlikely	that	Nephromyces	could	survive	on	uric	acid	alone,	it	is	a	promising	base	for	both	carbon	and	nitrogen	acquisition.	It	is	possible	that	the	Nephromyces	bacterial	endosymbionts	(Sabree	et	al.	2009;	Potrikus	&	Breznak	1980)	are	contributing	to	the	proposed	purine	to	glucose	pathway,	but	that	is	not	currently	supported	by	our	data.		As	the	adaptive	significance	of	uric	acid	deposits	in	tunicates,	and	particularly	in	Molgula,	are	unknown,	it	is	difficult	to	speculate	on	the	effects	of	
Nephromyces	uric	acid	degradation	to	the	host.	If	these	renal	sac	deposits	are	a	form	of	excretion	by	storage,	as	has	been	hypothesized	(Goodbody	1965),	then	
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having	a	symbiont	that	is	capable	of	digesting	uric	acid	may	be	beneficial	simply	by	digesting	an	indigestible	metabolite	and	converting	uric	acid	into	urea.		Alternatively,	once	the	uric	acid	has	been	broken	down,	the	tunicate	may	benefit	from	metabolites	derived	from	uric	acid	previously	unavailable	to	the	tunicate.	If	
Nephromyces	is	overexpressing	xanthine	dehydrogenase	in	order	to	outcompete	adenine	phosphoribosyltransferase	and	hypoxanthine-guanine	phosphoribosyltransferase,	diverting	hypoxanthine	from	purine	salvage	to	purine	degradation,	there	could	be	a	potential	cost	to	the	host	under	purine-limited	conditions.				Our	data	demonstrate	that	both	the	proposed	mutualistic	Nephromyces	and	parasitic	Cardiosporidium	encode	the	genes	for	purine	degradation,	which	have	been	lost	in	other	apicomplexans	sequenced	to	date.	Additionally,	these	genes	share	a	common	ancestry	with	chromerid	genes,	indicating	they	are	not	the	product	of	a	recent	horizontal	gene	transfer	from	bacteria.	These	data	also	add	support	to	the	growing	body	of	evidence	that	indicate	the	presence	of	peroxisomes	in	apicomplexans.	Nephromyces	and	Cardiosporidium	are	predicted	to	have	peroxisomes	and,	unlike	any	other	apicomplexan,	are	capable	of	preforming	both	purine	degradation	and	part	of	the	glyoxylate	cycle.	The	presence	of	purine	degradation,	AGXT,	and	MLS	allow	for	the	intriguing	possibility	of	conversion	of	uric	acid	into	a	primary	nitrogen,	carbon	and	energy	source.	This	predicted	metabolic	activity	would	be	a	completely	novel	substrate	for	an	apicomplexan	and	may	have	been	an	important	factor	in	the	reduction	of	
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virulence	in	Nephromyces.			
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CHAPTER	3	Abstract		Parasitism	has	been	referred	to	as	an	“evolutionary	dead	end”,	because	the	transition	to	parasitism	is	unidirectional.	Once	an	organism	becomes	an	obligate	parasite,	it	is	likely	to	remain	an	obligate	parasite	due	to	the	loss	of	metabolic	pathways.	Nephromyces	is	a	genus	in	the	parasitic	phylum	Apicomplexa,	but	has	an	apparent	mutualistic	relationship	with	Molgula	tunicates.	Support	for	a	mutualistic	relationship	is	based	largely	on	a	nearly	100%	host	infection	rate	with	no	known	clearance	of	Nephromyces.	Because	transition	away	from	obligate	parasite	is	so	rare,	little	is	known	about	the	evolutionary	steps	involved	in	such	a	transition	-	particularly	in	lineages	with	such	a	long	history	of	obligate	parasitism	as	Apicomplexa.	In	order	to	examine	this	unusual	evolutionary	transition,	we	sequenced	transcriptomes	from	
Nephromyces	and	its	parasitic	sister	taxon,	Cardiosporidium	cionae,	which	is	an	excellent	model	for	what	Nephromyces	might	have	looked	like	as	a	parasite.	Both	
C.	ciona	and	Nephromyces	have	tunicate	hosts	and	bacterial	endosymbionts,	but	each	maintains	a	different	lifestyle.	A	comparison	of	Nephromyces,	C.	ciona,	and	their	endosymbionts	will	be	presented	with	a	focus	on	system	dynamics,	relationships,	and	clues	to	how	this	transition	occurred.			Introduction	In	2010,	Saffo	et	al.	characterized	the	apicomplexan	Nephromyces	as	
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having	a	mutualistic	relationship	with	its	host	Molgula	tunicates.	The	significance	of	a	mutualistic	genus	within	a	group	of	>6000	obligate	parasites,	some	of	which	cause	massive	human	mortality,	prompted	us	to	initiate	a	genomic	investigation	of	Nephromyces.	The	unique	evolutionary	pressures	caused	by	an	obligate	parasitic	lifestyle,	namely	host	immune	system	evasion	and	the	ready	abundance	of	pre-formed	host	metabolites,	lead	to	predictable	patterns	of	gene	family	losses	and	expansions.	Typically	this	consists	of	the	expansion	of	gene	families	related	to	host	immune	system	evasion	and	other	parasitism	related	functions,	and	the	subsequent	loss	of	many	of	the	core	biosynthetic	genes	due	to	their	presence	in	the	intracellular	environment	[1–5].	Due	to	these	pressures,	obligate	parasitism	is	often	an	evolutionary	dead	end.	Besides	Nephromyces,	the	phylum	Apicomplexa	is	composed	entirely	of	obligate	metazoan	parasites.	As	a	result	of	an	estimated	800	million	years	of	evolution	as	obligate	parasites,	[6],	many	of	the	genomic	patterns	associated	with	parasitism	have	been	described	from	the	apicomplexan	lineages.	Gene	expansions	can	be	seen	in	the	plasmodium	var	protein	family,	which	are	involved	in	host	manipulation,	evasion	and	in	the	expansion	of	rhoptry,	microneme,	and	dense	granule	proteins.	The	list	of	core	biosynthetic	pathways	lost	in	apicomplexans	includes	purine	biosynthesis,	purine	degradation,	biosynthesis	of	many	amino	acids,	and	vitamin	biosynthesis.	These	losses	make	the	parasite	dependent	on	the	host,	not	only	for	primary	carbon	and	nitrogen,	but	also	for	any	metabolites	it	can	no	longer	generate	by	either	de	novo	synthesis	or	by	
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conversion.	High	demand	on	the	host	for	these	metabolites	to	fuel	parasite	growth	increases	the	cost	of	infection,	thereby	increasing	virulence.	Parasites	must	maintain	a	delicate	balance	between	transmission,	virulence,	and	host	immune	system	evasion.	The	trade	offs	in	this	balance	have	been	described	in	detail	[7–11],	but	one	common	solution	many	parasites	adopt	is	maintaining	low	relative	abundance	inside	the	host.	Higher	parasite	abundance	will	increase	the	cost	to	that	host,	and	increase	virulence.	If	the	parasites	kill	the	host	before	completing	their	lifecycle	or	before	transmission	to	a	new	host,	their	fitness	falls	to	zero.	Similarly,	if	parasites	have	a	high	prevalence	in	a	population	and	high	lethality,	they	risk	decimating	their	host	population.	High-sustained	infection	prevalence	is	a	good	indicator	of	low	virulence,	and	low	virulence	is	often	achieved	by	self-limited	reproduction	by	the	parasites.	In	this	way,	Nephromyces	stood	out	as	a	very	atypical	parasite.	Nephromyces	has	a	nearly	100%	infection	rate,	sustained	almost	year-round.	Unexpectedly,	based	on	typical	host	/	parasite	dynamics,	
Nephromyces	also	reaches	very	high	cell	densities.	These	atypical	epidemiological	factors	were	the	basis	for	the	Saffo	et	al.	2010	conclusion	that	Nephromyces	must	be	mutualistic.	In	order	to	reach	high	cell	densities	while	maintaining	low	virulence,	Nephromyces	was	predicted	to	produce	something	of	high	value	to	the	host,	to	offset	the	cost	associated	with	maintaining	such	high	densities	of	an	obligate	parasite.	The	unusual	epidemiology	of	Nephromyces	becomes	more	apparent	when	
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contrasted	with	its	parasitic	sister	taxon,	Cardiosporidium	cionae.	
Cardiosporidium,	first	described	in	1907	by	Van	Gaver	and	Stephan,	and	later	described	by	Ciancio	et	al	2008	is	a	blood	parasite	found	in	solitary	non-molgulidae	ascidian	hosts,	including	Ciona	intestinalis.	Cardiosporidium	quickly	reaches	and	maintains	~95%	infection	prevalence	by	late	July.	In	contrast	to	
Nephromyces,	Cardiosporidium	cell	densities	remain	low,	with	orders	of	magnitude	difference	in	cell	densities	(based	on	DNA	extraction	quantities	as	a	proxy	for	cell	density).	Virulence	in	both	of	these	apicomplexans	is	thought	to	be	low	based	on	histological	work	by	Ciancio	et	al.	2008	and	Saffo	and	Nelson	1982.	Low	virulence	is	also	predicted	from	the	high-sustained	infection	prevalence.	The	contrast	in	cell	densities	between	Nephromyces	and	Cardiosporidium,	along	with	the	lack	of	apparent	virulence,	indicates	an	unusual	relationship	between	
Nephromyces	and	its	host.	In	addition	to	being	sister	taxa,	Nephromyces	and	Cardiosporidium	share	a	number	of	other	traits.	Both	organisms	are	monoxenous,	with	ascidians	as	the	only	host,	both	have	infective	stages	that	are	transmitted	through	seawater,	localize	within	the	pericardium	of	the	host	and	each	harbor	a	monophyletic	bacterial	endosymbiont	species	that	has	been	maintained	since	Nephromyces	and	
Cardiosporidium	diverged	(Figure	3).	These	similarities	make	Cardiosporidium	an	ideal	organism	to	compare	with	Nephromyces	in	order	to	resolve	the	genomic	changes	taking	place	behind	the	transition	from	obligate	parasitism	to	a		mutualistic	host-symbiont	relationship.	
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However,	there	are	some	key	differences,	besides	the	epidemiological	factors,	between	Nephromyces	and	Cardiosporidium,	including	host	species.	
Cardiosporidium	infects	several	genera	of	tunicates	including	Ciona,	Halocynthia,	
Styela,	Ascidiella	and	possibly	others	[12,	13],	while	Nephromyces	is	restricted	to	the	Molgulidae	family	of	tunicates	[14].	Interestingly,	Cardiosporidium	has	not	been	found	in	any	Molgulidae	tunicates.	Another	key	difference	is	that	
Cardiosporidium	is	an	intracellular	blood	parasite,	while	Nephromyces	is	extracellular	(another	unusual	trait	for	an	apicomplexan).	Additionally,	
Nephromyces	is	exclusively	found	in	a	Molgulidae	specific	structure	called	the	renal	sac,	a	large	ductless	structure	of	unknown	function	[15,	16].	Despite	its	name,	the	renal	sac	does	not	seem	to	function	as	a	typical	renal	organ,	but	was	named	for	the	large	deposits	of	crystallized	uric	acid	and	calcium	oxalate	within	it.	Many	ascidians	have	localized	deposits	of	uric	acid,	but	tunicates	in	the	Molgulidae	family	have	the	largest	[17,	18].	While	the	function	of	these	deposits	in	the	tunicate	remain	unclear,	previous	work	demonstrated	that	
Nephromyces	is	able	to	degrade	uric	acid	because	it	retains	the	ancestral	purine	degradation	genes	lost	in	all	other	apicomplexans	(Chapter	2).	Transcriptome	data	and	pathway	analysis	suggest	that	uric	acid	may	be	the	primary	source	of	carbon	and	nitrogen	for	Nephromyces	(Chapter	2).	Uric	acid	is	an	atypical	source	of	carbon	and	nitrogen,	but	it	is	not	unheard	of.	There	are	several	species	of	bacteria	and	fungi	which	can	be	cultured	on	media	containing	only	uric	acid	[19–21].		Due	to	their	unusual	environment	inside	the	renal	sac	and	because	
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Nephromyces	is	extracellular,	this	organism	may	not	have	access	to	all	the	required	pre-formed	metabolites.	However,	the	genus	Nephromyces	is	reported	to	maintain	three	different	bacterial	endosymbionts	[22].		In	addition	to	the	monophyletic	alphaproteobacteria,	Nephromyces	also	harbors	two	other	bacterial	endosymbionts:	a	Betaproteobacteria	and	a	Bacteroidetes.	Acquisition	and	maintenance	of	bacterial	endosymbionts	is	a	common	way	for	eukaryotes	to	gain	new	metabolic	pathways	and	capabilities.	The	functional	capabilities	of	bacterial	endosymbionts	exploited	by	eukaryotic	hosts,	for	example	include	amino	acid	metabolism	and	vitamin	metabolism	[23],	nitrogen	metabolism	[24],	defense	[25],	chemotrophic	energy	production	[26],	and	photosynthesis	[27],	to	name	a	few.	While	bacterial	endosymbionts	are	common	in	many	protist	lineages,	they	are	rare	in	the	phylum	Apicomplexa.	The	only	known	apicomplexans	to	contain	bacterial	endosymbionts	are	
Cardiosporidium	and	Nephromyces.	This	limited	distribution	to	apicomplexans	with	ascidian	hosts	may	be	due	to	an	unknown	aspect	of	ascidian	biology.	Previous	speculation	that	Nephromyces’	bacterial	endosymbionts	are	responsible	for	the	observed	high	levels	of	purine	degradation	have	recently	been	rejected	(Chapter	2).	However,	the	bacterial	endosymbionts	are	likely	instrumental	to	
Nephromyces’	ability	to	colonize	the	renal	sac.	In	order	to	examine	the	claim	of	mutualism,	characterize	the	relationships	involved	in	this	tripartite	endosymbiosis,	and	determine	how	Nephromyces	achieves	low	virulence	with	high	cell	density,	we	sequenced	the	transcriptomes	
 72 
of	Molgula	manhattensis,	Ciona	intestinalis,	Nephromyces,	Cardiosporidium,	and	their	bacterial	endosymbionts.	Additionally,	to	better	understand	the	dynamics	of	the	renal	sac	and	the	interplay	between	Nephromyces	and	its	bacterial	endosymbionts,	we	sequenced	and	partially	assembled	the	Nephromyces	genome	and	the	genomes	of	all	three	types	of	the	bacterial	endosymbionts.			Results	RNA	Sequencing	The	contents	of	a	single	renal	sac	from	an	individual	Molgula	manhattensis	yielded	32	ng/µl	RNA	by	Qubit	and	resulted	in	195,694	transcripts	from	M.	
manhattensis,	Nephromyces,	and	the	bacterial	endosymbionts.	After	binning	by	species,	60,223	transcripts	were	attributed	to	Nephromyces.		The	cardiac	fluid	from	40	infected	Ciona	intestinalis	individuals	resulted	in	109,446	transcripts,	including	15,541	Cardiosporidium	transcripts.	The	large	number	of	transcripts	identified	from	Nephromyces	was	due	to	multiple	species	infection	of	a	single	host.	Clustering	sequences	together	resulted	in	26938	transcripts	at	90%,	23850	at	80%,	21762	at	70%,	19540	at	60%,	16668	at	50%.	Due	to	the	multi	species	nature	of	Nephromyces	infections,	the	transcriptome	is	a	pan-genome	assembly	rather	than	a	precise	uni-species	dataset,	but	we	estimate	that	there	are	between	8000	and	12000	unique	transcripts	in	Nephromyces.	Kyoto	Encyclopedia	of	Genes	and	Genomes	(KEGG)	functionally	predicts	13336	transcripts	in	the	full	dataset.	The	tool	BUSCO	was	
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used	to	assess	the	completeness	of	Nephromyces	transcriptome	resulting	in	81.8%	complete	transcripts	and	6.3%	partial.		RNA	extractions	for	Cardiosporidium	samples	yielded	164	ng/µl	for	non-sucrose	gradient	separated	blood,	48	ng/µl	from	cells	taken	from	the	25%	layer,	and	24	ng/µl	from	cells	taken	from	the	30%	layer.	These	resulted	in	97,417,356	reads	from	the	non-sucrose	separated	sample,	115,085,369	reads	from	cells	at	the	25%	layer,	and	116,393,114	reads	from	the	30%	layer.	Separated	by	species,	3877	transcripts	were	from	C.	intestinalis,	16,663	transcripts	were	from	
Cardiosporidium,	1,689	transcripts	were	from	the	bacterial	endosymbiont	of	
Cardiosporidium.	KEGG	functionally	predicts	9,775	total	transcripts	for	
Cardiosporidium,	and	BUSCO	analysis	for	reports	69.7%	complete	and	11.9%	partial	coverage.	BUSCO	analysis	for	the	bacterial	endosymbiont	transcriptome	resulted	in	14.8%	complete	and	19.6%	partial	against	bacterial_od9.			Nephromyces	genome	The	Nephromyces	genome	assembly	remains	highly	fragmented	and	consists	of	1176	contigs	greater	than	5kb	with	a	maximum	length	of	287,191	bp	and	an	average	length	of	36	kb.	α-proteobacteria	genome	(Nαe)	Two	different	alphaproteobacteria	endosymbionts	were	recovered	from	our	genomic	data	and	assembled	into	a	draft	genome.	The	presence	of	two	closely	related	alpha	proteobacteria	genomes	both	with	high	AT	bias	(25%	GC	content)	
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and	regions	of	low	complexity	have	limited	our	ability	to	assemble	these	genomes	completely	(Table	4).		The	two	genomes	assemble	into	11	contigs	ranging	in	size	from	13	kb	to	312	kb	for	a	combined	length	of	995,540	and	an	average	of	90,503.	Based	on	transcriptome	sequencing	we	estimate	that	the	genome	is	largely	complete.	The	draft	genome	contains	844	predicted	coding	sequences,	35	tRNAs	matching	all	codons,	and	4	rRNAs.	Of	the	546	predicted	genes	have	KASS	annotations	(119	Genetic	information	processing,	32	Carbohydrate	metabolism,	30	Energy	metabolism,	29	Cellular	processes,	26	Nucleotide	metabolism,	26	Metabolism	of	cofactors	and	vitamins,	25	environmental	information	processing,	15	lipid	metabolism,	12	amino	acid	metabolism,	15	unclassified).	Bacteroidetes	Genome	(Nbe)	
Nephromyces	bacteroidetes	genome	is	circular,	494,352	nucleotides	long,	and	extremely	AT	rich	(22%	GC	content)	(Table	4).	The	genome	contains	503	predicted	genes,	31	tRNAs	predicted	to	recognize	all	codons,	and	4	rRNAs.	391	of	the	predicted	genes	have	KASS	annotations	(110	Genetic	information	processing,	40	Carbohydrate	metabolism,	38	Energy	metabolism,	31	amino	acid	metabolism,	21	Metabolism	of	cofactors	and	vitamins,	17	Nucleotide	metabolism,	11	unclassified,	10	Lipid	metabolism,	9	Cellular	processes).	Betaproteobacteria	Genome	(Nβe) The	Betaproteobacteria	genome	is	circular	and	866,396	bp	long	with	30%	GC	content	(Table	4).	It	contains	880	predicted	genes,	40	tRNAs,	and	4	rRNAs		
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Nephromyces’s	Alphaproteobacterial	genome	(Nαe) Nephromyces’s	Bacteroidetes	Genome	(NBe) Nephromyces’s	Betaproteobacterial	Genome	(Nβe)
contigs 11 1 1
size	in	BP 995,540 494,352 866,396
CDS 844 503 880
tRNA 35 31 40
rRNA 4 4 4
GC	content 25% 22% 30%
Table	4)	Genomic	assembly	statistics	for	
Nephromyces	three	bacterial	endosymbionts.		Nαe	and	Nbe	were	assembled	from	a	hybrid	assembly	of	Illumina	HiSeq	and	Pacific	Biosciences	data,	while	Nβe	was	assembled	with	Pacific	Biosciences.	Sequence	data	contained	multiple	closely	related	strains	and	these	assemblies	represent	pan-genomes	of	the	various	symbionts.	
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	(two	identical	16s	copies	and	2	identical	23s	copies).	753	of	the	880	predicted	genes	have	KAAS	annotations	(156	Genetic	information	processing,	61	Carbohydrate	metabolism,	47	Energy	metabolism,	11	Cellular	processes,	45	Nucleotide	metabolism,	68	Metabolism	of	cofactors	and	vitamins,	39	environmental	information	processing,	18	lipid	metabolism,	62	amino	acid	metabolism,	14	unclassified).			Bacterial	Genome	BUSCO	Analysis	BUSCO	analysis	against	bacteria_odb9	for	the	alphaproteobacteria	endosymbionts	resulted	in	99	complete	BUSCO	copies,	97	single	copy	and	2	duplicate,	and	5	fragmented	copies,	and	is	predicted	to	be	66.9%	complete	and	3.4%	incomplete.	For	the	bacteroidetes	endosymbiont	BUSCO	returned	88	complete	single	copy,	no	duplicates,	and	10	fragmented	for	a	59.5%	complete	and	6.8%	incomplete.	The	Betaproteobacteria	endosymbiont	had	116	complete	BUSCO	copies,	all	single	copy	(78.4%),	15	incomplete	(10.1%),	and	17	missing	(11.5%).			
Nephromyces	and	Cardiosporidium	metabolic	pathway	characterization	Endocytosis	Both	Nephromyces/Cardiosporidium	are	predicted	to	encode	genes	for	clathrin-dependant	endocytosis.	An	additional	25	genes	related	to	endocytosis	
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are	predicted	in	Nephromyces/Cardiosporidium	than	in	P.	falciparum.	Many	of	the	additional	genes	found	in	Nephromyces/Cardiosporidium	are	in	the	VPS	and	CHMP	protein	families	and	form	part	of	the	ESCRT	machinery	important	in	the	biogenesis	of	multivesicular	bodies.	Multivesicular	bodies	transport	ubiquitinated	proteins	to	lysosomes	for	degradation.	Other	proteins	not	found	in	
P.	falciparum	include	a	number	of	genes	in	the	AP2	complex,	which	are	accessory	proteins	in	clathrin-mediated	endocytosis.	The	AP2	complex	plays	an	important	role	in	the	regulation	of	the	assembly	of	clathrin-coated	vesicles.	Carbohydrate	Metabolism			 Basic	carbon	metabolism	in	Nephromyces/Cardiosporidium	is	similar	to	other	apicomplexans	and	encodes	the	complete	pathways	for	the	citrate	acid	cycle,	glycolysis,	gluconeogenesis,	and	the	pentose	phosphate	pathway.	Interestingly,	Nephromyces/Cardiosporidium	are	predicted	to	encode	far	more	genes	involved	with	inositol	phosphate	metabolism	than	either	P.	falciparum	or	
T.	gondii.	Despite	the	absence	of	genes	involved	in	the	synthesis	of	myo-inositol	in	P.	falciparum	or	T.	gondii	there	is	support	that	myo-inositol	is	used	in	intracellular	calcium	signaling	in	these	two	organisms.	How	P.	falciparum	or	T.	
gondii	are	able	to	use	myo-inositol	without	being	able	to	synthesize	it	is	unclear,	but	it	is	presumed	that	they	have	divergent	and	unrecognizable	myo-inositol	biosynthesis	genes.	However,	both	Nephromyces/Cardiosporidium	are	predicted	to	be	able	to	synthesize	myo-inositol	and	these	genes	are	readily	identifiable	as	orthologous	to	myo-inositol	biosynthesis	genes	in	other	organisms.	Both	
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Nephromyces/Cardiosporidium	have	a	copy	of	serine-pyruvate	aminotransferase	(AGXT),	which	catalyzes	glyoxylate	to	glycine	and	pyruvate.	Additionally,	
Nephromyces	encodes	malate	synthase,	which,	in	conjunction	with	acetyl-CoA,	forms	malate	from	glyoxylate.	Fatty	Acid	Metabolism	
Nephromyces/Cardiosporidium	are	predicted	to	be	able	to	perform	fatty	acid	initiation	and	elongation	in	both	the	mitochondrial	and	cytoplasmic	pathways,	as	well	as	elongation	in	the	endoplasmic	reticulum.	Additionally,	
Nephromyces/Cardiosporidium	are	predicted	to	encode	D-glycerate	3-kinase	(GLYK),	aldehyde	dehydrogenase	(ALDH),	alcohol	dehydrogenase	(ADH),	glycerol	kinase	(glpK),	glycerol-3-phosphate	O-acyltransferase	(GPAT1),	and	1-acyl-sn-glycerol-3-phosphate	acyltransferase	(plsC),	and	thus	are	able	create	triglycerides	from	glucose.			Nucleic	acid	metabolism	Unique	among	apicomplexans,	Nephromyces/Cardiosporidium	contain	a	complete	pathway	for	the	biosynthesis	of	inosine	monophosphate	(IMP).	IMP	is	a	purine	and	the	starting	molecule	for	the	biogenesis	of	guanine	and	adenine.	De	
novo	biosynthesis	of	purines	has	been	lost	in	all	sequenced	apicomplexans.	Other	apicomplexans	are	capable	of	scavenging	precursor	molecules	to	IMP	and	converting	them	into	IMP,	but	Nephromyces/Cardiosporidium	encode	the	entire	IMP	biosynthesis	pathway	from	5-Phosphoribosyl	diphosphate	(PPRP).	The	genes	involved	in	this	pathway	include	amidophosphoribosyltransferase	(purF),	
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phosphoribosylamine---glycine	ligase	(purD),	phosphoribosylformylglycinamidine	synthase	(purL),	phosphoribosylformylglycinamidine	cyclo-ligase	(purM),	phosphoribosylaminoimidazole	carboxylase	(PAICS),	phosphoribosylaminoimidazole-succinocarboxamide	synthase	(purC),	adenylosuccinate	lyase	(purB),	IMP	cyclohydrolase	(purH).	From	IMP	both	
Nephromyces/Cardiosporidium	have	the	metabolic	machinery	for	the	biosynthesis	of	adenine	and	guanine.	In	addition	to	the	biosynthesis	of	purines,	
Nephromyces/Cardiosporidium	are	also	the	only	known	apicomplexans	capable	of	purine	degradation	(Chapter	2).	Biosynthesis	of	Amino	Acids	
Nephromyces	is	predicted	to	be	able	to	synthesis	10	amino	acids	(alanine,	asparagine,	aspartic	acid,	cysteine,	glutamine,	glutamic	acid,	glycine,	methionine,	serine,	and	threonine).	Cardiosporidium	is	predicted	to	be	able	to	synthesis	the	same	amino	acids	with	the	exception	of	cysteine.	In	addition	to	the	complete	pathways	Nephromyces/Cardiosporidium	have	partial	pathways	for	synthesis	of	phenylalanine	from	phenylpyruvate	and	can	convert	tyrosine	from	phenylalanine.	Both	Nephromyces/Cardiosporidium	encode	branched-chain	amino	acid	aminotransferase,	which	adds	the	final	amine	group	to	valine,	leucine,	and	isoleucine.	Vitamin	and	cofactor	synthesis	
Nephromyces	has	the	predicted	biosynthetic	capabilities	to	produce	
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riboflavin,	acetyl	CoA,	nicotinate,	folate,	retinol,	vitamin	E,	heme,	and	ubiquinone.	
Cardiosporidium	has	similar	predicted	biosynthetic	capabilities,	but	is	only	capable	of	synthesizing	6-Geranylgeranyl-2,3-dimethylbenzene-1,4-diol	and	lacks	the	final	two	enzymes	in	the	production	of	vitamin	E.		Both	
Nephromyces/Cardiosporidium	encode	a	copy	of	lipoyl	synthase	(lipA),	but	lack	lipoyl(octanoyl)	transferase	(lipB)	in	the	lipoic	acid	synthesis	pathway.	Lipoic	acid	is	an	essential	cofactor	involved	in	the	citric	acid	cycle,	pyruvate	dehydrogenase	complex,	2-oxoglutarate	dehydrogenase	complex,	branched-chain	oxoacid	dehydrogenase,	and	acetoin	dehydrogenase.			Endosymbiont	pathways	(Figure	3)	Carbohydrate	metabolism	The	α-proteobacteria	endosymbiont	of	Nephromyces	(Nαe)	has	an	extremely	reduced	carbohydrate	metabolism,	including	all	of	the	genes	involved	with	gluconeogenesis	and	glycolysis.	The	only	carbohydrate	metabolism	genes	present	are	a	complete	citrate	acid	cycle	and	pyruvate	dehydrogenase	E1	component	(aceE),	dihydrolipoamide	dehydrogenase	(pdhD),	and	pyruvate	dehydrogenase	E2	component	(aceF),	which	converts	pyruvate	to	acetyl-CoA.	With	such	severe	reduction	in	carbohydrate	metabolism,	pyruvate	appears	to	be		the	only	carbon	source	the	alphaproteobacteria	is	capable	of	processing.	The	bacteroidetes	endosymbiont	(Nbe)	has	a	similarly	reduced	carbohydrate	metabolism	as	in	the	α-proteobacteria,	however	the	reduction	is	
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Figure	3)	Metabolic	pathway	capabilities	of	Nephromyces	(orange)	and	its	bacterial	endosymbionts	(alpha=teal,	beta=purple,	bacteroidetes=green)	solid	colored	boxes	indicated	a	complete	pathway,	light	shaded	boxes	indicated	a	partial	pathway,	and	white	boxes	indicate	the	pathway	is	not	present.		
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		not	as	extreme.	Having	lost	gluconeogenesis	the	bacteroidetes	endosymbiont	can	process	fructose	into	phosphoenolpyruvate	and	contains	pyruvate	dehydrogenase	E1	component	(aceE),	dihydrolipoamide	dehydrogenase	(pdhD),	and	pyruvate	dehydrogenase	E2	component	(aceF)	to	convert	pyruvate	into	acetyl-CoA.	While	the	full	citrate	cycle	is	incomplete	the	partial	cycle	from	2-oxoglutarate	to	oxaloacetate	is	complete,	as	well	as	the	reductive	pentose	phosphate	pathway	from	glyceraldehyde-3P	to	ribulose-5P.	
Nephromyces	β-proteobacteria	endosymbiont	(Nβe)	has	the	most	complete	carbohydrate	metabolism	encoding	the	complete	non-oxidative	pentose	phosphate	pathway,	the	citrate	cycle	from	2-oxoglutarate	to	oxaloacetate,	and	the	core	glycolysis	module	involving	three	carbon	compounds.			Fatty	Acid	metabolism	Paradoxically,	while	the	enzymes	involved	with	fatty	acid	biosynthesis	(from	malonyl-CoA	in	Nαe	and	Nβe	and	from	acetyl-CoA	in	Nbe)	are	present	in	all	three	types	of	bacterial	endosymbiont,	all	the	genes	involved	in	fatty	acid	degradation	have	been	lost	in	every	symbiont.		Nαe	and	Nβe	have	a	reduced	glycerophospholipid	metabolism	and	must	convert	phosphatidate	to	synthesis	phosphatidylethanolamine,	phosphatidylglycerol,	and	phosphatidylserine,	while	Nβe	is	able	to	de	novo	synthesize	glycerophospholipids	from	glycerone.			
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Nucleic	acid	metabolism	Purine	metabolism	is	similarly	reduced	in	both	Nαe	and	Nbe.	Both	endosymbionts	lack	all	genes	in	the	IMP	biosynthesis	pathway,	as	well	as	the	ability	to	convert	IMP	to	guanine	or	adenine.	With	so	few	purine	biosynthesis	capabilities,	all	of	the	guanine	and	adenine	for	DNA	replication	must	be	obtained	as	preformed	nucleobases.	Nβe	purine	biosynthesis	is	complete	encoding	adenylosuccinate	lyase	(purB),	and	IMP	cyclohydrolase	(purH)	and	is	able	to	synthesize	IMP	from	5-Phosphoribosyl	diphosphate	(PRPP)	(with	the	histidine	synthesis	pathway)	as	well	as	the	genes	required	to	convert	IMP	to	both	guanine	and	adenine.	However,	none	of	the	three	endosymbionts	encode	any	genes	involved	in	purine	degradation.	Both	Nαe	and	Nβe	encode	the	necessary	genes	for	pyrimidine	biosynthesis.	However,	because	Nbe	is	missing	several	genes	involved	in	pyrimidine	biosynthesis	it	seems	likely	that	Nbe	is	dependent	on	Nephromyces	for	both	purines	and	pyrimidines			Biosynthesis	of	Amino	Acids	Nαe	is	only	capable	of	synthesizing	the	amino	acids	glutamine,	glutamic	acid,	and	lysine.	Of	these	three	amino	acids,	lysine	is	the	only	amino	acid	that	Nephromyces	is	unable	to	synthesize.		Nbe	is	capable	of	synthesizing	11	amino	acids:	arginine,	aspartic	acid,	glutamine,	glutamic	acid,	glycine,	isoleucine,	leucine,	lysine,	serine,	threonine,	and	
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valine.	Bacteroidetes	is	also	able	to	synthesis	phenylpyruvate,	but	lacks	the	ability	to	the	ability	to	synthesis	phenylalanine.	Biosynthesis	of	arginine,	isoleucine,	leucine,	lysine,	and	valine	are	not	present	in	the	Nephromyces	transcriptome	and	may	represent	the	bacteroidetes	contribution.	Additionally,	Bacteroidetes	synthesis	of	phenylpyruvate,	but	inability	to	synthesis	phenylalanine	compliments	Nephromyces	synthesis	of	phenylalanine	from	phenylpyruvate,	but	inability	to	synthesis	phenylpyruvate.	Nβe	encodes	the	genes	for	11	amino	acids:	arginine,	glutamine,	glutamic	acid,	glycine,	histidine,	lysine,	phenylalanine,	proline,	serine,	threonine,	and	tyrosine.	Nβe	also	encodes	all	the	genes	for	synthesis	of	isoleucine,	leucine,	and	valine,	but	lacks	the	last	gene	in	the	pathway	branched-chain	amino	acid	aminotransferase.	However,	Nephromyces	encodes	branched-chain	amino	acid	aminotransferase	and	may	be	able	to	complete	isoleucine,	leucine,	and	valine	by	adding	the	final	amine	group.			Vitamin	and	cofactor	synthesis	Nαe	only	encodes	genes	for	the	biosynthesis	three	vitamins	and	co-factors;	heme,	ubiquinone,	and	lipoic	acid.		Lipoic	acid	has	been	experimentally	shown	to	be	exclusively	synthesized	in	the	apicoplast	in	apicomplexans;	additionally	all	lipoic	acid	used		in	the	mitochondria	needs	to	be	scavenged	from	the	host.	Lipoic	acid	may	be	an	important	product	produced	by	the	alphaproteobacteria.	In	contrast	Nbe	is	capable	of	biosynthesis	of	vitamin	B6,	
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lipoic	acid,	folate	and	vitamin	K.	Nβe	is	able	to	synthesize	most	cofactors	including	riboflavin,	vitamin	B6,	nicotinate,	coenzyme-A,	folate,	heme,	and	ubiquinone.			Secretion	and	Transporters	All	three	symbionts	encode	at	least	a	partial	bacterial	sec	secretion	system.	Nβe	is	the	most	complete	missing	only	secM.	Nαe	lacks	secE,	secG,	and	secM.	Nbe	is	the	most	incomplete	missing	secB,	secD,	secE,	secM	with	so	many	genes	missing	it	is	not	clear	if	the	sec	secretion	system	is	functional	in	Nbe.	Both	Nβe	and	Nbe	have	the	twin-arginine	translocation	pathway.	Nαe	has	TatC,	but	lacks	TatA	and	is	therefore	incomplete	[28].	While	Nαe	is	missing	the	Tat	transport	system,	Nαe	does	encode	the	type	4	bacterial	secretion	system.	In	addition	to	the	more	general	secretion	systems	there	are	also	more	specific	ABC	transporters.	Nbe	has	the	fewest	ABC	transporters	only	phospholipid	and	possibly	a	heme	transporter.	Nαe	also	encodes	a	phospholipid	and	heme	transporter	in	addition	to	a	lipoprotein	transporter	and	possibly	a	zinc	transporter.	Nβe’s	genome	contain	the	most	ABC	transporters,	including	Iron(III),	putracine,	General	L-amino	acid,	branched-chain	amino	acid,	phosphate,	lipoprotein,	lipopolysaccharide,	and	possibly	a	molybdate	transporter.			Bacterial	phylogeny	
Nephromyces	and	Cardiosporidium	alphaproteobacteria	endosymbionts	
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are	monophyletic	(98	bootstrap	support)	and	are	in	the	genus	Rickettsia	(94	bootstrap	support).	Nephromyces	bacteroidetes	endosymbiont	is	sister	to	the	genus	Pedobacter	(87	bootstrap	support)	in	the	family	Sphingobacteriaceae.	The	Betaproteobacteria	fall	within	the	genus	Bordetella	(98	bootstrap	support)		(Figure	4).					Orthology	
Nephromyces	had	21,762	genes	when	clustered	at	70%	of	these	20881	were	assigned	to	orthogroups.	39.7%	of	orthogroups	made	contained	
Nephromyces	and	there	were	eight	genus	specific	orthogroups	containing	21	genes	(Figure	5).	3,455	orthogroups	were	shared	by	Nephromyces,	Apicomplexa,	and	Chromerids.	421	orthogroups	were	shared	between	Nephromyces	and	Apicomplexa	(Figure	6).	218	orthogroups	were	shared	between	Nephromyces	and	Chromerids	that	were	not	found	in	Apicomplexa.	Cardiosporidium	had	7,395	genes,	of	which	6,977	were	assigned	to	orthogroups.	31.5%	of	orthogroups	contained	Cardiosporidium	and	there	was	one	species-specific	orthogroup	containing	five	genes.	2,778	orthogroups	were	shared	between	Cardiosporidium,	Apicomplexa,	and	Chromerids.	236	orthogroups	were	shared	between	
Cardiosporidium	and	Apicomplexa	and	not	found	in	Chromerid.	219	orthogroups	were	shared	between	Cardiosporidium	and	Chromerids	that	were	not	found	in	Apicomplexa.	Nephromyces	and	Cardiosporidium	had	3,	106	shared	orthogroups.	
Nephromyces	had	1,178	orthogroups	not	found	in	Cardiosporidium.	289		
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Figure 4) Subsets from larger 
maximum liklihood16s rRNA 
trees composed of 
Alphaproteobacteria, 
Bacteroidetes, and 
Betaproteobacteria sequences. 
Nodes are labeled with percentage 
bootstrap support values. 
Nephromyces and 
Cardiosporidium 
alphaproteobacteria 
endosymbionts are monophyletic 
and sister to the family 
rickettsiaceae. Nephromyces 
bacteroidetes endosymbiont is in 
the family sphingobacteriaceae. 
Nephromyces betaproteobacteria 
endosymbiont is sister to the 
genus Bordetella. 
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Figure	5)	Collapsed	Venn	Diagram	of	orthologous	gene	groups	from	
Nephromyces	(70%	identity	level),	Cardiosporidium,	Chromera	(V.	
brassicaformis,	C.	velia),	and	Apicomplexa	(C.	parvum,	G.	niphandrodes,	
B.	bovis,	T.	parva,	P.	falciparum,	C.	cayetanensis,	E.	brunetti,	E.	
falciformis,	E.	tenella,	H.	hammondi,	N.	caninum,	S.	neurona,	T.	gondii).	Orthology	was	predicted	with	OrthoFinder.	
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Figure	6)	Venn	Diagram	of	orthologous	gene	groups	from	
Nephromyces	(70%	identity	level),	Cardiosporidium,	Toxoplasma,	
Cryptosporidium	and	Plasmodium.	Orthology	was	predicted	with	OrthoFinder.		
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	orthogroups	were	found	in	Cardiosporidium	and	not	in	Nephromyces.	Discussion	Our	initial	aim	in	sequencing	and	comparing	the	transcriptomes	of	
Nephromyces/Cardiosporidium	was	to	better	characterize	mutualism	in	
Nephromyces.	A	mutualistic	relationship	was	described	based	on	the	unusual	epidemiology	Nephromyces,	but	high	infection	prevalence	is	not	proof	of	mutual	benefit.	While	our	current	efforts	do	not	conclusively	characterize	Nephromyces’	relation	to	its	host,	the	data	do	provide	insight	into	Nephromyces’	atypical	lifestyle.	By	comparing	Nephromyces	(a	proposed	mutualist)	to	Cardiosporidium	(a	blood	parasite)	we	are	able	to	extricate	the	evolutionary	effects	of	a	changing	relationship	from	the	evolutionary	effects	of	an	ascidian	host.	Since	all	of	the	sequencing	on	Nephromyces	has	been	on	samples	containing	multiple	Nephromyces	species,	our	Nephromyces	data	is	therefore	a	pan-transcriptome/genome.	This	approach	limits	our	results	and	conclusions.		This	is	particularly	evident	in	our	genomic	assemblies,	which	are	highly	fragmented	and	almost	certainly	poly-species	chimeric.	In	addition	to	problems	with	assembling	the	genomes	of	closely	related	organisms,	we	are	also	unable	to	estimate	gene	family	expansions	or	reductions	in	Nephromyces.	While	these	limitations	are	significant,	the	pan-transcriptome/genome	does	reflect	the	natural	biology	of	Nephromyces.	All	of	the	renal	sacs	sampled	from	the	host	M.	
manhattensis	to	date	have	contained	multiple	Nephromyces	infections.	Efforts	to	
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culture	single	species	isolates	in	the	lab	have	met	with	limited	success.	This	indicates	that	sustained	Nephromyces	infection	is	dependent	on	contributions	from	the	community	of	species	and	endosymbionts.		Notably,	by	sequencing	multiple	Nephromyces	species	we	were	able	to	recover	the	transcriptomes/genomes	of	all	three	of	Nephromyces	endosymbionts.	Recovering	multiple	bacterial	endosymbiont	types	provides	key	insights	into	how	this	system	works,	and	outweighs	the	disadvantages	of	a	pan-transcriptome/genome	approach.	The	transcriptomes	for	Nephromyces/Cardiosporidium	are	largely	complete	(estimated	by	BUSCO),	but	Cardiosporidium	is	estimated	to	be	about	10%	less	complete	than	Nephromyces.	We	have	taken	this	difference	into	account	when	comparing	these	two	data	sets.	Both	Nephromyces/Cardiosporidium	encode	an	estimated	eight	thousand	genes,	which	is	a	large	number	of	genes	for	an	apicomplexan.	This	estimate	is	similar	to	the	number	of	genes	in	the	most	gene	rich	apicomplexan,	Toxoplasma,	which	also	encodes	eight	thousand	genes.	This	is	interesting	given	the	phylogenetic	placement	of	Nephromyces/Cardiosporidium	in	the	hematozoa.	Hematozoa,	which	contains	plasmodiidae	and	piroplasmida	lineages,	have	some	of	the	smallest	genomes	with	the	least	number	of	genes	of	any	sequenced	apicomplexans.	This	high	gene	number	in	both	
Nephromyces/Cardiosporidium	may	indicate	that	greater	biosynthesis	and	metabolic	capabilities	are	necessary	for	living	in	an	ascidian	host.	The	two	most	striking	observations	made	over	the	course	of	this	
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exploration	involve	purine	metabolism.	The	first	is	purine	degradation;	both	
Nephromyces/Cardiosporidium	have	the	metabolic	capabilities	to	convert	xanthine	into	glyoxylate.	Glyoxylate	can	then	be	converted,	with	serine-pyruvate	aminotransferase	(AGXT),	into	glycine	and	pyruvate;	Nephromyces	additionally	encodes	malate	synthase	(MLS),	which	combines	Glyoxylate	and	acetyl-CoA,	into	malate.	This	is	the	proposed	primary	route	of	carbon,	nitrogen,	and	energy	acquisition	for	Nephromyces	(Chapter	2).	This	pathway	is	absent	in	all	other	sequenced	apicomplexans,	but	it	appears	the	enzymes	in	this	pathway	were	retained	from	the	last	common	ancestor	of	Apicomplexa,	and	not	a	more	recent	horizontal	gene	transfer.	
Nephromyces/Cardiosporidium	also	purine	metabolism	is	de	novo	purine	biosynthesis.	While	some	apicomplexan	lineages	have	one	or	two	genes	to	synthesize	inosine	monophosphate	(IMP)	from	immediate	precursors,	
Nephromyces/Cardiosporidium	are	predicted	to	encode	the	entire	de	novo	purine	synthesis	from	5-Phosphoribosyl	diphosphate	(PRPP).	As	the	inability	to	synthesize	purines	has	been	widely	targeted	for	drug	development	against	other	apicomplexan	species,	its	presence	in	Nephromyces/Cardiosporidium	is	surprising	[29].	 The	presence	of	both	purine	degradation	and	purine	synthesis	could	be	critical	to	Nephromyces’	unusual	epidemiology.	By	obtaining	the	bulk	of	the	required	carbon,	nitrogen	and	energy	from	a	metabolic	waste	product	(i.e.	tunicates	lack	the	enzymatic	ability	to	degrade	purines	past	uric	acid),	
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Nephromyces	is	able	to	limit	its	impact	on	the	host	while	still	reaching	high	cellular	densities.	De	novo	synthesis	of	purines	indicates	that	neither	
Nephromyces/Cardiosporidium	is	dependent	of	the	host	for	IMP.	In	fact,	these	purine	degradation	and	biosynthesis	pathways	may	have	been	the	integral	factors	that	allowed	Nephromyces	to	leave	the	intracellular	environment	and	colonize	the	renal	sac.	Another	critical	factor	in	Nephromyces’	ability	to	survive	in	the	renal	sac	is	likely	its	bacterial	endosymbionts.	The	α-proteobacteria	endosymbionts	found	in	
Nephromyces	and	Cardiosporidium	are	monophyletic,	which	indicates	they	have	been	maintained	and	vertically	transmitted	since	the	divergence	of	Nephromyces	and	Cardiosporidium.	In	addition	to	the	α-proteobacteria,	Nephromyces	has	acquired	a	β-proteobacteria	and	a	Bacteroidetes	endosymbiont.	The	α-proteobacteria	and	Bacteroidetes	symbionts	show	a	marked	reduction	in	carbon	metabolism	with	the	Nαe,	only	encoding	genes	for	the	citric	acid	cycle.	Bacteroidetes	is	only	capable	of	processing	three	carbon	compounds	and	encodes	a	partial	citric	acid	cycle.	Such	pronounced	reduction	suggests	that	Nephromyces	provides	its	symbionts	a	limited	‘diet’.	In	both	symbionts,	carbon	metabolism	may	be	dependent	on	pyruvate,	which	is	one	of	the	products	of	AGXT.	Related	to	this	limited	carbon	metabolism,	all	three	of	the	bacterial	endosymbionts	paradoxically	encode	complete	fatty	acid	biosynthesis,	but	lack	fatty	acid	degradation.	Presumably,	the	fatty	acid	biosynthesis	is	for	the	construction	of	membranes,	but	without	fatty	acid	degradation	these	symbionts	are	incapable	of	
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processing	fatty	acids	as	a	carbon	source.	Both	Nαe	and	Nβe	lack	complete	pathways	for	the	creation	of	glycerophospholipids,	and	both	contain	phospholipid	ABC	transporters.	This	could	indicate	a	dependence	on	
Nephromyces	for	phospholipids.	None	of	the	three	endosymbionts	of	Nephromyces	contain	any	genes	involved	in	purine	degradation.	The	absence	of	this	entire	pathway	in	the	genomes	of	the	endosymbionts	is	further	support	that	the	high	levels	of	uric	oxidase	detected	are	from	Nephromyces	and	not	from	any	of	its	bacterial	endosymbionts.	Similarly,	Nβe	and	Nαe	do	not	encode	any	genes	involved	in	de	
novo	purine	biosynthesis,	including	genes	for	the	conversion	from	IMP	to	adenine	and	guanine.	Nβe	can	likely	synthesize	purines	from	PPRP	through	the	histidine	biosynthesis	pathway	and	contains	the	genes	to	synthesize	adenine	and	guanine	from	IMP.		The	total	lack	of	purine	biosynthesis	genes	in	both	Nβe	and	Nαe	makes	these	symbionts	dependent	on	Nephromyces	for	both	adenine	and	guanine.	If	
Nephromyces	were	incapable	of	de	novo	purine	biosynthesis	then	the	entire	renal	sac	community	would	be	dependent	on	either	the	tunicate	host	for	all	purines,	or	on	Nβe.	This	would	be	a	significant	burden	on	the	host	and	would	markedly	increase	the	cost	of	infection,	which	does	not	align	with	Nephromyces’	strategy	of	low	virulence	and	high-density	infection	of	its	host.		This	argument	adds	support	to	the	prediction	that	Nephromyces/Cardiosporidium	are	able	to	synthesize	purines.			Given	the	reduced	genomes	and	correspondingly	reduced	metabolic	
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capabilities,	Nβe	and	Nbe	encode	a	large	proportionally	high	number	of	genes	for	synthesizing	amino	acids,	vitamins,	and	co-factors.	Together	Nβe	and	Nbe	could	provide	Nephromyces	with	all	but	one	essential	amino	acid	(tryptophan).	Nβe	is	predicted	to	synthesize	leucine,	isoleucine,	and	valine	up	to	the	last	step,	where	the	final	amine	group	is	added.	Conversely,	Nephromyces	only	encodes	the	last	step	in	the	conversion	of	these	three	amino	acids.	Similarly,	Nbe	encodes	a	partial	biosynthetic	pathway	for	phenylalanine,	which	seems	to	be	complemented	by	
Nephromyces.	Nαe	is	capable	of	synthesizing	three	amino	acids	and	only	one,	which	is	an	essential	amino	acid,	is	not	encoded	by	Nephromyces	(lysine).	Vitamin	and	cofactor	biosynthesis	in	Nαe	is	also	limited,	synthesizing	heme,	ubiquinone,	and	lipoic	acid,	with	lipoic	acid	being	the	only	product	Nephromyces	may	be	incapable	of	synthesizing	itself.	With	such	limited	vitamin	and	amino	acid	metabolism	encoded	in	the	Nαe	genome	it	is	unlikely	that	Nephromyces	is	maintaining	Nαe	just	for	lysine	biosynthesis,	but	from	the	data	we	are	unable	to	propose	what	particular	function	Nαe	serves	Nephromyces.	In	addition,	all	of	the	limited	species	infections	of	Nephromyces	we	have	been	able	to	culture	so	far	have	an	Nαe	type	of	symbiont.	While	neither	the	frequency	of	Nαe	or	the	limited	species	cultures	are	strong	support	for	the	Nαe	symbiont	being	essential,	it	does	suggest	that	Nαe	may	have	an	important	role	in	Nephromyces	metabolism.			As	more	apicomplexan	genomes	are	sequenced	it	is	becoming	apparent	that	while	they	do	share	a	large	core	subset	of	proteins,	the	differential	losses	and	
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expansions	are	very	lineage	specific.	This	is	likely	due	to	adaptations	required	for	specific	host	biology.	Each	lineage	displays	a	characteristic	patchwork	of	different	gene	losses	and	expansions.	Many	of	these	lineages	contain	orthologs	with	the	Chromerids	that	are	not	found	in	other	apicomplexan	lineages.	Nephromyces	and	
Cardiosporidium	have	retained	both	purine	biosynthesis	and	degradation,	which	has	been	lost	in	all	other	apicomplexan	lineages.	There	may	be	something	particular	to	ascidian	biology	that	necessitates	retaining	and	expressing	these	purine	metabolism	pathways.	Nephromyces	and	Cardiosporidium	share	the	vast	majority	of	their	genes	with	each	other,	as	well	as	encoding	the	majority	of	the	commonly	shared	apicomplexan	genes.	With	so	many	metabolic	similarities	between	Cardiosporidium	and	Nephromyces,	we	were	unable	to	detect	any	clear	differences	related	to	Nephromyces’	proposed	mutualistic	relationship.		While	there	are	no	obvious	differences	between	Nephromyces	and	
Cardiosporidium,	we	are	severely	limited	by	a	lack	of	lineage	specific	proteomic	work.	In	other	apicomplexans	the	gene	families	that	modulate	host	immunity	are	highly	lineage	specific.	In	Nephromyces/Cardiosporidium,	the	mechanisms	of	host	manipulation	are	entirely	unknown.	Without	a	greater	understanding	of	how	both	Cardiosporidium	and	Nephromyces	interact	with	their	host	at	a	proteomic	level,	we	are	unable	to	conclusively	say	that	there	is	a	difference	between	these	two	organisms.		
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Methods	
Molgula	manhattensis	collection	
Molgula	manhattensis	tunicates	were	collected	from	a	dock	in	Greenwich	Bay,	Rhode	Island	(41°39'22.7"N	71°26'53.9"W)	in	July	2014.	A	single	renal	sac	was	separated	from	one	tunicate,	and	all	extraneous	tissue	removed.	The	intact	renal	sac	was	placed	in	liquid	nitrogen	for	5	min	and	then	stored	at	-80°C.			
Cardiosporidium	cionae	collection,	isolation,	and	concentration	
Ciona	intestinalis	were	collected	from	Matunuck	Marina,	RI	(41.3890°	N,	71.5201°	W),	in	August	2017.	Tunics	were	removed	and	the	body	wall	was	opened	to	allow	access	to	the	heart.	A	sterile	syringe	was	used	to	remove	cardiac	blood	as	cleanly	as	possible.	Blood	was	kept	at	4°	C	until	Cardiosporidium	infection	was	verified	using	Giemsa	stain	to	visualize	Cardiosporidium.	Heavily	infected	samples	were	pooled	together	and	centrifuged	at	500g	for	5	minutes.	The	resulting	supernatant	was	removed	and	the	samples	were	frozen	in	liquid	nitrogen	and	stored	at	-80°	C.	Samples	with	high	rates	of	infection	were	enriched	for	Cardiosporidium	using	sucrose	gradients	[30,	31].	Gradients	of	20,	25,	30,	35,	40%	sucrose	solutions	in	phosphate	buffer	were	layered	together.	Approximately	5	ml	of	tunicate	blood	was	added	to	the	column	and	centrifuged	at	1750g	for	30	mins	at	4°	C.	The	25%	and	30%	layers	were	collected	(based	on	visual	screens	showing	high	Cardiosporidium	cell	density	and	low	tunicate	cell	density),	washed	with	PBS	twice,	pelleted	and	then	frozen	in	liquid	nitrogen	and	stored	at	-80°	C.	
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		RNA	Extraction	RNA	extraction	buffer	(Zymo	Research	LLC.	Irvine,	CA)	was	added	to	samples	and	ground	with	a	pestle.	Following	grinding,	the	Zymo	Quick-RNA	kit	(Zymo	Research	LLC.	Irvine,	CA)	was	used	and	the	manufacturer's	protocol	was	followed.	RNA	was	converted	to	cDNA	and	sequenced	at	the	School	of	Medicine	Genome	Resource	Center,	University	of	Maryland.	One	paired-end	RNA	library	was	run	on	one	lane	of	the	Illumina	HiSeq	platform.	Resulting	in	40,606,230	from	the	M.	manhattensis	renal	sac.	For	Cardiosporidium,	three	samples	of	C.	
intestinalis	blood	were	used:	one	with	unseparated	blood,	one	enriched	with	cells	collected	at	the	25%	sucrose	gradient,	and	one	enriched	with	cells	from	the	30%	sucrose	gradient	were	multiplexed	on	one	lane	of	the	Illumina	HiSeq	platform,	resulting	in	92,250,706,	109,023,104,	and	110,243,954	reads	respectively.	Transcriptome	data	was	assembled	and	proteins	were	predicted	with	Trinity/Trinotate	pipeline	version	2.4.0	run	on	the	server	at	Brown	University	Center	for	Computation	and	Visualization	[32].	Reads	assembled	into	145674	and	109,446	contigs	from	M.	manhattensis	and	C.	intestinalis	respectively.	Protein	sequences	were	predicted	using	Transdecoder	[32].	Blastp	was	used	to	identify	bacterial	sequences	from	assembled	transcripts	against	NCBI’s	refseq	and	binned.	Remaining	Eukaryotic	sequences	were	separated	with	blastp	against	a	custom	database	of	alveolate	and	ascidian	transcriptomes.	Trimmed	reads	were	mapped	back	to	each	of	the	six	bins	(Nephromyces,	M.	manhattensis,	Nephromyces	
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bacteria,	Cardiosporidium,	C.	intestinalis,	and	Cardiosporidium	bacteria)	and	then	reassembled	independently	in	Trinity.	The	Nephromyces	transcriptome	was	composed	of	multiple	Nephromyces	species,	and	CD-hit	was	used	to	cluster	transcripts	based	on	50	percent	identity.	Transcriptome	completeness	was	assessed	with	Busco	v3	against	the	Eukaryotic	and	bacterial	reference	data	sets	[33].	Transcripts	were	annotated	using	Interproscan	[34].	DNA	Extraction	The	renal	sacs	from	8	lab	grown	M.	manhattensis	individuals	were	dissected	and	their	renal	fluid	was	pooled	in	a	1.5ml	Eppendorf	tube.	Contents	were	centrifuged	at	8000g	for	5	min.	to	pellet	Nephromyces	cells,	and	following	centrifugation	the	renal	fluid	was	discarded.	500µl	of	CTAB	buffer	with	5ul	of	proteinase	K	and	ceramic	beads	were	added	to	the	pelleted	Nephromyces	cells.	The	sample	was	placed	in	a	bead	beater	for	3	min.	and	then	on	a	rotator	for	1.5hrs	at	room	temp.	500µl	of	chloroform	was	added,	mixed	gently	and	centrifuged	for	5	min.	The	top	layer	was	removed	and	twice	the	sample	volume	of	ice	cold	100%	EtOH	and	10%	sample	volume	of	3M	sodium	acetate	were	added	to	the	sample	and	incubated	a	-20C	overnight.	The	sample	was	centrifuged	at	16000g	for	30	min.	and	the	liquid	was	removed.	Ice	cold	70%	EtOH	was	added	and	centrifuged	at	16000g	for	15	min.	Liquid	was	removed	and	sample	air	dried	for	2	min.	DNA	was	re-eluted	in	50ul	of	deionized	water.	Illumina	Sequencing	A	nanodrop	(2000c,	Thermo	Scientific)	was	used	to	assess	DNA	purity	and	
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DNA	concentration,	and	a	genomic	gel	was	run	to	assess	DNA	fragmentation.	Following	quality	control,	an	Illumina	library	was	constructed.	Library	prep	and	sequencing	were	done	at	the	URI	Genomics	and	Sequencing	Center	(URI	GSC).	The	completed	library	was	sequenced	on	the	Illumina	MiSeq	platform	at	the	URI	GSC	and	the	HiSeq	platform	at	the	University	of	Baltimore	sequencing	center	on	three	lanes.	Pacific	Biosciences	Sequencing	Using	the	contents	of	150	M.	manhattensis	renal	sacs	(done	in	batches	of	10	then	pooled),	the	same	DNA	extraction	protocol	was	performed	as	for	Illumina	sequencing.	DNA	was	sequenced	using	three	SMRT	cells	on	the	Pacific	Biosciences	platform	at	the	University	of	Baltimore	sequencing	center.	Illumina	assembly	One	MiSeq	lane	and	three	lanes	of	HiSeq,	all	from	the	same	library,	were	trimmed	using	Trimmomatic	[35]	and	then	assembled	using	Spades	[36]	assembler	on	the	URI	server	BlueWaves.		Pacific	Biosciences	assembly	Pacific	Biosciences	reads	were	error	corrected	using	pbsuite/15.8.24	[37]	on	the	Brown	University	server,	Oscar.	Reads	were	then	assembled	using	Canu	[38].	Contigs	generated	by	Canu	were	combined	with	Illumina	MiSeq/HiSeq	short	reads	with	Abyss	v2.02	[39].	Nephromyces	contigs	were	identified	by	mapping	
Nephromyces	transcriptome	reads	using	Bowtie2.	Contigs	with	greater	than	90x	coverage	as	assessed	with	bedtools	[40]	were	binned	as	Nephromyces.	
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Bacterial	endosymbiont	genome	assembly	Using	the	contigs	from	the	Abyss	assembly	bacterial	contigs	were	initially	identified	by	hexemers	using	VizBin	[41].	Transcriptomic	reads	that	were	identified	as	bacterial	were	mapped	using	Bowtie2	[42].		Bacterial	contigs	were	separated	based	on	a	90x	coverage	threshold	with	bbmap.	Binned	bacterial	contigs	were	preliminarily	annotated	with	Prokka	[43].	Resulting	annotations	were	run	through	KEGG	GhostKoala	to	assign	and	separate	by	taxonomy.	Taxon	separated	contig	bins	were	merged	and	scaffolded	using	PBJelly	from	the	PBsuite	of	tools	[37].	Trimmed	Illumina	MiSeq	and	HiSeq	reads	were	remapped	to	resulting	contigs	to	insure	accurate	assembly	using	Bowtie2.	Final	assembled	bacterial	genomes	were	re-annotated	with	Prokka	with	a	genus	specific	database.	Bacterial	phylogeny	16s	rRNA	sequences	from	Nephromyces	bacterial	endosymbiont	genomes,	predicted	by	rRNAammer,	and	16S	rRNA	sequences	from	Cardiosporidium	transcriptome	were	used	in	the	phylogenetic	analysis.	All	16s	rRNA	rickettsiales,	sphingobacteriaceae,	and	alcaligenaceae	sequences	with	a	minimum	length	of	1300bp	available	on	NCBI’s	refseq	were	downloaded	separately.	Sequences	were	aligned	with	MAFFT	[44]	with	G-INS-I	and	trimmed	to	length	in	Geneious	6.	Maximum	likelihood	trees	of	the	alignments	were	generated	with	RAxML	v	8.2.0	using	the	GTRCAT	model	run	for	10000	generations	with	100	generation	burn	in	[45].	Orthology	
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The	following	apicomplexan	and	Chromerid	transcriptomes	were	downloaded	from	EuPathDB:	C.	parvum	Iowa,	G.	niphandrodes,	B.	bovis	T2Bo,	T.	
parva	Muguga,	P.	falciparum	3D7,	C.	cayetanensis,	E.	brunetti	Houghton,	E.	
falciformis	Bayer	Haberkorn,	E.	tenella	Houghton,	H.	hammondi	HH34,	N.	caninum	LIV,	S.	neurona	SN3,	T.	gondii	ME49,	C.	velia	CCMP2878,	V.	brassicaformis	CCMP3155.	These	transcriptomes	were	combined	with	Cardiosporidium	and	
Nephromyces	(clustered	at	the	70%	identity)	Orthofinder	v.	2.2.6	was	used	to	assign	transcripts	to	orthologous	groups.	
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CHAPTER	4	
Abstract	Monogenus	multi-species	infections	are	common	in	many	Apicomplexans.	However,	these	multi-species	infections	are	often	overlooked	unless	specifically	targeted.	Using	amplicon	primers	designed	to	target	18s	rRNA,	COI,	and	16s	rRNA	we	attempted	to	quantify	the	species	diversity	and	incidence	of	multi-species	infections	of	Nephromyces	in	the	tunicate	host	Molgula	manhattensis	collected	in	a	limited	geographic	area	from	the	waters	of	Rhode	Island.	Our	data	indicate	that	Nephromyces	is	hyper	diverse	and	multispecies	infections	are	nearly	universal.	
	
Introduction	
Nephromyces	is	a	genus	of	Apicomplexa	with	a	symbiotic	relationship	with	their	hosts,	tunicates	in	the	family	molgulidae.	First	described	in	1874	by	de	Lacaze-Duthiers,	Nephromyces	was	given	several	“identities”	until	it	was	finally	placed	in	Apicomplexa	using	molecular	phylogenetics	(Saffo	et	al.	2010).	Part	of	the	confusion	over	its	taxonomic	affinity	was	because	Nephromyces	inhabits	the	renal	sac,	a	structure	unique	to	the	molgulid	tunicates.	While	the	function	of	the	renal	sac	in	not	understood,	it	contains	high	levels	of	uric	acid	and	calcium	oxalate	(Saffo	and	Lowenstam	1978).	Based	on	the	metabolic	capacity	of	
Nephromyces,	it	appears	to	use	uric	acid	for	the	purpose	of	primary	carbon	and	nitrogen	acquisition	(Chapter	2).	In	order	to	supplement	a	diet	of	uric	acid,	
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Nephromyces	relies	on	bacterial	endosymbionts	for	the	biosynthesis	of	metabolites	from	pathways	missing	from	its	genome	(Chapter	3).	Three	different	types	of	bacterial	endosymbionts	have	been	found	in	the	genus	Nephromyces,	an	alphaproteobacteria	in	Rickettsia,	a	betaproteobacteria	in	Bordetella,	and	a	bacteroidetes	in	the	family	sphingobacteriaceae	(Chapter	3).	Despite	genomic	data,	which	indicates	that	these	different	types	of	bacteria	are	not	functionally	equivalent,	no	species	of	Nephromyces	has	been	shown	to	have	more	than	one	type	of	bacterial	endosymbiont	(Seah	et	al.	2011).		Based	on	preliminary	genomic	and	transcriptomic	sequencing	of	
Nephromyces	it	became	apparent	that	there	was	a	surprising	amount	of	genetic	diversity	in	the	genus.	In	addition	to	the	high	levels	of	genetic	diversity,	
Nephromyces	also	had	high	incidences	of	multi-species	infections	within	individual	renal	sacs.	Attempts	to	culture	single	species	infections	and	limited	species	(3-5	isolates)	infections	in	the	lab	were	met	with	mixed	success,	but	even	limited	species	populations	did	poorly	compared	to	the	cultures	that	contained	species	numbers	that	better	approximated	wild	samples.	To	quantify	the	biological	diversity	and	the	incidence	of	multispecies	
Nephromyces	infections	found	in	molgulid	tunicates,	we	used	an	amplicon	sequencing	approach.	Because	polymorphic	18S	rDNA	sequences	have	been	reported	in	Plasmodium	(Li	et	al.	1997),	we	targeted	the	Cytochrome	Oxidase	I	(CO1)	mitochondrial	gene,	as	well	as	the	18S.	In	order	to	account	for	the	endosymbiotic	diversity	within	the	Nephromyces	population,	we	also	targeted	the	
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bacterial	16S	rRNA.	Genomic	data	indicate	that	members	of	Rickettsia,	Bordetella,	and	sphingobacteriaceae	are	endosymbionts	of	Nephromyces	isolates,	but	their	diversity	is	unknown.			
Methods		Fifty	Molgula	manhattensis	tunicates	were	collected	from	a	single	floating	dock	located	in	Greenwich	Bay,	RI	(41°	39'	11.009"	N	71°	27'	5.843"	W),	over	a	period	of	4	weeks	in	the	summer	of	2016.	Renal	sacs	were	dissected	out	of	the	animals	and	contents	were	collected	by	a	micropipette	and	placed	in	1.5	ml	Eppendorf	tubes.	Dissecting	tools	were	sterilized	in	a	10%	bleach	solution	for	15	min	and	then	rinsed	between	tunicates.	Sample	tubes	were	immediately	frozen	in	liquid	nitrogen	for	five	minutes	and	subsequently	stored	at	-80°	C.	DNA	was	extracted	using	the	method	described	in	(Chapter	2).	Extracted	DNA	was	stored	at	-20°	C.	The	18S	rRNA	primers	and	CO1	primers	were	designed	to	target	Nephromyces	based	on	available	genomic	data	(Chapter	3).	The	universal	16S	rRNA	primers	from	(Klindworth	et	al.	2013)	were	used	to	amplify	the	bacterial	endosymbionts	from	Nephromyces.	The	Illumina	adaptor	sequence	was	added	to	the	start	of	each	primer	resulting	in	the	following	sequences	18Sf	(TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCGGTAATTCCAGCTCC),	18Sr	(GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGTGCTTTCGCAGTAGTYYGTCTTT),	CO1f	(TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGYGGWGTAGGWSCWGGWTGGA),	
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CO1r	(GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGACTTCWGGATGWCCAAARAA)	16Sf	(TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG),	16Sr	(GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC).	For	each	sample,	PCR	was	performed	with	all	three	primer	sets	with	the	following	cycle	94°	C	2	min	(94°	C	30	sec,	55°	C	30	sec,	72°	C	45	sec)	x	35,	72°	C	5	min.	Resulting	PCR	products	were	visually	inspected	on	an	agarose	gel	and	quantity	estimated	with	a	nanodrop.	Twenty	microliters	of	PCR	product	from	each	of	the	three	primer	sets	was	pooled	into	a	single	tube	corresponding	to	an	individual	tunicate.	The	pooled	sample	was	cleaned	using	the	ampure	bead	purification	with	a	0.7%	solution	of	Agencourt	AMPure	beads	(Beckman	Coulter).	The	addition	of	well	specific	adaptors,	library	preparation,	and	sequencing	was	done	at	the	URI	genomic	sequencing	center	on	the	Illumina	MiSeq	platform.	Sequence	data	were	de-multiplexed	prior	to	analysis.	Bduck	from	the	bbmap	suit	of	tools	was	used	to	bin	reads	based	on	CO1	primers	(Bushnell	2014).	The	universal	18S	rRNA	and	16S	rRNA	primers	were	too	conserved	for	reliable	binning	based	on	primers,	so	reads	were	screened	against	the	PR2	database	using	the	NCBI’s	magicblast	(Boratyn	et	al.	2018).	Sequences	with	an	85%	ID	and	35%	coverage	were	classified	as	18S	sequences	and	binned	into	a	new	file	composed	of	18S	reads.		Adaptors	and	primer	sequences	were	remove	from	the	forward	and	reverse	reads	from	each	of	the	three	read	sets	using	bduck.	
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Cleaned	and	binned	read	sets	were	individually	processed	in	R	using	dada2	with	the	pool=”pseudo”	setting	(Callahan	et	al.	2016).	Assembled	18S	and	16S	were	assigned	taxonomies	with	the	PR2	database	(Guillou	et	al.	2013).	Cytochrome	oxidase	1	(CO1)	sequences	were	assigned	taxonomy	using	BLASTx	against	NCBI’s	refseq_protein	database.	All	18S	and	CO1	sequences	that	were	not	apicomplexan	were	removed	from	the	count	table,	taxonomy	table,	and	sequence	files.	Remaining	sequences	were	aligned	with	MAFFT	(Katoh	and	Standley	2013)	to	16S	rRNA	sequences	from	the	three	known	bacterial	endosymbionts	found	in	
Nephromyces.	Reference	sequences	were	trimmed	to	the	amplicon	sequence	length	and	CD-hit	was	used	to	cluster	sequences	with	85%	sequence	identity.	All	bacterial	sequences,	which	did	not	cluster	were	deemed	contamination	and	removed	from	count	table,	taxonomy	table,	and	sequences	file.	Remaining	18S	and	CO1	sequences	were	aligned	with	MAFFT	and	trimmed	to	the	same	length.	Sequences	were	clustered	at	100%,	99%,	98%,	97%,	96%,	95%,	94%	sequence	identity	levels	using	CD-hit	(Li	and	Godzik	2006).	Sequences	from	18S,	CO1	clusters	and	16S	bins	corresponding	to	endosymbiont	type	were	processed	individually	in	R.	Figures	were	made	in	R	using	ggplot	(Wickham	2016).		
Results	The	amplicon	sequencing	run	resulted	in	25,895,690	reads	with		average	reads	per	sample	of	137,743.	After	binning	there	were	4,930,010	CO1	reads,	
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6,491,918	18S	reads,	and	14,468,228	16S	reads.	Following	assembly	in	dada2	and	decontamination	there	were	1,876,107	sequences	corresponding	to	329	amplicon	sequence	variants	(ASVs)	for	18S,	1,522,378	sequences	corresponding	to	188	ASVs	for	CO1,	and	62,905	sequences	with	152	ASVs	for	16S.	Of	the	329	18S	ASVs	there	is	an	average	of	79.26	ASVs	per	tunicate	individual	with	a	max	of	145	ASVs	and	a	min	of	34	ASVs.	When	clustered	at	the	more	taxonomically	relevant	98%	identity	there	are	23	clusters	with	an	average	of	5.1	per	tunicate	individual	with	a	max	of	11	and	a	min	of	3	(Figure	7).	The	most	common	ASVs	were	seen	in	59.57%	of	samples	the	least	common	in	2.12%,	when	clustered	at	98%	these	numbers	rise	to	86.17%	and	2.12%.	There	is	a	total	of	188	CO1	ASVs	with	an	average	of	52.8	ASVs	per	tunicate	a	max	of	101	and	a	min	of	16.	When	clustered	to	the	98%	identity	level	there	are	a	total	of	26	clusters	an	average	of	6.24	and	10/2	max/min	(Figure	8).	The	most	common	AVSs	were	found	in	53%	of	tunicates	sampled	and	the	rarest	ASVs	were	in	2%.	After	clustering	at	98%	the	most	common	clusters	were	in	75.5%	of	tunicates	the	rarest	in	2%.	From	a	total	of	152	16s	ASVs	classified	as	Nephromyces	bacterial	endosymbionts	49	were	recovered	from	Bordetella,	89	from	Rickettsia,	and	14	from	sphingobacteriaceae.	The	average	number	of	16S	ASVs	per	tunicate	is	13.94	with	a	max	of	49	and	a	min	of	0	(Figure	9).	Forty	percent	of	samples	contained	all	three	types	of	bacterial	endosymbiont	and	90%	contained	at	least	two	of	the	bacterial	endosymbiont	types.	There	were	two	samples,	which	did	not	contain		
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Figure	7)	Grouped	scatterplot	of	Nephromyces	18s	rRNA	ASV’s	clustered	at	different	percent	identity	levels.	Each	dot	represents	the	number	of	ASV’s	from	an	individual	tunicate	sample,	squares	indicate	mean	per	sample	(labeled	to	the	side),	and	error	bars	indicate	one	standard	deviation.	Without	clustering	the	average	number	of	ASV’s	is	79.26	per	sample	and	max	of	145	and	a	min	of	34.	When	clustered	at	98%	identity	the	average	number	of	sequences	per	sample	falls	to	5.1	with	a	max	of	11	and	a	min	of	3.	
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Figure	8)	Grouped	scatterplot	of	Nephromyces	COI	ASV’s	clustered	at	different	percent	identity	levels.	Each	dot	represents	the	number	of	ASV’s	from	an	individual	tunicate	sample,	squares	indicate	mean	per	sample	(labeled	to	the	side),	and	error	bars	indicate	one	standard	deviation.	Without	clustering	the	average	number	of	ASV’s	is	52.8	per	sample	and	max	of	101	and	a	min	of	16.	When	clustered	at	98%	identity	the	average	number	of	sequences	per	sample	falls	to	6.24	with	a	max	of	10	and	a	min	of	2.	
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Figure	9)	Grouped	scatterplot	of	16s	rRNA	ASV’s	from	Nephromyces	bacterial	endosymbionts.	Purple	is	all	bacterial	combined,	blue	is	the	Bordetella	only,	red	is	Rickettsia,	and	green	in	sphingobacteriaceae.		Each	dot	represents	the	number	of	ASV’s	from	an	individual	tunicate	sample,	squares	indicate	mean	per	sample	(labeled	to	the	side),	and	error	bars	indicate	one	standard	deviation.	An	average	of	13.98	bacterial	ASV’s	per	sample	with	7.08	
Bordetella,	5.1	Rickettsia,	and	1.8	sphingobacteriaceae.	
 
 116 
	any	ASVs	assigned	as	Nephromyces	bacterial	endosymbionts.	Of	the	25	samples	that	contained	two	bacterial	endosymbionts	the	
Bordetella	type	was	in	23	of	the	samples,	Rickettsia	was	in	21	of	the	samples,	and	the	sphingobacteriaceae	type	was	present	in	6	of	the	samples.	Bordetella	and	
Rickettsia	were	found	together	in	76%	(19)	of	renal	sacs	with	two	detected	bacterial	endosymbiont	types,	Bordetella	and	sphingobacteriaceae	in	16%	(4),	and	Rickettsia	and	sphingobacteriaceae	in	8%	(2).				
Discussion	The	high	numbers	of	ASVs	obtained	in	this	study	reveal	that	Nephromyces	is	extremely	diverse,	and	in	all	instances,	Nephromyces	infections	are	multi-species	infections.	There	was	one	renal	sac	that	only	contained	a	single	18S	rRNA	sequence,	but	that	renal	sac	had	multiple	CO1	sequences	and	is	likely	the	result	of	poor	18S	PCR	amplification	of	this	sample.	The	diversity	observed	from	amplicon	sequencing	is	extreme,	but	it	is	supported	by	genomic	and	transcriptomic	sequencing	on	Nephromyces	(Chapter	2),	as	well	as	by	cloning	of	full-length	18S	sequences.	Despite	the	substantial	diversity,	the	results	are	consistent	across	multiple	datasets.	The	different	number	of	18S	and	CO1	ASVs	indicate	that	each	
Nephromyces	species	encodes	multiple	copies	of	18S	with	different	sequences,	as	previously	described	from	Plasmodium	(Li	et	al.	1997).	While	CO1	is	also	likely	found	in	multiple	copies	in	a	cell,	based	on	genomic	data	we	do	not	have	any	
 117 
reason	to	suspect	that	CO1	copies	differ	in	sequence.	A	similar	level	of	diversity	is	observed	among	the	16S	ASVs,	which	is	consistent	with	a	vertically	transmitted	bacterial	endosymbiont.	When	ASVs	for	18S	and	CO1	are	clustered	at	a	98%	sequence	identity	to	give	an	approximate	species	number,	we	estimate	that	there	are	an	average	of	~5	different	Nephromyces	species	per	M.	manhattensis	host,	with	some	M.	
manhattensis	containing	as	many	as	10-11	Nephromyces	species.	Whereas	multispecies	apicomplexan	infections	are	relatively	common	(Anderson	et	al.	2000;	Lee	et	al.	2011;	Arnott	et	al.	2012;	Lalremruata	et	al.	2017),	the	diversity	found	among	Nephromyces	infecting	a	single	host	species	is	striking.	The	precise	reasons	for	such	high	diversity	are	not	known.	However,	we	hypothesize	that	high	levels	of	diversity	may	be	due	to	the	dependence	of	Nephromyces	species	on	essential	amino	acids,	co-factors,	and	vitamins	produced	by	their	bacterial	endosymbionts.	Based	on	the	different	metabolic	capabilities	of	the	Nephromyces	bacterial	endosymbionts,	we	postulated	that	Nephromyces	might	be	dependent	on	metabolites	produced	by	bacterial	endosymbionts	in	conspecifics	(Chapter	2).	The	high	proportion	of	tunicates	containing	at	least	two	of	the	bacterial	endosymbiont	types,	90%,	supports	this	hypothesis.	Only	two	samples	did	not	contain	any	bacterial	endosymbionts	and	three	contained	only	one	type	of	bacterial	endosymbiont.	This	may	be	due	to	sampling	error	and	the	endosymbionts	were	either	not	amplified	in	the	initial	PCR,	or	one	endosymbiont	
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was	preferentially	amplified.		In	samples	where	only	two	types	of	bacterial	endosymbionts	were	detected	the	Bordetella/Rickettsia	pairing	were	the	most	common	(76%	of	renal	sacs	with	two	bacterial	types).	Based	on	the	genomes	of	the	endosymbionts	
Bordetella	encodes	the	most	complete	vitamin	and	amino	acid	biosynthesis	capabilities,	and	is	predicted	to	be	providing	essential	amino	acids	and	vitamins	to	Nephromyces.	Despite	a	largely	complete	genome	assembly	of	the	Rickettsia	symbiont,	its	functional	role	is	not	clear.	It	encodes	the	least	complete	amino	acid	and	vitamin	synthesis	of	any	of	the	three	endosymbiont	types	found	in	
Nephromyces,	and	all	the	amino	acids	and	vitamin	biosynthesis	capabilities	are	also	encoded	by	both	the	Bordetella	and	sphingobacteriaceae.	However,	given	the	high	prevalence	of	Rickettsia	in	our	samples	and	its	presence	in	82%	of	renal	sacs	with	only	two	types	of	symbionts,	it	does	appear	that	the	Rickettsia	symbionts	are	providing	an	essential	function	not	encoded	by	either	the	Bordetella	or	the	sphingobacteriaceae.		Based	on	previous	(Seah	et	al.	2011)	and	our	own	microscopy	results	(Figure	10),	no	Nephromyces	individual	has	been	observed	containing	multiple	types	of	bacterial	endosymbiont.	If	our	hypothesis	is	correct	and	Nephromyces	needs	metabolites	from	multiple	symbiont	types,	Nephromyces	species	with	dual	endosymbionts	could	survive	in	hosts	without	conspecifics,	as	has	been	repeatedly	observed	in	insects	(McCutcheon	and	Moran	2007;	Bennett	and	Moran	2013;	Rao	et	al.	2015;	Brown	et	al.	2018).	One	possibility	is	that	since	the		
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Figure	10)	Photos	of	Nephromyces	taken	on	a	Zeiss	confocal	microscope	labeled	with	two	16S	rRNA	FISH	probes,	one	targeting	sphingobacteriaceae	(green,	top,	630x)	and	Rickettsia	(red,	bottom,	1000x).	Images	from	left	to	right	were	captured	under	fluorescence,	TPMT,	and	both	overlaid.	The	top	pictures	are	of	the	tachyzoite	life	stage	and	the	bottom	show	the	oocyst	or	merozoite	stage.	Bacterial	endosymbionts	have	been	observed	in	all	of	Nephromyces	life	stages,	but	no	Nephromyces	has	been	shown	to	contain	multiple	types	of	bacterial	endosymbiont.	(Courtesy	of	Liz	Hunter)	
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bacterial	endosymbionts	of	Nephromyces	are	vertically	transferred	through	the	oocyst	stage,	there	simply	may	not	be	enough	space	for	multiple	endosymbiont	cells.	In	insects	with	dual	endosymbionts	the	bacteria	are	typically	vertically	transmitted	through	a	much	larger	egg	cell	than	the	oocyst	stage	of	Nephromyces.	Alternatively,	it	may	be	disadvantageous	to	carry	multiple	endosymbionts	when	multispecies	infections	are	universal	in	molgulid	renal	sacs.	Given	the	extreme	Muller’s	ratchet	known	to	occur	in	bacterial	endosymbionts	(Moran	1996),	it	may	be	evolutionarily	cheaper	to	maintain	one	bacterial	endosymbiont	and	rely	on	conspecifics	with	other	types	of	bacterial	endosymbiont.	Such	a	system	could	not	evolve	unless	there	was	a	high	probability	of	a	multispecies	infection	of	any	given	host.		 In	a	system	with	so	much	co-dependence	there	is	the	potential	for	“cheaters”	to	develop	and	indeed	we	have	found	Nephromyces	species,	that	do	not	seem	to	contain	any	bacterial	endosymbiont	and	are	presumed	to	parasitize	the	system.	The	absence	of	bacterial	endosymbionts	is	based	on	single	species	isolates	and	fluorescent	in	situ	hybridization	(FISH)	microscopy	(Figure	6),	but	as	the	lack	of	signal	in	FISH	microscopy	is	not	definitive	of	absence,	this	has	not	yet	been	confirmed.	Given	the	high	sequence	diversity	among	our	Nephromyces	datasets,	universal	prevalence	of	multispecies	infections	within	individual	renal	sacs,	and	that	90%	of	renal	sac	samples	contain	at	least	two	types	of	bacterial	endosymbionts,	Nephromyces	may	not	be	capable	of	establishing	single	species	
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infections	in	the	wild.	Combined	with	the	metabolic	capabilities	of	the	different	bacterial	endosymbiont	types	(Chapter	2),	Nephromyces	likely	exists	as	a	co-dependent	species	complex	or	species	swarm.	This	raises	interesting	questions	about	the	evolution	of	co-dependence	and	co-evolution	of	Nephromyces	species	that	require	further	exploration.		
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CHAPTER	5	CONCLUSION	The	impetus	for	this	research	was	the	characterization	of	Nephromyces	symbiotic	relationship	with	its	host	(Saffo	et	al	2010).	In	a	phylum	composed	of	parasites	Nephromyces	alone	provided	greater	benefits	to	its	host	than	costs.	This	characterization	was	premature	and	no	work	was	done	to	demonstrate	the	details	of	the	relationship	between	Nephromyces	and	Molgula	tunicates.	As	is	the	case	with	most	symbiosis,	the	relationship	between	organisms	is	complex	and	can	be	dependent	on	external	factors.	Despite	the	extensive	research	into	
Nephromyces	there	is	not	enough	support	to	either	confirm	or	refute	the	classification	of	Nephromyces/Molgula	relationship	as	mutualistic.	However,	the	claim	of	mutualism	was	entirely	based	on	the	unusual	epidemiology	of	
Nephromyces	and	our	work	does	provide	insight	into	how	Nephromyces	is	able	to	maintain	nearly	universal	prevalence,	reach	extremely	high	cell	densities,	and	remain	avirulent.		Central	to	Nephromyces	epidemiology	is	Nephromyces	ability	to	degrade	purines	into	glyoxylate	and	subsequently	convert	glyoxylate	into	malate,	pyruvate,	and	glycine.	This	pathway	provides	a	primary	nitrogen,	carbon	and	energy	source	from	uric	acid.	Malate	is	part	of	the	citrate	cycle	critical	in	the	generation	of	ATP	and	NADH	or	it	can	be	converted	into	oxaloacetate	for	gluconeogenesis.	Pyruvate	is	extremely	versatile	and	is	easily	converted	into	fatty	acids,	acetyl-CoA,	or	gluconeogenesis.	Glycine,	the	most	basic	amino	acid,	can	be	
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processed	into	other	amino	acids	and	represents	nitrogen	capture.	Tunicates	have	lost	the	ability	to	degrade	purines	past	uric	acid	essentially	making	uric	acid	nitrogenous	waste.	By	using	a	metabolic	waste	product,	for	the	host,	as	a	primary	substrate,	Nephromyces	can	presumably	utilize	uric	acid	at	little	to	no	cost	to	the	host.	This	novel	substrate	decouples	the	relationship	between	high	parasite	growth	and	virulence,	which	Nephromyces	to	reach	high	cell	densities	and	remain	avirulent.			With	the	exception	of	malate	synthase	Cardiosporidium	encodes	the	same	purine	degradation	capabilities	as	Nephromyces	and	is	capable	of	converting	uric	acid	into	pyruvate	and	glycine.	However,	due	to	the	different	hosts,	
Cardiosporidium	has	access	to	far	smaller	quantities	of	uric	acid	than	
Nephromyces	and	therefore	must	rely	on	additional	sources	of	nutrition	from	the	host.	Molgula	storage	and	concentration	of	uric	acid	to	the	renal	sac	has	enabled	
Nephromyces	to	develop	its	unusual	uric	acid	based	metabolism.		It	has	been	proposed	that	the	mutualistic	benefit	to	its	host	is	the	processing	of	indigestible	uric	acid.		This	may	be	the	case,	but	it	is	likely	an	oversimplification.	First,	it	is	unclear	if	Molgula	ever	recovers	anything	back	from	the	uric	acid	imported	into	the	renal	sac.	It	is	possible	that	valuable	metabolites	like	amino	acids	or	vitamins	are	exported	out	of	the	renal	sac,	but	this	has	not	been	demonstrated.	Second,	the	purpose	of	the	renal	sac	has	not	been	established.	Sequestration	of	uric	acid	to	the	renal	sac	may	have	developed	over	time	as	a	way	of	ridding	Molgula	of	an	apicomplexan	blood	parasite;	by	providing	
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a	parasite	with	a	metabolic	waste	product	as	an	alternative	to	infecting	blood	cells.	In	this	case,	Molgula	benefits	from	losing	a	parasite,	but	this	relationship	is	hardly	mutualistic,	it	is	more	of	a	clever	host	defense	mechanism.	Third,	Nephromyces	has	been	shown	to	express	xanthine	dehydrogenase	at	high	levels	(99	percentile	of	all	gene	expression).	Hypoxanthine	is	the	interchange	between	purine	recycling	and	purine	degradation.	Xanthine	dehydrogenase	converts	hypoxanthine	to	xanthine	and	xanthine	to	uric	acid;	this	represents	the	beginning	of	purine	degradation.	The	competing	enzyme,	hypoxanthine-guanine	phosphoribosyltransferase	(HGPRT),	converts	hypoxanthine	to	inosine	monophosphate	(IMP)	and	from	IMP	to	adenine	or	guanine.	Since	the	source	of	uric	acid	within	the	renal	sac	has	been	shown	to	be	from	the	tunicate	it	is	curious	that	Nephromyces	would	have	such	high	expression	of	xanthine	dehydrogenase	(Saffo	1988).		A	possible	explanation	of	Nephromyces	high	expression	of	xanthine	dehydrogenase	is	as	a	form	of	host	manipulation.	By	outcompeting	host	production	of	HGART,	Nephromyces	forces	greater	production	of	uric	acid	than	may	be	ideal	for	the	host.	This	is	potentially	a	cost	to	the	host,	particularly	in	times	when	purines	are	scarce		Almost	as	surprising	as	an	apicomplexan	with	a	uric	acid	based	metabolism	was	where	the	genes	in	the	purine	degradation	pathway	come	from.	All	other	sequenced	apicomplexans	have	lost	the	purine	degradation	pathway.	It	was	thought	that	the	high	levels	of	uric	oxidase	measured	inside	the	renal	sac	originated	from	the	Nephromyces	bacterial	endosymbionts.	Our	data	conclusively	
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show	that	the	genes	involved	in	purine	degradation	are	encoded	in	Nephromyces	and	Cardiosporidium	genome.		Additionally,	these	genes	are	not	the	result	of	a	gene	transfer	event,	but	are	the	genes	that	were	present	when	Apicomplexa	split	with	the	Chromerids.	This	pathway	had	previously	been	attributed	to	the	bacterial	endosymbionts,	but	is	in	fact	encoded	by	
Nephromyces/Cardiosporidium.	If	the	bacterial	endosymbionts	are	not	being	utilized	for	purine	degradation	then	they	must	be	contributing	in	another	way.	Using	16s	rRNA	we	have	determined	that	the	α-proteobacteria	in	
Nephromyces	and	Cardiosporidium	are	monophyletic	and	therefore	present	when	
Nephromyces/Cardiosporidium	lineages	split.	This	indicates	that	there	may	be	some	aspect	of	ascidian	biology	that	makes	maintaining	a	bacterial	endosymbiont	worthwhile.	Particularly	as	bacterial	endosymbionts	are	not	found	in	other	apicomplexan	lineages.	We	have	yet	to	determine	exactly	what	the	critical	function	of	the	α-proteobacteria	is,	however	because	it	is	maintained	in	
Cardiosporidium,	which	is	intracellular,	and	in	Nephromyces,	which	is	extracellular	in	the	renal	sac,	the	function	seems	to	be	not	exclusively	connected	to	renal	sac	biology.		We	do	not	have	any	genomic	data	on	the	Cardiosporidium	α-proteobacteria	endosymbiont	at	this	time,	making	any	comparisons	between	
Nephromyces	and	Cardiosporidium	α-proteobacteria	endosymbiont	is	preliminary.	The	genome	from	the	α-proteobacteria	in	Cardiosporidium	will	need	to	be	sequenced	and	assembled	for	more	robust	analysis.	Preliminarily	based	on	
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RNAseq	data,	Cardiosporidium	α-proteobacteria	appears	to	have	more	biosynthetic	capabilities	than	Nephromyces’.	This	includes	several	essential	amino	acids	and	vitamins	not	present	in	the	α-proteobacteria	of	Nephromyces.				In	addition	to	α-proteobacteria	in	the	genus	Rickettsia,	the	genus	
Nephromyces	also	maintains	a	β-proteobacteria	in	the	genus	Bordetella	and	a	Bacteroidetes	bacterial	endosymbiont	in	the	family	Sphingobacteriaceae.	We	have	assembled	the	complete	genome	for	Nephromyces	Sphingobacteriaceae	endosymbiont	and	Nephromyces	Bordetella.	NBe	and	Nβe	have	the	biosynthesis	capabilities	for	a	number	of	amino	acids	and	vitamins,	which	are	not	encoded	in	the	Nephromyces	genome.	Providing	Nephromyces	with	amino	acids	and	vitamins	eliminates	the	need	for	Nephromyces	to	scavenge	those	metabolites	from	the	host.	Presumably,	this	reduces	Nephromyces	dependence	on	the	host	and	also	provides	a	reliable	source	of	these	metabolites,	which	may	not	be	available	in	the	renal	sac.		Despite	the	three	types	of	bacterial	endosymbionts	(Nαe,	NBe,	Nβe)	being	inside	different	Nephromyces	species,	we	do	see	some	similar	patterns	to	the	dual	endosymbiont	example	in	glassy	winged	sharpshooters.	While	we	do	not	see	the	single	pathway	integration	where	one	symbiont	produces	fabF	and	the	other	produces	the	remainder	of	the	pathway.	The	lack	of	overlapping	functions	seems	to	indicate	that	despite	being	in	different	Nephromyces	species,	that	the	close	proximity	in	the	renal	sac	is	sufficient	to	allow	for	metabolite	exchange	between	bacterial	endosymbionts	in	conspecific	Nephromyces	species.	The	result	is	
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completely	unexpected	and	represents	an	unusual	evolutionary	quirk	for	the	community	inside	the	renal	sac.	If	the	renal	sac	community	is	in	close	enough	to	allow	for	the	development	of	non-overlapping	functions	in	bacterial	endosymbionts	in	different	species,	it	must	be	concluded	that	conspecific	
Nephromyces	species	are	frequently	exchanging	metabolites.	Based	on	our	isolation	and	culturing	experiments,	we	hypothesize	that	Nephromyces	may	be	incapable	of	existing	in	isolation	without	conspecific	Nephromyces	species	which	contain	a	different	type	of	bacterial	endosymbiont	than	their	own.	We	have	not	found	a	Nephromyces	species	containing	two	different	types	of	bacterial	endosymbionts,	however	we	can’t	conclusively	say	that	Nephromyces	species	with	dual	endosymbionts	don’t	exist.		It	remains	unclear	why	a	system	dependent	on	conspecifics	would	develop	when	maintaining	multiple	endosymbionts	would	eliminate	the	need	for	competing	Nephromyces	species	and	guarantee	that	whatever	host	Nephromyces	infected	would	be	able	to	be	colonized	independent	of	conspecifics.	Perhaps	the	cost	of	maintaining	multiple	endosymbionts	is	greater	than	the	cost	of	sharing.	Indeed	we	have	found	that	some	Nephromyces	species	do	not	maintain	any	endosymbiont	and	presumably	parasitize	the	community,	i.e.	relying	on	the	products	of	other	Nephromyces’	bacterial	endosymbionts.	In	order	for	such	a	system	to	develop	any	given	Nephromyces	species	must	colonize	a	renal	sac	where	there	will	be	complimentary	Nephromyces	species.	The	rate	at	which	this	happens	needs	to	be	greater	than	the	cost	of	maintaining	two	endosymbionts	
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otherwise	we	would	presumably	see	dual	endosymbiont	Nephromyces	species.		A	number	of	factors	seem	to	contribute	to	the	development	of	this	co-dependent	species	complex.	First,	the	infection	prevalence	of	Nephromyces	is	nearly	100%	nearly	year	round.	Second,	Nephromyces	seems	capable	of	infecting	at	any	point	in	the	tunicates	adult	life	stage.	Third,	we	have	uncovered	a	staggering	amount	of	Nephromyces	diversity.		Some	individual	M.	manhattensis	contain	as	many	as	11	distinct	Nephromyces	species.	Based	on	amplicon	sequencing	data	there	is	an	estimated	60	species	of	Nephromyces	in	Greenwich	Bay,	RI	alone.	The	extreme	amount	of	both	species	and	sequence	diversity	in	
Nephromyces	is	not	observed	in	Cardiosporidium	and	is	likely	connected	to	the	unusual	renal	sac	community	dynamics.	With	so	many	species,	each	with	a	lineage	of	vertically	inherited	bacterial	endosymbionts,	we	predict	that	even	bacterial	endosymbionts	of	the	same	type	may	differ	widely	in	their	metabolic	capabilities.	Presumably	bacterial	endosymbionts,	even	within	the	same	taxa,	could	contribute	different	metabolites	to	the	renal	sac	community.	Given	the	tremendous	amount	of	diversity,	our	sequencing	of	just	a	few	of	the	different	bacterial	endosymbionts	is	insufficient	to	develop	a	complete	picture	of	the	intricacies	of	this	system.	It	is	likely	that	different	bacterial	endosymbionts	within	the	same	type	may	differ	in	metabolic	capabilities.	Adding	to	our	uncertainties	we	do	not	currently	know	if	there	are	any	genetic	barriers	preventing	reproduction	between	different	Nephromyces	species.	Sexual	reproduction	occurs	inside	the	renal	sac	in	the	presence	of	multiple	other	
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Nephromyces	species;	interbreeding	between	species	seems	likely,	unless	there	are	strong	genetic	barriers	between	species.	Indeed,	the	proximity	and	the	interdependence	of	the	system	in	general	seems	to	indicate	a	great	deal	of	interspecific	breeding.		As	our	genomic	assemblies	of	Nephromyces	are	incomplete,	due	in	large	part	to	the	difficulties	in	assembling	a	metagenome	of	closely	related	species,	we	are	not	able	to	say	how	Nephromyces	unusual	epidemiology,	environment,	and	community	composition	has	affected	its	genome.	Given	the	difficulties	with	
Nephromyces	sequencing	and	assembling,	the	genome	of	Cardiosporidium	is	a	more	attractive	target.	There	are	plans	to	sequence	the	genome,	but	currently	we	do	not	have	any	genomic	data	for	Cardiosporidium.		We	do	have	good	transcriptomic	data	for	both	Nephromyces	and	Cardiosporidium,	meaning	we	can	compare	the	protein	coding	genes	of	Nephromyces	and	Cardiosporidium	to	each	other,	as	well	as	to	other	apicomplexans.			
Nephromyces	and	Cardiosporidium	have	very	similar	metabolic	capabilities	based	on	KEGG	pathway	analysis.	This	includes	purine	degradation	to	glyoxylate	and	then	to	glycine	and	pyruvate,	which	shows	that	this	pathway	was	being	utilized	before	Nephromyces	colonized	the	renal	sac.	Based	on	expression	data,	this	pathway	is	more	important	for	Nephromyces	than	Cardiosporidium.	Expression	of	these	genes	in	Cardiosporidium	is	still	high	(80-90th	percentile,	the	highest	expression	of	all	Cardiosporidium	genes).	Such	high	expression	suggests	that	Cardiosporidium	has	access	to	high	concentrations	of	uric	acid	inside	
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tunicate	blood	cells,	which	may	still	represent	an	important	source	of	carbon	and	nitrogen.			Despite	the	differences	in	epidemiology,	habitat,	and	life	histories	between	
Nephromyces	and	Cardiosporidium,	their	metabolomes	are	quite	similar,	including	the	complete	apicomplexan	infection	machinery.	While	Nephromyces	may	have	a	mutualistic	relationship	with	its	host,	it	is	entering	the	renal	sac	like	an	apicomplexan	parasite.	Related	to	this	infection	machinery,	both	
Cardiosporidium	and	Nephromyces	have	the	same	known	dense	granule,	microneme,	and	rhoptry	proteins.	Proteins	from	these	organelles	have	been	shown	in	other	apicomplexans	to	be	important	for	invasion,	immune	evasion,	and	host	manipulation.	Based	on	Orthofinder	analysis	we	find	surprisingly	few	lineage-specific	genes	that	might	be	involved	in	dealing	with	an	ascidian	immune	system.	We	also	find	few	genes	without	orthologous	in	either	Nephromyces	or	
Cardiosporidium	compared	to	other	apicomplexans.	It	is	possible	that	these	genes	without	orthologous	are	involved	in	the	specific	challenges	imposed	by	intracellular	ascidian	life	cycle	in	Cardiosporidium	and	the	renal	sac	for	
Nephromyces.	However,	because	these	genes	do	not	have	known	orthologs	studied	in	other	species,	we	are	unable	to	determine	function	bioinformatically.								Nephromyces	and	Cardiosporidium	have	a	large	number	of	protein	coding	genes	and	metabolic	capabilities.	With	respect	to	gene	number	and	function	Nephromyces/Cardiosporidium	are	similar	to	Toxoplasma.	This	is	surprising	because	phylogenetically	Nephromyces/Cardiosporidium	belong	to	
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hematozoa,	the	lineage	that	contains	Plasmodium,	Babesia,	and	Theileria.	The	other	members	of	hematozoa	have	lost	peroxisomes,	which	we	have	demonstrated	in	Nephromyces/Cardiosporidium.	Additionally,	hematozoa	show	more	metabolic	reduction.	Babesia,	and	Theileria	in	particular	have	the	smallest	genomes	of	any	apicomplexan	and	the	fewest	number	of	protein	coding	genes	(Kappmeyer	et	al.	2012;	Brayton	et	al.	2007).	The	placement	of	
Nephromyces/Cardiosporidium	in	hematozoa	adds	to	the	growing	body	of	support	that,	these	gene	losses	in	Apicomplexa	were	gradual	and	lineage	specific,	with	losses	occurring	later	than	predicted.	These	gene	losses	often	occur	in	parallel	in	different	lineages	confounding	assumptions	based	on	the	most	parsimonious	solutions.	Indeed	we	see	in	nearly	every	apicomplexan	lineage,	lineage	specific	orthologs	present	only	in	chromerids	and	lost	in	all	other	apicomplexans.	In	the	case	of	Nephromyces/Cardiosporidium	lineage	specific	orthologs	include	purine	degradation	and	de	novo	purine	biosynthesis.	These	retained	pathways	appear	to	have	particular	significance	to	
Nephromyces/Cardiosporidium,	but	lineage	specific	gene	retention	is	consistent	with	the	general	patterns	observed	across	the	phyla	Apicomplexa.	This	work	represents	a	step	toward	fully	understanding	the	complexities	of	this	unusual	system,	but	leaves	many	questions	unresolved.	First,	sequencing	the	genome	of	both	Cardiosporidium	and	Cardiosporidiums	bacterial	endosymbiont	would	allow	for	more	robust	comparison	to	Nephromyces	
Rickettsia	endosymbiont.	This	would	provide	a	better	understanding	of	the	
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evolutionary	history	of	both	Nephromyces	and	its	endosymbionts.	Secondly,	the	biochemical	pathways	were	based	on	bioinformatics	with	minimal	confirmation	at	the	protein	level,	the	presented	pathways	need	to	be	confirmed.	Another	step	would	be	to	show	that	uric	acid	is	central	to	the	metabolism	of	Nephromyces.	A	potential	method	to	demonstrate	this	pathway	is	by	injecting	isotope	labeled	uric	acid	into	the	renal	sac,	and	then	using	a	new	method	for	identifying	the	proteins	from	a	specific	organism	in	a	metaproteomic	sample	(Kleiner	et	al.	2018).	If	this	could	be	adapted	to	this	system	we	could	potentially	confirm	uric	acid	as	the	primary	carbon	and	nitrogen	source	for	Nephromyces,	and	determine	the	metabolites	exchanged	with	the	bacterial	endosymbiont.	This	could	also	show	if	any	of	the	carbon	or	nitrogen	from	uric	acid	makes	its	way	across	the	renal	wall	back	to	the	tunicate.	If	useful	metabolites	are	exported	or	leaked	out	of	the	renal	sac	this	would	be	the	best	support	yet	that	the	relationship	between	Nephromyces	and	Molgula	is	in	fact	mutualistic.	
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APPENDICES	
Gene PSORTII Ppero	pts1 TargetP topcons predotar
MLS cyto:	8,	extr:	5,	chlo:	1 No _ Yes possibly	plastid
MLS cyto:	11,	nucl:	2,	vacu:	1 No _ Yes none
MLS chlo:	5.5,	chlo_mito:	5.33333,	mito:	4,	cyto:	3,	cyto_mito:	2.83333,	plas:	1No M No possibly	mitochondrial
MLS chlo:	9,	mito:	4,	plas:	1 No M No possibly	mitochondrial
MLS cyto:	8,	nucl:	3,	vacu:	1,	golg:	1,	cysk_plas:	1No _ No none
MLS cyto:	7,	nucl:	3,	chlo:	2,	golg:	1,	cysk_plas:	1No _ No none
MLS cyto:	8,	extr:	5,	chlo:	1 No _ No possibly	plastid
MLS chlo:	6,	cyto:	3,	mito:	3,	nucl:	1,	plas:	1No M No possibly	mitochondrial
MLS cyto:	6,	extr:	3,	chlo:	1,	nucl:	1,	mito:	1,	E.R.:	1,	cysk:	1No _ No possibly	plastid
MLS chlo:	5.5,	chlo_mito:	5.33333,	mito:	4,	cyto:	3,	cyto_mito:	2.83333,	plas:	1No M No possibly	mitochondrial
MDH extr:	9,	chlo:	2,	nucl:	1,	cyto:	1,	mito:	1No S No none
PEX1 chlo:	5,	nucl:	2,	cyto:	2,	plas:	2,	mito:	1,	extr:	1,	vacu:	1No S No none
PEX2 nucl:	13.5,	cyto_nucl:	7.5 No _ No none
PEX2 nucl:	6,	cyto:	5,	mito:	1,	extr:	1,	cysk:	1No _ No none
PEX4 cyto:	5,	chlo:	3,	nucl:	2,	plas:	2,	mito:	1,	extr:	1No _ No none
PEX4 cyto:	5,	chlo:	3,	nucl:	2,	plas:	2,	mito:	1,	extr:	1No _ No none
PEX5 mito:	7,	chlo:	4,	nucl:	2,	cyto:	1No M No possibly	mitochondrial
PEX5 plas:	5,	nucl_plas:	4.5,	cyto:	3,	chlo:	2,	nucl:	2,	mito:	1,	extr:	1No _ No none
PEX7 nucl:	7,	cyto:	7 No _ No none
PEX7 nucl:	14 No _ No none
PEX7 nucl:	14 No _ No none
PEX7 extr:	7,	nucl:	4,	chlo:	2,	cyto:	1No _ No none
PEX7 extr:	7,	nucl:	4,	chlo:	2,	cyto:	1No _ No none
PEX10 nucl:	12,	extr:	2 No S No possibly	ER
PEX12 plas:	7,	E.R.:	4,	cyto:	1,	mito:	1,	extr:	1No _ No none
PEX12 nucl:	3,	extr:	3,	vacu:	2,	E.R.:	2,	golg:	2,	cyto:	1,	plas:	1No _ No none
PEX12 nucl:	3,	extr:	3,	vacu:	2,	E.R.:	2,	golg:	2,	cyto:	1,	plas:	1No _ No none
PEX14 nucl:	10,	cyto:	3,	plas:	1 No _ No none
PEX14 pero:	11,	cyto_nucl:	2,	nucl:	1.5,	cyto:	1.5No _ No none
MPV17 E.R.:	5,	plas:	3,	chlo:	2,	vacu:	2,	pero:	1,	golg:	1Perha s	yes _ No possibly	plastid
MPV17 plas:	8,	vacu:	4,	E.R.:	2 No S No none
MPV17 chlo:	4,	nucl:	3,	vacu:	2,	E.R.:	2,	cyto:	1,	mito:	1,	extr:	1No S No ER
ABCD plas:	9,	vacu:	2,	nucl:	1,	cyto:	1,	E.R.:	1No _ No none
ABCD plas:	5,	vacu:	4,	E.R.:	2,	nucl:	1,	cyto:	1,	mito:	1No _ No none
ABCD plas:	9,	mito:	2,	chlo:	1,	E.R.:	1,	pero:	1No _ No none
ABCD chlo:	4,	vacu:	4,	plas:	2,	nucl:	1,	mito:	1,	extr:	1,	golg:	1No _ No none
ABCD chlo:	4,	vacu:	4,	plas:	2,	nucl:	1,	mito:	1,	extr:	1,	golg:	1No _ No none
ABCD3 chlo:	7,	cyto:	3,	mito:	3,	pero:	1No _ No none
Appendix	Table	1)	Nephromyces	peroxisomal-related	genes	Identified	PeroxDB	and	KAAS.	
Complete	transcripts	were	run	through	Wolf	PSORTII,	Ppero,	TargetP,	Topcons	and	Predotar	
to	identify	possible	signal	motifs	inclding	PTS1
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ABCD3 plas:	8,	vacu:	3,	E.R.:	2,	mito:	1No _ No possibly	ER
ACAA1 cyto:	8,	chlo:	2,	nucl:	1,	mito:	1,	plas:	1,	pero:	1No _ No none
ACAA1 chlo:	4,	cyto:	3.5,	golg:	3,	cyto_nucl:	3,	nucl:	1.5,	plas:	1,	vacu:	1No _ No none
ACAA1 chlo:	4,	cyto:	3.5,	golg:	3,	cyto_nucl:	3,	nucl:	1.5,	plas:	1,	vacu:	1No _ No none
ACAA1 cyto:	8,	chlo:	2,	nucl:	1,	mito:	1,	plas:	1,	pero:	1No _ No none
ACAA1 chlo:	11.5,	chlo_mito:	7,	mito:	1.5,	cyto:	1No M No mitochondrial
ACAA1 chlo:	9,	mito:	3,	nucl:	2 No _ No none
ACAA1 chlo:	11.5,	chlo_mito:	7,	mito:	1.5,	cyto:	1No M No mitochondrial
ACAA1 chlo:	5,	nucl:	4,	cyto:	2,	mito:	1,	cysk:	1,	golg:	1No _ No none
ACAA1 cyto:	6,	chlo:	4,	nucl:	2,	plas:	1,	extr:	1No _ No none
ACAA1 cyto:	6,	chlo:	4,	nucl:	2,	plas:	1,	extr:	1No _ No none
ACAA1 chlo:	5,	nucl:	4,	cyto:	2,	mito:	1,	cysk:	1,	golg:	1No _ Yes none
ACAA1 chlo:	5,	nucl:	4,	cyto:	2,	mito:	1,	cysk:	1,	golg:	1No _ No none
ACAA1 nucl:	7,	cyto:	4,	mito:	2,	chlo:	1No _ No none
ACAA1 nucl:	7,	cyto:	4,	mito:	2,	chlo:	1No _ No none
ACAA1 nucl:	7,	cyto:	4,	mito:	2,	chlo:	1No _ No none
ACAA1 nucl:	7,	cyto:	4,	mito:	2,	chlo:	1No _ No none
ACAA1 nucl:	7,	cyto:	4,	mito:	2,	chlo:	1No _ No none
ACAA1 nucl:	7,	cyto:	4,	mito:	2,	chlo:	1No _ No none
ACAA1 nucl:	7,	cyto:	4,	mito:	2,	chlo:	1No _ No none
ACAA1 nucl:	6,	mito:	4,	cyto:	2,	chlo:	1,	cysk:	1No _ No none
ACAA1 nucl:	6,	mito:	4,	cyto:	2,	chlo:	1,	cysk:	1No _ No none
ACOX cyto:	9,	nucl:	2,	mito:	2,	plas:	1No _ No none
ACOX cyto:	7.5,	cyto_nucl:	5,	E.R.:	4,	nucl:	1.5,	mito:	1No _ No none
ACOX cyto:	7.5,	cyto_nucl:	5,	E.R.:	4,	nucl:	1.5,	mito:	1No _ No none
ACOX cyto:	9,	nucl:	2,	mito:	2,	plas:	1No _ No none
ACOX pero:	11,	cyto:	2,	golg:	1 No _ No none
ACOX pero:	11,	cyto:	2,	golg:	1 Yes _ No none
ACOX pero:	11,	cyto:	2,	golg:	1 Yes _ No none
ACOX pero:	11,	cyto:	2,	golg:	1 Yes _ No none
ACOX pero:	11,	cyto:	2,	golg:	1 Yes _ No none
ACOX pero:	11,	cyto:	2,	golg:	1 Yes _ No none
ACOX pero:	11,	cyto:	2,	golg:	1 Yes _ No none
AGXT chlo:	11,	mito:	3 No M No possibly	mitochondrial
AGXT cyto:	7,	mito:	4,	chlo:	1,	extr:	1,	golg:	1No _ No none
AGXT cyto:	8,	mito:	4,	chlo:	1,	extr:	1No _ No none
AGXT chlo:	9,	mito:	2,	pero:	2,	E.R.:	1No M No possibly	mitochondrial
AGXT chlo:	9,	mito:	2,	pero:	2,	E.R.:	1No M No possibly	mitochondrial
AK nucl:	8,	cyto:	2.5,	cyto_E.R.:	2,	chlo:	1,	mito:	1,	cysk:	1No _ No none
AK nucl:	8,	cyto:	2.5,	cyto_E.R.:	2,	chlo:	1,	mito:	1,	cysk:	1No _ No none
AK cyto:	7.5,	cyto_E.R.:	5,	chlo:	3,	E.R.:	1.5,	nucl:	1,	cysk:	1No _ No none
AK cyto:	5,	nucl:	4,	chlo:	2,	mito:	1,	extr:	1,	pero:	1No _ No none
ANT nucl:	5,	chlo:	4,	cyto:	3,	extr:	1,	cysk:	1No _ No none
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ANT nucl:	6,	cyto:	4,	chlo:	2,	extr:	1,	vacu:	1No _ No none
ANT nucl:	5,	cyto:	3.5,	cyto_E.R.:	2.5,	chlo:	2,	mito:	1,	extr:	1,	vacu:	1No _ No none
ANT nucl:	6,	cyto:	4,	chlo:	2,	extr:	1,	vacu:	1No _ No none
ANT nucl:	7,	cyto:	3,	chlo:	1,	mito:	1,	extr:	1,	vacu:	1No _ No none
CAT pero:	12,	cyto:	1,	golg:	1 Yes _ No none
CAT pero:	12,	cyto:	1,	golg:	1 Yes _ No none
CAT pero:	12,	cyto:	1,	golg:	1 Yes _ No none
CAT nucl:	7,	pero:	2,	chlo:	1,	mito:	1,	extr:	1,	vacu:	1,	cysk_plas:	1No _ No none
CAT nucl:	7,	cyto:	2,	pero:	2,	cysk:	1.5,	cysk_plas:	1.5,	mito:	1No _ N none
CAT nucl:	7,	cyto:	2,	pero:	2,	cysk:	1.5,	cysk_plas:	1.5,	mito:	1No _ N none
CAT nucl:	7,	cyto:	2,	pero:	2,	cysk:	1.5,	cysk_plas:	1.5,	mito:	1No _ N none
CHY chlo:	8,	nucl:	2,	extr:	2,	plas:	1,	E.R.:	1No S No possibly	ER
CHY chlo:	8,	nucl:	2,	extr:	2,	plas:	1,	E.R.:	1No S No possibly	ER
CHY chlo:	10,	mito:	3,	nucl:	1 No M No none
CHY chlo:	10,	mito:	3,	nucl:	1 No M No none
CHY nucl:	6,	cyto:	3,	chlo:	1,	mito:	1,	vacu:	1,	cysk:	1,	golg:	1No _ No none
CPK cyto:	12,	nucl:	1,	pero:	1 No _ No none
DECR2 cyto:	5,	chlo:	4,	extr:	2,	nucl:	1,	cysk:	1,	golg:	1No _ No none
DECR2 chlo:	6.5,	chlo_mito:	4.5,	cyto:	2,	vacu:	2,	mito:	1.5,	plas:	1,	extr:	1Yes S No ER
DECR2 pero:	7,	cyto:	3.5,	cyto_nucl:	2.5,	chlo:	2,	golg:	1Yes M No none
DECR2 pero:	10,	cyto:	3,	golg:	1 Yes _ No none
DECR2 pero:	7,	cyto:	3.5,	cyto_nucl:	2.5,	chlo:	2,	golg:	1Yes M No none
DECR2 pero:	7,	cyto:	3.5,	cyto_nucl:	2.5,	chlo:	2,	golg:	1Yes M No none
DECR2 pero:	7,	chlo:	3,	cyto:	3,	golg:	1Yes _ No none
DECR2 pero:	7,	chlo:	3,	cyto:	3,	golg:	1Yes _ No none
DECR2 pero:	7,	chlo:	3,	cyto:	3,	golg:	1Yes _ No none
DECR2 pero:	7,	cyto:	3.5,	cyto_nucl:	2.5,	chlo:	2,	golg:	1Yes M No none
DECR2 pero:	7,	chlo:	3,	cyto:	3,	golg:	1Yes _ No none
DECR2 cyto:	5,	chlo:	4,	extr:	2,	nucl:	1,	cysk:	1,	golg:	1No _ No none
DECR2 chlo:	13,	plas:	1 Perhaps	yes S No possibly	plastid
DECR2 chlo:	11,	extr:	2,	cyto:	1 Perhaps	yes S No none
DECR2 pero:	7,	cyto:	3.5,	cyto_nucl:	2.5,	chlo:	2,	golg:	1Yes M No none
DECR2 pero:	7,	cyto:	3.5,	cyto_nucl:	2.5,	chlo:	2,	golg:	1Yes M No none
DECR2 pero:	7,	cyto:	3.5,	cyto_nucl:	2.5,	chlo:	2,	golg:	1Yes M No none
DECR2 pero:	7,	cyto:	3.5,	cyto_nucl:	2.5,	chlo:	2,	golg:	1Yes M No none
DECR2 pero:	7,	cyto:	3.5,	cyto_nucl:	2.5,	chlo:	2,	golg:	1Yes M No none
DECR2 pero:	7,	cyto:	3.5,	cyto_nucl:	2.5,	chlo:	2,	golg:	1Yes M Yes none
DECR2 pero:	10,	cyto:	3,	golg:	1 Yes _ No none
DECR2 pero:	7,	cyto:	3.5,	cyto_nucl:	2.5,	chlo:	2,	golg:	1Yes M No none
DECR2 pero:	7,	cyto:	3.5,	cyto_nucl:	2.5,	chlo:	2,	golg:	1Yes M No none
DECR2 chlo:	13,	plas:	1 Perhaps	yes S No possibly	plastid
DECR2 chlo:	11,	extr:	2,	cyto:	1 Perhaps	yes S No none
DECR2 pero:	11,	chlo:	1,	nucl:	1,	cyto:	1Perhaps	yes _ No none
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DECR2 pero:	11,	chlo:	1,	nucl:	1,	cyto:	1Perhaps	yes _ No none
DHRS4 pero:	9,	cyto:	4,	nucl:	1 Yes _ No none
DHRS4 pero:	9,	cyto:	4,	nucl:	1 Yes _ No none
DHRS4 chlo:	7,	E.R.:	2.5,	extr:	2,	E.R._plas:	2,	nucl:	1,	mito:	1No S No ER
DHRS4 cyto:	12,	mito:	1,	cysk_nucl:	1No _ No none
DHRS4 cyto:	10,	chlo:	2,	nucl:	1.5,	cysk_nucl:	1.5No _ No none
DHRS4 extr:	5,	chlo:	3,	vacu:	3,	nucl:	1,	mito:	1,	golg:	1No S No ER
DHRS4 extr:	5,	chlo:	3,	vacu:	3,	nucl:	1,	mito:	1,	golg:	1No S No ER
DHRS4 chlo:	6,	E.R.:	2.5,	extr:	2,	E.R._plas:	2,	nucl:	1.5,	cyto_nucl:	1.5,	mito:	1No S No ER
DHRS4 chlo:	7,	E.R.:	2.5,	extr:	2,	E.R._plas:	2,	nucl:	1,	mito:	1No S No ER
DHRS4 chlo:	8,	pero:	3,	cyto:	2.5,	cyto_nucl:	2No _ No none
DHRS4 pero:	6,	cyto:	3.5,	cyto_nucl:	3,	chlo:	2,	nucl:	1.5,	golg:	1Yes _ No none
DHRS4 pero:	11,	cyto:	3 Yes _ No none
DHRS4 chlo:	12,	extr:	2 No _ No none
DHRS4 chlo:	8,	cyto:	2.5,	cyto_nucl:	2.5,	pero:	2,	nucl:	1.5Yes _ No none
DJP1 cyto:	8,	nucl:	4,	mito:	1,	pero:	1No _ No none
DJP1 cyto:	8,	nucl:	4,	mito:	1,	pero:	1No _ No none
DJP1 nucl:	10,	plas:	2,	chlo:	1,	extr:	1No _ Yes none
DJP1 nucl:	10,	cyto:	4 No _ No none
DJP1 nucl:	6,	cyto:	6,	plas:	1,	pero:	1No _ No none
DJP1 nucl:	12,	cyto:	1,	plas:	1 No _ No none
E1.3.3.6 chlo:	6,	nucl:	4,	cyto:	2,	mito:	2No M No none
E1.3.3.6 extr:	7,	chlo:	4,	vacu:	1,	golg:	1,	cyto_nucl:	1No _ No possibly	mitochondrial
E1.3.3.6 mito:	7,	chlo:	5,	nucl:	1,	cyto:	1No _ No none
E1.3.3.6 chlo:	7,	mito:	4,	nucl:	2,	plas:	1No _ No none
ECH mito:	8,	nucl:	5,	chlo:	1 No _ No none
ECH mito:	8,	nucl:	5,	chlo:	1 No _ No none
ECH pero:	4,	E.R.:	3,	plas:	2,	cyto_nucl:	2,	nucl:	1.5,	cyto:	1.5,	chlo:	1,	vacu:	1Yes _ No none
ECH pero:	5,	E.R.:	3,	plas:	2,	nucl:	1.5,	cyto_nucl:	1.5,	chlo:	1,	vacu:	1Yes _ No none
ECH pero:	5,	E.R.:	3,	plas:	2,	nucl:	1.5,	cyto_nucl:	1.5,	chlo:	1,	vacu:	1Yes _ No none
ECH cyto:	6,	E.R.:	3,	nucl:	2,	chlo:	1,	mito:	1,	extr:	1No _ No none
ECH pero:	5,	E.R.:	3,	plas:	2,	cyto:	1.5,	cyto_nucl:	1.5,	chlo:	1,	vacu:	1Yes _ No none
ECH chlo:	5,	cyto:	3.5,	cyto_nucl:	3,	plas:	2,	extr:	2,	nucl:	1.5No _ No none
ECH E.R.:	3,	pero:	3,	nucl:	2.5,	chlo:	2,	plas:	2,	cyto_nucl:	2,	vacu:	1Yes _ No none
ECH chlo:	4,	cyto:	4,	extr:	3,	plas:	2,	nucl:	1No _ No none
ECH E.R.:	3,	pero:	3,	nucl:	2.5,	chlo:	2,	plas:	2,	cyto_nucl:	2,	vacu:	1No _ No none
ECH chlo:	4,	cyto:	4,	plas:	2,	extr:	2,	nucl:	1,	golg:	1Yes _ No none
ECH mito:	8,	nucl:	5,	chlo:	1 No _ No none
ECH1 cyto:	5,	extr:	4,	E.R.:	2.5,	E.R._plas:	2.5,	plas:	1.5,	mito:	1No _ N none
ECH1 pero:	4,	chlo:	3,	E.R.:	3,	plas:	2,	vacu:	1,	cyto_nucl:	1Yes _ No none
ECH1 cyto:	4,	extr:	3,	E.R._plas:	3,	plas:	2.5,	E.R.:	2.5,	mito:	2No _ No none
ECH1 chlo:	6,	cyto:	3.5,	cyto_nucl:	3.5,	nucl:	2.5,	extr:	2No _ No none
ECH1 pero:	4,	chlo:	3,	E.R.:	3,	plas:	2,	vacu:	1,	cyto_nucl:	1Yes _ No none
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ECH2 pero:	12,	cyto:	2 Yes _ No none
ECH2 pero:	12,	cyto:	2 Yes _ No none
fabG pero:	6,	cyto:	3.5,	cyto_nucl:	3.5,	nucl:	2.5,	chlo:	2Yes M No none
fabG pero:	6,	cyto:	3.5,	cyto_nucl:	3.5,	nucl:	2.5,	chlo:	2Yes M No none
FACL nucl:	4,	mito:	4,	chlo:	3,	cyto:	3No _ No none
FACL nucl:	4,	mito:	4,	chlo:	3,	cyto:	3No _ No none
FACL nucl:	4,	mito:	4,	chlo:	3,	cyto:	3No _ No none
FACL nucl:	4,	mito:	4,	chlo:	3,	cyto:	3No _ No none
FACL chlo:	6,	extr:	4,	vacu:	1.5,	E.R._vacu:	1.5,	cyto:	1,	mito:	1No _ N none
FACL chlo:	6,	extr:	4,	vacu:	1.5,	E.R._vacu:	1.5,	cyto:	1,	mito:	1No _ N none
FACL nucl:	4,	mito:	4,	chlo:	3,	cyto:	3Yes _ No none
FACL nucl:	4,	mito:	4,	chlo:	3,	cyto:	3No _ No none
FAR chlo:	11,	mito:	2,	nucl:	1 No S No none
FBPA cyto:	7,	pero:	3,	chlo:	2,	nucl:	1,	mito:	1No _ No possibly	mitochondrial
FBPA cyto:	7,	pero:	3,	chlo:	2,	nucl:	1,	mito:	1No _ No possibly	mitochondrial
FBPA cyto:	7,	pero:	3,	chlo:	2,	nucl:	1,	mito:	1No _ No possibly	mitochondrial
FBPA cyto:	7,	pero:	3,	chlo:	2,	nucl:	1,	mito:	1No _ No possibly	mitochondrial
FBPA cyto:	7,	pero:	3,	chlo:	2,	nucl:	1,	mito:	1No _ No possibly	mitochondrial
FBPA plas:	4.5,	nucl_plas:	4,	chlo:	3,	nucl:	2.5,	cyto:	2,	mito:	1,	golg:	1No _ No none
FR cyto:	6,	cysk:	6,	nucl:	2 Perhaps	yes _ No none
FR cyto:	6,	cysk:	6,	nucl:	2 No _ No none
FR chlo:	8,	vacu:	3,	nucl:	2,	mito:	1No S No none
FR chlo:	8,	vacu:	3,	nucl:	2,	mito:	1No S No none
FR chlo:	4,	nucl:	3.5,	cyto_nucl:	3.5,	mito:	3,	cyto:	2.5,	plas:	1No _ No possibly	mitochondrial
FR chlo:	3,	extr:	3,	nucl:	2,	cyto:	2,	vacu:	2,	mito:	1,	plas:	1No S No none
FR chlo:	10,	cyto:	2,	nucl:	1,	vacu:	1No S No ER
FR chlo:	10,	cyto:	2,	nucl:	1,	vacu:	1No S No ER
FR chlo:	3,	extr:	3,	nucl:	2,	cyto:	2,	vacu:	2,	mito:	1,	plas:	1No S No none
FR chlo:	7,	cyto:	2,	plas:	2,	mito:	1,	extr:	1,	vacu:	1No S No possibly	ER
FR chlo:	7,	cyto:	2,	plas:	2,	mito:	1,	extr:	1,	vacu:	1No S No possibly	ER
G6PI plas:	8,	cyto:	2,	E.R.:	2,	chlo:	1,	golg:	1N _ No none
G6PI plas:	8,	cyto:	2,	E.R.:	2,	chlo:	1,	golg:	1N _ No none
GAPDH cyto:	14 No M No possibly	mitochondrial
GAPDH pero:	6,	cyto:	3.5,	cyto_nucl:	3,	chlo:	2,	nucl:	1.5,	golg:	1Perhaps	yes M No none
GAPDH cyto:	5.5,	cyto_nucl:	3.5,	chlo:	3,	mito:	3,	vacu:	1,	E.R.:	1No M No none
GAPDH pero:	6,	cyto:	3.5,	cyto_nucl:	3,	chlo:	2,	nucl:	1.5,	golg:	1Perhaps	yes M No none
GAPDH cyto:	14 No M No none
GAPDH cyto:	13,	mito:	1 No M No none
GAPDH cyto:	13,	mito:	1 No M Yes none
GAPDH cyto:	14 No M No possibly	mitochondrial
GAPDH cyto:	14 No M No none
GAPDH cyto:	5.5,	cyto_nucl:	3.5,	chlo:	3,	mito:	3,	vacu:	1,	E.R.:	1No M No none
GCDH mito:	4,	chlo:	3,	nucl:	2,	cyto:	2,	pero:	2,	plas:	1No _ No none
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GK cysk:	10,	cyto:	3,	nucl:	1 No _ No none
GNPAT pero:	4,	E.R.:	3,	plas:	2,	chlo:	1,	nucl:	1,	cyto:	1,	vacu:	1,	golg:	1Perhaps	yes S No ER
GNPAT E.R.:	3,	chlo:	2,	nucl:	2,	cyto:	2,	plas:	2,	mito:	1,	extr:	1,	pero:	1No S No ER
GNPAT pero:	11,	cyto:	2,	nucl:	1 Yes _ No none
GNPAT cyto:	4,	E.R.:	3,	nucl:	2,	mito:	2,	plas:	1,	vacu:	1,	pero:	1No S Yes ER
GNPAT cyto:	4,	E.R.:	3,	nucl:	2,	mito:	2,	plas:	1,	vacu:	1,	pero:	1No S No ER
GNPAT pero:	4,	E.R.:	3,	nucl:	2,	plas:	2,	chlo:	1,	cyto:	1,	vacu:	1No _ No none
GNPAT chlo:	6,	E.R.:	3,	plas:	2,	pero:	2,	vacu:	1Perhaps	yes S No none
GOT cyto:	10,	nucl:	1,	mito:	1,	cysk:	1,	golg:	1No _ Yes none
GOT cyto:	11,	mito:	1,	cysk:	1,	golg:	1No _ No none
GOT cysk:	8,	cyto:	4,	nucl:	2 No _ No none
GOT cyto:	8,	cysk:	3.5,	cysk_plas:	2.5,	nucl:	1,	golg:	1No _ No none
GOT cyto:	10,	cysk:	3,	mito:	1 No _ No none
GOT chlo_mito:	7.33333,	mito:	7,	chlo:	6.5,	cyto_mito:	4.33333N M No possibly	mitochondrial
GPD pero:	8,	cyto:	3.5,	cyto_nucl:	3.5,	nucl:	2.5Yes _ No none
GPD pero:	8,	cyto:	3.5,	cyto_nucl:	3.5,	nucl:	2.5Yes _ No none
GPD cyto:	4.5,	nucl:	3,	cyto_E.R.:	3,	chlo:	2,	extr:	1,	vacu:	1,	cysk:	1,	golg:	1No _ No none
GPD nucl:	5,	chlo:	3,	cyto:	3,	pero:	1,	cysk:	1,	golg:	1No _ No possibly	plastid
GPD cyto:	6,	chlo:	4,	nucl:	2,	golg:	2No _ No possibly	plastid
GPD cyto:	7,	chlo:	5,	vacu:	1,	cysk:	1No _ No none
GSTK1 chlo:	6,	cyto:	3.5,	cyto_nucl:	3,	pero:	2,	nucl:	1.5,	golg:	1No _ Yes none
GSTK1 pero:	4,	cyto:	3.5,	cyto_nucl:	3.5,	chlo:	3,	nucl:	2.5,	golg:	1No _ N none
GSTK1 pero:	10,	nucl:	2,	chlo:	1,	cyto:	1Yes _ No none
GSTK1 chlo:	4,	pero:	4,	cyto_nucl:	3,	nucl:	2.5,	cyto:	2.5,	golg:	1Perhaps	yes _ No none
GSTK1 pero:	4,	cyto:	3.5,	cyto_nucl:	3.5,	chlo:	3,	nucl:	2.5,	golg:	1No _ N none
GSTK1 chlo:	6,	cyto:	3.5,	cyto_nucl:	3,	pero:	2,	nucl:	1.5,	golg:	1No _ No none
GSTK1 pero:	10,	nucl:	2,	chlo:	1,	cyto:	1No _ No none
GTO nucl:	4,	cyto:	4,	mito:	4,	chlo:	2No _ No possibly	mitochondrial
GTO cyto:	13,	nucl:	1 No M No possibly	plastid
GTO mito:	6,	chlo:	3,	cyto:	3,	nucl:	1,	plas:	1No M No plastid
HAO cysk:	12,	chlo:	1,	cyto:	1 No _ No none
HAO cysk:	12,	chlo:	1,	cyto:	1 No _ No none
HAO cysk:	12,	chlo:	1,	cyto:	1 No _ No none
HAO cyto:	6,	cysk:	3,	chlo:	2,	nucl:	2,	plas:	1No _ No none
HAO cysk:	9,	nucl:	4,	chlo:	1 No _ No none
HAO cyto:	8,	cysk:	2.5,	cysk_plas:	2,	chlo:	1,	nucl:	1,	golg:	1No _ No none
HAO cysk:	13,	cyto:	1 No _ Yes none
HAO cyto:	8,	mito:	3,	chlo:	2,	pero:	1No _ Yes none
HAO cyto:	8,	mito:	3,	chlo:	2,	pero:	1No _ No none
HAO cyto:	12,	nucl:	2 No _ No none
HEX1 cyto:	9,	E.R.:	3,	golg:	2 No _ No none
HEX1 cyto:	9,	nucl:	2,	cysk:	2,	golg:	1No _ No none
HEX1 cyto:	6,	cysk:	4,	extr:	2,	chlo:	1,	golg:	1No _ No none
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HEX1 cyto:	6,	cysk:	4,	extr:	2,	chlo:	1,	golg:	1No _ No none
HEX1 cyto:	10,	extr:	2,	cysk:	1,	golg:	1No _ No none
HEX1 nucl:	4,	cyto:	4,	extr:	2,	cysk:	2,	plas:	1,	golg:	1No _ No none
HEX1 nucl:	4,	cyto:	4,	extr:	2,	cysk:	2,	plas:	1,	golg:	1No _ No none
HEX1 cyto:	8,	E.R.:	3,	golg:	2,	mito:	1No _ No none
HEX1 cyto:	8,	golg:	3,	E.R.:	2,	chlo:	1No _ No none
HEX1 cyto:	8,	E.R.:	3,	golg:	2,	mito:	1No _ No none
HEX1 cyto:	8,	golg:	3,	E.R.:	2,	chlo:	1Yes _ No none
HEX1 cyto:	9,	E.R.:	3,	golg:	2 No _ No none
HK cyto:	7,	chlo:	3,	nucl:	3,	golg:	1Perhaps	yes _ No none
HK cyto:	4,	chlo:	3,	nucl:	2,	extr:	2,	plas:	1,	cysk:	1,	golg:	1No _ No none
HK cyto:	8,	nucl:	2,	extr:	2,	cysk:	1,	golg:	1No _ No none
HK cyto:	8,	chlo:	2,	cysk_plas:	2,	plas:	1.5,	cysk:	1.5,	nucl:	1No _ No none
HK chlo:	5.5,	nucl:	5,	chlo_mito:	4,	mito:	1.5,	extr:	1,	vacu:	1Perhaps	yes _ No none
HK cyto:	8,	nucl:	2,	extr:	2,	cysk:	1,	golg:	1Perhaps	yes _ No none
HK cyto:	7,	chlo:	3,	nucl:	3,	golg:	1Perhaps	yes _ No none
HMGCL cyto:	9,	cysk:	3,	nucl:	1,	golg:	1No _ No none
HMGCL cyto:	9,	cysk:	3,	nucl:	1,	golg:	1No _ No none
HMGCL cyto:	5,	extr:	5,	chlo:	2,	nucl:	1,	golg:	1No _ No none
HMGCL mito:	7,	chlo:	6,	nucl:	1 No M No possibly	mitochondrial
HMGCL cyto:	9,	cysk:	3,	nucl:	1,	golg:	1No _ No none
HMGCL cyto:	10,	nucl:	2,	vacu:	1,	cysk:	1No _ No none
HMGCL cyto:	10,	nucl:	2,	vacu:	1,	cysk:	1No _ No none
HMGCL cyto:	10,	nucl:	2,	vacu:	1,	cysk:	1No _ No none
HMGCL cyto:	10,	nucl:	2,	vacu:	1,	cysk:	1No _ No none
HPR cyto:	10,	nucl:	1,	extr:	1,	vacu:	1,	cysk:	1No _ No none
HSD17B4 extr:	8,	mito:	2,	E.R.:	1.5,	E.R._plas:	1.5,	chlo:	1,	vacu:	1No S No ER
HSD17B4 chlo:	7,	extr:	3,	cyto:	2,	nucl:	1,	vacu:	1No _ No possibly	plastid
HSD17B4 pero:	10,	chlo:	2,	nucl:	1.5,	cyto_nucl:	1.5Yes _ No possibly	plastid
HSD17B4 pero:	10,	chlo:	2,	nucl:	1.5,	cyto_nucl:	1.5Perhaps	yes _ No possibly	plastid
HSD17B4 extr:	5,	chlo:	4,	cyto:	4,	nucl:	1No _ No possibly	plastid
HSD17B4 pero:	9,	nucl:	2.5,	cyto_nucl:	2.5,	cyto:	1.5,	golg:	1Yes _ No mitochondrial
HSD17B4 pero:	8,	nucl:	3.5,	cyto_nucl:	3.5,	cyto:	2.5No _ No none
HSD17B4 pero:	8,	nucl:	3.5,	cyto_nucl:	3.5,	cyto:	2.5No _ No none
HSD17B4 pero:	10,	cyto:	2,	nucl:	1,	golg:	1Perhaps	yes _ No none
HSD17B4 pero:	12,	cyto:	2 Perhaps	yes _ No none
HSD17B4 pero:	12,	cyto:	2 Perhaps	yes _ No none
HSD17B4 pero:	12,	cyto:	2 No _ No none
HSD17B4 pero:	12,	cyto:	2 Yes _ No none
HSD17B4 pero:	13,	cyto:	1 Yes _ No none
HSD17B4 pero:	13,	cyto:	1 Yes _ No none
HSD17B4 pero:	10,	cyto:	3,	nucl:	1 No _ No none
HSD17B4 pero:	9,	cyto:	3,	nucl:	2 Yes _ No none
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IDI cyto:	7,	mito:	2,	chlo:	1,	nucl:	1,	plas:	1,	E.R.:	1,	cysk:	1No _ No none
katE nucl:	5,	mito:	5,	cyto:	1,	plas:	1,	extr:	1,	cysk:	1No _ No none
katE nucl:	5,	mito:	5,	cyto:	1,	plas:	1,	extr:	1,	cysk:	1No _ No none
katE pero:	12,	cyto:	2 Yes _ No none
katE nucl:	9,	mito:	4,	extr:	1 No _ No none
katE nucl:	5,	mito:	5,	cyto:	1,	plas:	1,	extr:	1,	cysk:	1No _ No none
katE nucl:	11,	mito:	2,	plas:	1 No _ No none
katE pero:	12,	cyto:	2 Yes _ No none
katE nucl:	11,	mito:	2,	plas:	1 No _ No none
katE nucl:	11,	mito:	3 No _ No none
katE nucl:	5,	mito:	5,	cyto:	1,	plas:	1,	extr:	1,	cysk:	1No _ No none
katE nucl:	5,	mito:	5,	cyto:	1,	plas:	1,	extr:	1,	cysk:	1No _ No none
katE nucl:	5,	mito:	5,	cyto:	1,	plas:	1,	extr:	1,	cysk:	1No _ No none
katE nucl:	5,	cyto:	2,	plas:	2,	pero:	2,	chlo:	1,	extr:	1,	cysk:	1No _ No none
katE cyto:	7,	nucl:	2,	pero:	2,	mito:	1,	plas:	1,	extr:	1No _ No none
LYS4 cyto:	7,	chlo:	3,	nucl:	2,	vacu:	1,	golg:	1No S No none
LYS4 nucl:	8,	cyto:	5,	extr:	1 No _ No none
LYS4 cyto:	8,	chlo:	3,	nucl:	2,	cysk:	1No _ No none
LYS4 cyto:	11,	nucl:	2,	cysk:	1 No _ No none
LYS4 nucl:	7,	cyto:	4,	chlo:	2,	mito:	1No _ No mitochondrial
LYS4 nucl:	5,	chlo:	4,	cyto:	4,	vacu:	1No _ No none
LYS4 cyto:	7,	chlo:	3,	nucl:	2,	vacu:	1,	golg:	1No S No none
LYS4 chlo:	8,	cyto:	5,	cysk:	1 No _ No possibly	plastid
LYS4 mito:	7.5,	chlo:	6,	cyto_mito:	4.5No M No mitochondrial
LYS4 cyto:	5,	mito:	4,	chlo:	2,	nucl:	2,	golg:	1No _ No mitochondrial
LYS4 cyto:	5,	mito:	4,	chlo:	2,	nucl:	2,	golg:	1No _ No mitochondrial
LYS4 cyto:	8,	chlo:	5,	mito:	1 No _ No possibly	mitochondrial
LYS4 nucl:	4,	cyto:	4,	chlo:	3,	mito:	3No _ No mitochondrial
LYS4 chlo:	10.5,	chlo_mito:	7.5,	mito:	3.5No M No mitochondrial
MDAR mito:	8,	chlo:	6 Yes M No mitochondrial
MDAR cysk:	8,	nucl:	4,	chlo:	1,	cyto:	1No _ No none
MDAR mito:	8,	chlo:	6 No M No mitochondrial
MDAR cysk:	8,	nucl:	4,	chlo:	1,	cyto:	1No _ No none
MYA2 cyto:	11,	nucl:	2,	vacu:	1 No _ No none
MYA2 cyto:	11,	nucl:	2,	vacu:	1 No _ No none
NUDT12 chlo:	7,	extr:	3,	cyto:	2,	nucl:	1,	vacu:	1No _ No none
OPDC-PRT extr:	9,	cyto:	2,	nucl:	1,	mito:	1,	E.R.:	1No _ No none
OPDC-PRT extr:	9,	cyto:	2,	nucl:	1,	mito:	1,	E.R.:	1No _ No none
PAOX cyto:	8,	nucl:	3,	chlo:	1,	plas:	1,	cysk:	1No M No possibly	mitochondrial
PAOX nucl:	5,	chlo:	4,	cyto:	3,	mito:	1,	cysk:	1Yes _ No none
PAOX nucl:	9,	chlo:	2,	cysk:	2,	cyto:	1No _ No none
PDCR pero:	10,	chlo:	2,	cyto:	1.5,	cyto_nucl:	1.5Perhaps	yes _ No none
PDCR pero:	11,	cyto:	2,	nucl:	1 Yes _ No none
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HSD17B4 pero:	6,	E.R.:	3,	plas:	2,	chlo:	1,	cyto:	1,	vacu:	1Yes _ No none
HSD17B4 pero:	12,	nucl:	1,	cyto:	1 No _ No none
HSD17B4 pero:	8,	nucl:	3.5,	cyto_nucl:	3.5,	cyto:	2.5No _ No none
HSD17B4 pero:	12,	nucl:	1,	cyto:	1 No _ No none
HSD17B4 pero:	12,	cyto:	2 Yes _ No none
HSD17B4 pero:	12,	cyto:	2 Perhaps	yes _ No none
HXGPRT cyto:	7,	nucl:	3,	cysk:	2,	chlo:	1,	mito:	1No _ No none
HXGPRT cyto:	7,	nucl:	3,	cysk:	2,	chlo:	1,	mito:	1No _ No none
HXGPRT cyto:	7,	nucl:	3,	cysk:	2,	chlo:	1,	mito:	1No _ No none
HXGPRT cyto:	7,	nucl:	3,	cysk:	2,	chlo:	1,	mito:	1No _ No none
HXGPRT cyto:	7,	nucl:	3,	cysk:	2,	chlo:	1,	mito:	1No _ No none
HXGPRT cyto:	11,	nucl:	1,	extr:	1,	pero:	1Perhaps	yes _ No none
HXGPRT cyto:	11,	nucl:	1,	extr:	1,	pero:	1No _ No none
HXGPRT cyto:	11,	nucl:	1,	extr:	1,	pero:	1No _ Yes none
HXGPRT cyto:	11,	nucl:	1,	extr:	1,	pero:	1No _ No none
HXGPRT cyto:	11,	nucl:	1,	extr:	1,	pero:	1Perhaps	yes _ No none
HXGPRT cyto:	11,	nucl:	1,	extr:	1,	pero:	1No _ No none
HXGPRT cyto:	11,	nucl:	1,	extr:	1,	pero:	1No _ No none
HXGPRT cyto:	11,	nucl:	1,	extr:	1,	pero:	1No _ No none
HXGPRT cyto:	11,	nucl:	1,	extr:	1,	pero:	1No _ No none
HXGPRT cyto:	11,	nucl:	1,	extr:	1,	pero:	1No _ No none
HXGPRT cyto:	11,	nucl:	1,	extr:	1,	pero:	1No _ No none
HXGPRT cyto:	11,	nucl:	1,	extr:	1,	pero:	1No _ No none
HXGPRT cyto:	11,	nucl:	1,	extr:	1,	pero:	1No _ No none
I5PDH cysk:	11,	cyto:	3 No _ No none
I5PDH cysk:	11,	cyto:	3 No _ No none
IDH cysk:	11,	cyto:	3 No _ No none
IDH chlo_mito:	6,	chlo:	5.5,	mito:	5.5,	cyto:	2,	plas:	1No _ No none
IDH chlo_mito:	6,	chlo:	5.5,	mito:	5.5,	cyto:	2,	plas:	1No _ Yes none
IDH cysk:	14 No _ No none
IDH cysk:	14 No _ No none
IDH pero:	13,	cyto:	1 Yes _ No none
IDH pero:	13,	cyto:	1 Yes _ No none
IDH cysk:	11,	cyto:	3 No _ No none
IDH1 nucl:	6,	cyto:	3,	chlo:	2,	cysk:	2,	mito:	1No _ No none
IDH1 extr:	11,	cysk_plas:	1.33333,	mito_plas:	1.33333,	E.R.:	1No S No possibly	ER
IDH1 extr:	10,	cysk_plas:	1.33333,	mito_plas:	1.33333,	vacu:	1,	E.R.:	1No S No possibly	ER
IDH1 pero:	12,	cyto:	2 Yes _ No none
IDH1 cysk:	9,	chlo:	2,	cyto:	2,	nucl:	1No _ No none
IDH1 cyto:	7.5,	cyto_E.R.:	4.5,	chlo:	3,	cysk:	2,	vacu:	1No _ No none
IDH1 cyto:	5.5,	chlo:	5,	cyto_E.R.:	3.5,	mito:	1,	extr:	1,	cysk:	1No _ No none
IDI chlo:	5,	cyto:	3,	mito:	3,	nucl:	2,	extr:	1No _ No possibly	mitochondrial
IDI chlo:	5,	mito:	5,	cyto:	2,	nucl:	1,	extr:	1No _ No mitochondrial
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PDCR pero:	11,	cyto:	2,	nucl:	1 Yes _ No none
PECR extr:	4,	mito:	3,	cyto:	2.5,	chlo:	2,	cyto_nucl:	2,	vacu:	1,	E.R.:	1No S No ER
PECR extr:	4,	mito:	3,	cyto:	2.5,	chlo:	2,	cyto_nucl:	2,	vacu:	1,	E.R.:	1No S No ER
PEPCK chlo:	3,	mito:	2,	plas:	2,	E.R.:	2,	nucl:	1.5,	cysk_nucl:	1.5,	cyto:	1,	extr:	1,	vacu:	1No _ No none
PEPCK chlo:	3,	mito:	2,	plas:	2,	E.R.:	2,	nucl:	1.5,	cysk_nucl:	1.5,	cyto:	1,	extr:	1,	vacu:	1No _ No none
PEPCK chlo:	6,	extr:	3,	vacu:	3,	nucl:	1,	cyto:	1No _ No none
PEPCK chlo:	3,	extr:	3,	cyto:	2,	E.R.:	2,	nucl:	1.5,	cysk_nucl:	1.5,	mito:	1,	vacu:	1No _ No none
PEPCK chlo:	6,	extr:	3,	vacu:	3,	nucl:	1,	cyto:	1No _ No none
PEPCK chlo:	3,	extr:	3,	cyto:	2,	E.R.:	2,	nucl:	1.5,	cysk_nucl:	1.5,	mito:	1,	vacu:	1No _ No none
PNC1 chlo:	10,	cyto:	2,	nucl:	1,	plas:	1No _ No none
PNC1 chlo:	6,	cyto:	3,	extr:	3,	nucl:	1,	plas:	1No _ No none
PNC1 chlo:	6,	cyto:	3,	extr:	3,	nucl:	1,	plas:	1No _ No none
PNC1 cyto:	10,	cysk:	3,	golg:	1 No _ No none
PRDX1 chlo:	4,	nucl:	3,	extr:	3,	cyto:	2,	cysk:	1,	golg:	1No _ No none
PRDX1 cyto:	9,	cysk:	2,	chlo:	1,	nucl:	1,	pero:	1No _ No none
PRDX1 chlo:	4,	nucl:	3,	extr:	3,	cyto:	2,	cysk:	1,	golg:	1No _ No none
PRDX1 nucl:	7,	cyto:	6,	plas:	1 No _ No none
PRDX1 cyto:	6,	nucl:	3,	extr:	3,	chlo:	1,	cysk:	1No _ No none
PRDX1 cyto:	6,	nucl:	3,	extr:	3,	chlo:	1,	cysk:	1No _ No none
PXMP2 plas:	6,	chlo:	5,	mito:	2,	pero:	1No M No possibly	mitochondrial
SHBP cyto:	7,	E.R.:	3,	extr:	2,	chlo:	1,	mito:	1No _ No none
SHBP cyto:	7,	E.R.:	3,	extr:	2,	chlo:	1,	mito:	1No _ No none
SLC25A17 plas:	9,	golg:	2,	cyto:	1,	vacu:	1,	E.R.:	1No _ No none
SLC25A17 plas:	9,	golg:	2,	cyto:	1,	vacu:	1,	E.R.:	1No _ No none
SOD2 mito:	5.5,	nucl:	4.5,	cyto_mito:	3.5,	cyto_nucl:	3,	chlo:	2,	plas:	1No M No mitochondrial
SOD2 mito:	6,	nucl:	5.5,	cyto_nucl:	5,	chlo:	1No M No mitochondrial
SOD2 cyto:	7,	chlo:	2,	nucl:	2,	mito:	1,	plas:	1,	pero:	1No S No possibly	mitochondrial
SOD2 cyto:	7,	chlo:	2,	nucl:	2,	mito:	1,	plas:	1,	pero:	1No S Yes possibly	mitochondrial
SOD2 chlo:	4,	vacu:	3,	mito:	2,	extr:	2,	nucl:	1,	plas:	1,	E.R.:	1No M No possibly	mitochondrial
SOD2 mito:	12,	chlo:	2 No M No mitochondrial
SOD2 chlo:	4,	vacu:	3,	mito:	2,	extr:	2,	nucl:	1,	plas:	1,	E.R.:	1No M No possibly	mitochondrial
SOD2 chlo:	4,	vacu:	3,	mito:	2,	extr:	2,	nucl:	1,	plas:	1,	E.R.:	1No M No possibly	mitochondrial
SOD2 chlo:	4,	vacu:	3,	mito:	2,	extr:	2,	nucl:	1,	plas:	1,	E.R.:	1No M No possibly	mitochondrial
SOD2 mito:	6,	cyto:	4,	pero:	2,	nucl:	1.5,	cysk_nucl:	1.5No _ No none
TPI chlo:	9,	nucl:	2,	extr:	2,	cyto:	1No _ No none
TPI chlo:	6,	cyto:	4,	nucl:	2,	extr:	1,	E.R.:	1No S Yes none
TPI cyto:	4,	nucl:	3.5,	mito:	3,	cysk_nucl:	2.5,	pero:	2,	extr:	1No _ No none
TPI cyto:	10,	chlo:	2,	mito:	2 No _ No none
TPI cyto:	10,	chlo:	2,	mito:	2 No _ No none
TPI cyto:	10,	chlo:	2,	mito:	2 No _ No none
TPI cyto:	8,	nucl:	4,	chlo:	1,	extr:	1No _ No none
TPN nucl:	6.5,	cyto_nucl:	5.5,	cyto:	3.5,	chlo:	2,	mito:	1,	extr:	1No _ No none
TPN chlo:	10,	mito:	2,	nucl:	1,	extr:	1No S No ER
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TPN chlo:	10,	mito:	2,	nucl:	1,	extr:	1No S No ER
TPN chlo:	12,	mito:	1,	E.R._vacu:	1 No _ No possibly	plastid
TPN E.R.:	14 No _ Yes possibly	plastid
TPN nucl:	8,	mito:	3,	chlo:	1,	cyto:	1,	golg_plas:	1No M No possibly	mitochondrial
TPN nucl:	8,	mito:	3,	chlo:	1,	cyto:	1,	golg_plas:	1No M No possibly	mitochondrial
TR chlo:	8,	mito:	6 No M No possibly	mitochondrial
TR cyto:	6.5,	cyto_nucl:	4,	chlo:	3,	E.R.:	2,	mito:	1,	pero:	1Yes _ No none
TR cyto:	6.5,	cyto_nucl:	4,	chlo:	3,	E.R.:	2,	mito:	1,	pero:	1Yes _ No none
TR cyto:	6.5,	cyto_nucl:	4,	chlo:	3,	E.R.:	2,	mito:	1,	pero:	1Yes _ No none
TR cyto:	6.5,	cyto_nucl:	4,	chlo:	3,	E.R.:	2,	mito:	1,	pero:	1Yes _ No none
TR cyto:	6.5,	cyto_nucl:	4,	chlo:	3,	E.R.:	2,	mito:	1,	pero:	1Yes _ No none
TR chlo:	4,	cyto:	3,	extr:	3,	nucl:	1,	E.R.:	1,	pero:	1,	cysk:	1No _ No none
TR chlo:	6,	extr:	3,	cyto:	2,	nucl:	1,	mito:	1,	E.R.:	1No _ No none
TR chlo:	6,	extr:	3,	cyto:	2,	nucl:	1,	mito:	1,	E.R.:	1No _ No none
TR E.R.:	5,	cyto:	3,	mito:	2,	chlo:	1,	plas:	1,	vacu:	1,	pero:	1Yes _ No none
TR chlo:	12,	mito:	2 No M No possibly	mitochondrial
TR chlo:	8,	mito:	6 No M No possibly	mitochondrial
uaZ cyto:	11,	cysk:	2,	chlo:	1 No _ No none
UGP cyto:	7,	nucl:	5,	vacu:	1,	golg:	1No _ No none
UGP cyto:	7,	nucl:	5,	vacu:	1,	golg:	1No _ No none
UGP cyto:	10,	nucl:	2,	chlo:	1,	pero:	1No _ No none
UGP cyto:	6,	nucl:	4,	chlo:	1,	vacu:	1,	pero:	1,	golg:	1No _ No none
UGP chlo:	7,	cyto:	3,	nucl:	2,	mito:	1,	cysk:	1No _ No none
UGP chlo:	5,	nucl:	4,	cyto:	3,	mito:	1,	cysk:	1No _ No none
UGP chlo:	7,	cyto:	3,	nucl:	2,	mito:	1,	cysk:	1No _ No none
UGP chlo:	5,	nucl:	4,	cyto:	3,	mito:	1,	cysk:	1No _ No none
UOX cyto:	10,	nucl:	3,	pero:	1 No _ No none
UOX cyto:	10,	nucl:	3,	pero:	1 No _ No none
VPS1 cyto:	9,	nucl:	4,	chlo:	1 No _ No none
XDH nucl:	9,	cyto:	2,	chlo:	1,	plas:	1,	cysk:	1No _ No none
XDH nucl:	9,	cyto:	2,	chlo:	1,	plas:	1,	cysk:	1No _ No none
ZADH2 chlo:	4,	nucl:	4,	cyto:	4,	extr:	1,	golg_plas:	1No _ No none
ZADH2 cyto:	5,	nucl:	4,	cysk:	4,	golg:	1No _ No none
ZADH2 cyto:	7,	chlo:	2,	nucl:	2,	mito:	2,	vacu:	1No _ No none
ZADH2 cyto:	9,	nucl:	2,	mito:	2,	E.R.:	1No _ No none
ZADH2 extr:	10,	chlo:	3,	mito:	1 No _ No none
ZADH2 extr:	9,	chlo:	4,	mito:	1 No _ No none
ZADH2 mito:	4.5,	chlo_mito:	4.5,	nucl:	4,	chlo:	3.5,	cyto:	2No _ No none
ZADH2 mito:	4.5,	chlo_mito:	4.5,	nucl:	4,	chlo:	3.5,	cyto:	2No _ No none
ZADH2 chlo:	6,	extr:	6,	cyto:	1,	vacu:	1Yes _ No none
ZADH2 chlo:	10,	mito:	2,	extr:	2 No M No none
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Gene PSORTII Ppero	pts1 TargetP topcons predotar
PEX4 chlo:	6,	nucl:	5,	cyto:	2,	extr:	1	No _ No none
PEX5 mito:	5,	chlo:	4,	nucl:	2,	cyto:	2,	cysk:	1	No _ No none
PEX5 cyto:	7,	nucl:	4,	plas:	3	 No _ No none
PEX5 mito:	5,	chlo:	3,	cyto:	3,	nucl:	2,	cysk:	1	No _ No none
PEX6 cyto:	7,	nucl:	3,	chlo:	2,	cysk:	2	Perhaps	yes _ No none
PEX7 chlo:	7,	nucl:	3,	mito:	3,	cysk:	1	No _ No ER
PEX7 chlo:	7,	nucl:	3,	mito:	3,	cysk:	1	No _ No none
PEX7 chlo:	7,	nucl:	3,	mito:	3,	cysk:	1	No _ No none
PEX7 chlo:	7,	nucl:	3,	mito:	3,	cysk:	1	No _ No none
PEX7 chlo:	7,	nucl:	3,	mito:	3,	cysk:	1	No _ No none
PEX7 chlo:	7,	nucl:	3,	mito:	3,	cysk:	1	No _ No none
PEX7 chlo:	7,	nucl:	3,	mito:	3,	cysk:	1	No _ Yes none
PEX7 chlo:	7,	nucl:	3,	mito:	3,	cysk:	1	No _ No none
PEX10 cyto:	6,	nucl:	4,	chlo:	1,	mito:	1,	extr:	1,	cysk:	1	No _ No none
PEX10 cyto:	6,	nucl:	4,	chlo:	1,	mito:	1,	extr:	1,	cysk:	1	No _ No none
PEX10 cyto:	6,	nucl:	4,	chlo:	1,	mito:	1,	extr:	1,	cysk:	1	No _ Yes none
PEX10 mito:	7,	chlo:	5,	nucl:	2	 No _ Yes none
PEX14 cyto:	6,	chlo:	3,	nucl:	2,	plas:	2,	extr:	1	No _ No none
PEX14 chlo:	7,	cyto:	2,	nucl:	1,	plas:	1,	extr:	1,	vacu:	1,	E.R.:	1	No _ No none
MPV17 mito:	4,	E.R.:	4,	chlo:	3,	plas:	3No M No possibly	mitochondrial
ABCD vacu:	10,	golg:	2,	plas:	1,	extr:	1	No _ No possibly	plastid
ACAA1 nucl:	3,	mito:	3,	E.R.:	2.5,	E.R._plas:	2.5,	cyto:	2,	plas:	1.5,	vacu:	1,	pero:	1	No _ No none
ACAA1 chlo:	13.5,	chlo_mito:	7.5	 No M No none
ACAA1 cyto:	8,	chlo:	3,	nucl:	1,	vacu:	1,	golg:	1No _ Yes none
ACAA1 nucl:	4.5,	cyto_nucl:	3.5,	chlo:	3,	mito:	2,	golg:	2,	cyto:	1.5,	plas:	1No C No none
ACAA1 chlo:	12,	nucl:	1,	plas:	1 No _ No none
ACAA1 chlo:	12,	nucl:	1,	plas:	1 No _ No none
ACAA1 nucl:	4.5,	cyto_nucl:	4,	cyto:	2.5,	chlo:	2,	mito:	2,	golg:	2,	plas:	1No C No none
ACOX chlo:	9,	cyto:	2,	plas:	2,	mito:	1	No _ Yes none
ACOX pero:	4,	E.R.:	3,	plas:	2,	cyto_nucl:	2,	nucl:	1.5,	cyto:	1.5,	chlo:	1,	vacu:	1	Perhaps	yes _ No none
AGPS cyto:	7,	cysk:	3,	mito:	2,	pero:	1,	golg:	1No _ No none
AGPS cysk:	8,	nucl:	3,	cyto:	3 No _ No none
AGPS cyto:	7,	cysk:	4,	nucl:	3 No _ No none
AGPS cyto:	7,	cysk:	3,	mito:	2,	pero:	1,	golg:	1No _ No none
AGXT cyto:	6,	chlo:	4,	mito:	3,	vacu:	1	No _ No none
ANT chlo:	3,	nucl:	3,	mito:	3,	cyto:	2,	plas:	1,	vacu:	1,	golg:	1	No _ No none
ANT chlo:	3,	nucl:	3,	mito:	3,	cyto:	2,	plas:	1,	vacu:	1,	golg:	1	No _ No none
CAT pero:	13,	cyto:	1	 Yes _ No none
CPK cyto:	5,	nucl:	4,	plas:	2,	E.R.:	2,	mito:	1	No S No none
Appendix	Table	2)	Cardiosporidium	peroxisomal-related	genes	Identified	PeroxDB	and	KAAS.	
Complete	transcripts	were	run	through	Wolf	PSORTII,	Ppero,	TargetP,	Topcons	and	Predotar	to	
identify	possible	signal	motifs	inclding	PTS1	
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CPK cyto:	5,	nucl:	4,	plas:	2,	E.R.:	2,	mito:	1	No S No none
CPK cyto:	5,	nucl:	4,	plas:	2,	E.R.:	2,	mito:	1	No S No none
CPK cyto:	5,	nucl:	4,	plas:	2,	E.R.:	2,	mito:	1	No S No none
CPK chlo:	4,	nucl:	3,	cyto:	2,	extr:	2,	mito:	1,	plas:	1,	vacu:	1	No _ No ER
DJP1 nucl:	11,	chlo:	1,	plas:	1,	extr:	1	No _ No none
DJP1 nucl:	6,	cyto:	3,	mito:	3,	chlo:	2	No _ No none
DJP1 mito:	5,	nucl:	3.5,	cyto:	3,	cysk_nucl:	2.5,	chlo:	2	No _ No none
DJP1 cyto:	6,	nucl:	3,	mito:	2,	chlo:	1,	plas:	1,	extr:	1	No _ No none
DJP1 cyto:	5.5,	golg:	4,	cyto_nucl:	3.5,	chlo:	1,	mito:	1,	vacu:	1,	E.R.:	1	No _ No none
E1.3.3.6 chlo:	8,	mito:	3,	cyto:	2,	plas:	1No M No none
ECH mito:	5,	chlo:	2,	nucl:	2,	cyto:	2,	plas:	1,	pero:	1,	cysk:	1	No _ No none
ECH cyto:	7,	chlo:	2,	nucl:	2,	pero:	2,	plas:	1	Yes _ No none
ECH nucl:	6,	mito:	5,	chlo:	2,	cyto:	1	No _ No none
ECH nucl:	6,	mito:	5,	chlo:	2,	cyto:	1	No _ No none
EHHADH chlo:	12,	cyto:	1,	mito:	1	 No M No none
FBPA chlo:	5,	cyto:	4,	extr:	3,	nucl:	1,	mito:	1	No _ Yes none
FBPA cyto:	10,	chlo:	2,	nucl:	1,	golg:	1	No _ No none
FR cyto:	8,	nucl:	3,	extr:	1,	E.R.:	1,	cysk:	1	No _ No none
FR cyto:	8,	nucl:	3,	extr:	1,	E.R.:	1,	cysk:	1	No _ No none
FR chlo:	4,	nucl:	4,	mito:	4,	cyto:	2	No _ No none
FR chlo:	4,	nucl:	4,	mito:	4,	cyto:	2	No _ No none
FR chlo:	4,	nucl:	4,	mito:	4,	cyto:	2	No _ No none
FR chlo:	4,	nucl:	4,	mito:	4,	cyto:	2	No _ No none
FR chlo:	13,	cyto:	1	 No S No none
G6PI cyto:	5,	chlo:	4,	nucl:	3,	mito:	1,	cysk:	1	No M No mitochondrial
G6PI cyto:	5,	chlo:	4,	nucl:	4,	cysk:	1	No M No none
GAPDH cyto:	13,	mito:	1	 No M No none
GAPDH cysk:	8,	cyto:	5,	chlo:	1	 No _ No none
GK cysk:	11,	chlo:	2,	cyto:	1	 Yes _ No none
GK cysk:	11,	chlo:	2,	cyto:	1	Perhaps	yes _ No none
GOT chlo:	10,	mito:	4	 No M No none
GOT pero:	11,	cyto:	2,	nucl:	1	 Yes _ No none
GOT pero:	11,	cyto:	2,	nucl:	1	Perhaps	yes _ No none
GPD plas:	8,	golg:	3,	E.R.:	2,	vacu:	1	No S No none
GPD plas:	8,	golg:	3,	E.R.:	2,	vacu:	1	No S No ER
GSTK1 pero:	4,	cyto_nucl:	4,	nucl:	3.5,	cyto:	3.5,	chlo:	2,	golg:	1	Yes _ No ER
GSTK1 pero:	5,	cyto:	4.5,	cyto_nucl:	4,	nucl:	2.5,	chlo:	1,	golg:	1	Yes _ No none
HAO pero:	12,	cyto:	2	 Yes _ No none
HEX1 cyto:	11,	extr:	1,	cysk:	1,	golg:	1	No _ No none
HEX1 cyto:	11,	extr:	1,	cysk:	1,	golg:	1	No _ No none
HK chlo:	4,	E.R.:	3,	cyto:	2.5,	cyto_nucl:	2.5,	nucl:	1.5,	mito:	1,	vacu:	1,	pero:	1	No _ No none
HK cyto:	5,	chlo:	3,	nucl:	2,	golg:	2,	extr:	1,	E.R.:	1	No _ No none
HK cyto:	5.5,	E.R.:	4,	cyto_nucl:	3.5,	chlo:	2,	mito:	2	No _ No none
 148 
HK cyto:	5,	golg:	3,	mito:	2,	E.R._plas:	2,	plas:	1.5,	E.R.:	1.5,	nucl:	1	No _ No none
HK nucl:	12,	cyto:	1,	mito:	1	 No _ Yes none
HK cyto:	5,	golg:	3,	mito:	2,	E.R._plas:	2,	plas:	1.5,	E.R.:	1.5,	nucl:	1	No _ No none
HMGCL nucl:	6,	cyto:	5,	chlo:	2,	plas:	1	No _ No none
HMGCL nucl:	6,	cyto:	5,	chlo:	2,	plas:	1	No _ No none
HPR cyto:	13,	chlo:	1	 No _ No mitochondrial
HPR cyto:	13,	nucl:	1	 No _ No none
HSD17B4 chlo:	8,	cyto:	4,	nucl:	1,	plas:	1	No M No none
HSD17B4 cyto:	8,	chlo:	3,	pero:	2,	cysk_nucl:	1	No M No possibly	mitochondrial
HSD17B4 pero:	10,	cyto:	2.5,	cyto_nucl:	2.5,	nucl:	1.5	Yes _ No possibly	mitochondrial
HSD17B4 pero:	6,	cyto:	4.5,	cyto_nucl:	3.5,	nucl:	1.5,	chlo:	1,	golg:	1	Yes M No none
HSD17B4 pero:	9,	cyto:	2.5,	cyto_nucl:	2.5,	nucl:	1.5,	chlo:	1	Yes _ No possibly	mitochondrial
HSD17B4 chlo:	8,	nucl:	2,	pero:	2,	cyto:	1,	golg:	1	Yes M No none
HSD17B4 chlo:	8,	nucl:	2,	pero:	2,	cyto:	1,	golg:	1	Yes M No mitochondrial
HSD17B4 chlo:	8.5,	chlo_mito:	7,	mito:	4.5,	nucl:	1	No M No mitochondrial
HSD17B4 chlo:	8,	nucl:	2,	pero:	2,	cyto:	1,	golg:	1	Yes M No mitochondrial
HSD17B4 chlo:	8,	nucl:	2,	pero:	2,	cyto:	1,	golg:	1	Yes M No mitochondrial
HSD17B4 chlo:	8,	nucl:	2,	pero:	2,	cyto:	1,	golg:	1	Yes M No mitochondrial
HSD17B4 pero:	11,	cyto:	2,	nucl:	1	 Yes _ No mitochondrial
HSD17B4 chlo:	8,	nucl:	2,	pero:	2,	cyto:	1,	golg:	1	Yes M No none
HSD17B4 chlo:	8.5,	chlo_mito:	7,	mito:	4.5,	nucl:	1	No M No mitochondrial
HSD17B4 chlo:	8,	nucl:	2,	pero:	2,	cyto:	1,	golg:	1	Yes M No mitochondrial
HSD17B4 chlo:	8,	nucl:	2,	pero:	2,	cyto:	1,	golg:	1	Yes M No mitochondrial
HSD17B4 chlo:	8,	nucl:	2,	pero:	2,	cyto:	1,	golg:	1	Yes M No mitochondrial
HSD17B4 chlo:	14	 No S Yes none
I5PDH nucl:	5,	cyto:	4,	chlo:	2,	cysk:	2,	vacu:	1	No _ No none
IDH pero:	12,	cyto:	2	 Perhaps	yes _ No none
IDH1 mito:	7,	chlo:	6,	cyto_nucl:	1No M No possibly	mitochondrial
IDH1 chlo:	6,	cyto_nucl:	3,	nucl:	2.5,	cyto:	2.5,	pero:	2,	golg:	1No _ No none
IDI chlo:	9,	mito:	2,	nucl:	1,	plas:	1,	E.R.:	1	No M No none
katE pero:	13,	cyto:	1 Yes _ No none
katE pero:	9,	nucl:	2,	chlo:	1,	cyto:	1,	mito:	1No _ No none
katE pero:	8,	cyto:	3,	nucl:	1,	mito:	1,	extr:	1No _ Yes none
LYS4 cyto:	3,	nucl_plas:	3,	nucl:	2.5,	plas:	2.5,	chlo:	2,	mito:	2,	extr:	1,	pero:	1	No _ No none
LYS4 chlo:	10,	cyto:	4	 No _ No none
LYS4 cyto:	6,	cysk:	4,	chlo:	3,	nucl:	1	No _ No none
LYS4 mito:	7,	chlo:	4,	nucl:	2,	cyto:	1	No M No none
LYS4 mito:	7.5,	cyto_mito:	4.5,	chlo:	3,	nucl:	2,	cyto:	1	No M No none
MDAR cyto:	4,	chlo:	3,	mito:	3,	extr:	2,	plas:	1,	E.R.:	1	No S Yes ER
MYA2 nucl:	8,	cyto:	3,	chlo:	1,	plas:	1,	golg:	1	No _ No none
MYA2 cyto:	7,	nucl:	5,	chlo:	1,	golg:	1	No _ No none
MYA2 cyto:	6,	nucl:	5,	chlo:	1,	cysk:	1,	golg:	1	No _ No none
MYA2 cyto:	6,	nucl:	5,	chlo:	1,	cysk:	1,	golg:	1	No _ No none
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OPDC-PRT chlo:	8,	nucl:	3,	cyto:	2,	cysk:	1	No _ No ER
PDCR pero:	7,	cyto:	3.5,	cyto_nucl:	2.5,	chlo:	2,	golg:	1	Yes _ No possibly	plastid
PDCR pero:	7,	cyto:	3.5,	cyto_nucl:	2.5,	chlo:	2,	golg:	1	Yes _ No possibly	plastid
PDCR pero:	7,	cyto:	3.5,	cyto_nucl:	2.5,	chlo:	2,	golg:	1	Yes _ No possibly	plastid
PDCR pero:	7,	cyto:	3.5,	cyto_nucl:	2.5,	chlo:	2,	golg:	1	Yes _ No possibly	plastid
PEPCK cyto:	3,	E.R.:	3,	nucl:	2,	vacu:	2,	golg:	2,	mito:	1,	plas:	1	No _ Yes none
PNC1 cyto:	10,	nucl:	1,	extr:	1,	cysk:	1,	golg:	1	No _ No none
PRDX1 chlo:	9,	cyto:	2,	nucl:	1,	mito:	1,	extr:	1	No _ No none
PXMP2 mito:	7,	chlo:	5,	nucl:	1,	cysk:	1	No M Yes ER
SHBP cyto:	10,	plas:	1,	extr:	1,	cysk:	1,	golg:	1	No _ No none
SOD2 chlo:	9,	extr:	3,	nucl:	1,	cyto:	1No S No ER
SOD2 cyto:	9,	chlo:	2,	nucl:	2,	cysk:	1No S No ER
SOD2 chlo:	5,	mito:	4,	E.R.:	2,	nucl:	1,	extr:	1,	pero:	1No M No possibly	mitochondrial
SOD2 cyto:	8,	nucl:	2,	plas:	2,	cysk:	1,	golg:	1No _ No none
TPI chlo:	4,	extr:	4,	cyto:	2,	E.R.:	2,	nucl:	1,	mito:	1	No S No none
TPI chlo:	4,	extr:	4,	cyto:	2,	E.R.:	2,	nucl:	1,	mito:	1	No S No ER
TPN cyto:	5,	nucl:	4,	chlo:	2,	pero:	1,	cysk:	1,	golg:	1	No _ No none
TPN cyto:	7,	chlo:	2,	nucl:	2,	mito:	1,	extr:	1,	cysk_plas:	1	No _ No none
TR vacu:	4,	chlo:	3,	mito:	2,	golg:	2,	nucl:	1,	extr:	1,	E.R.:	1	No S No none
TR chlo:	5,	mito:	3,	vacu:	3,	golg:	2,	nucl:	1	No S No ER
TR cyto:	6,	E.R.:	5,	mito:	2,	pero:	1	No _ No ER
TR cyto:	6,	E.R.:	5,	mito:	2,	pero:	1	No _ No none
uaZ pero:	9,	cyto:	2.5,	cyto_nucl:	2.5,	nucl:	1.5,	golg:	1Yes _ No none
uaZ pero:	11,	cyto:	2,	golg:	1 Yes _ No none
uaZ pero:	9,	cyto:	2.5,	cyto_nucl:	2.5,	nucl:	1.5,	golg:	1Yes _ No none
ZADH2 chlo:	6,	nucl:	2.5,	cyto:	2,	pero:	2,	cysk_nucl:	2,	mito:	1	No _ Yes none
ZADH2 chlo:	6,	nucl:	2.5,	cyto:	2,	pero:	2,	cysk_nucl:	2,	mito:	1	No _ Yes none
ZADH2 chlo:	9,	extr:	2,	nucl:	1,	cyto:	1,	mito:	1	No M Yes possibly	plastid
ZADH2 chlo:	6,	cyto:	6,	nucl:	1,	cysk:	1	No _ Yes none
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Appendix Figures 1) Comparison of biological process GOSlim terms from lineage 
specific orthologous genes from both Nephromyces (blue) and Cardiosporidium (red), 
respectively. GOSlim terms are grouped by their major function, showing no clear 
pattern of gene losses by functional category between Cardiosporidium and 
Nephromyces. 
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 Appendix Figure 2) Comparison of molecular function GOSlim terms from lineage 
specific orthologous genes from both Nephromyces (blue) and Cardiosporidium (red), 
respectively. GOSlim terms are grouped by their major molecular function, showing 
no clear pattern of gene losses by functional category between Cardiosporidium and 
Nephromyces. 
 
